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Abstract 
Oxygen is an important molecule in life and is essential for a broad spectrum of 
physiological reactions that include, but are not restricted to, cell metabolism, respiration 
and growth. Under physiological conditions, oxygen levels vary from one tissue to another 
ranging from 0.002% to 10% and substantially lower than the atmospheric level of 21 % 
O2. Hypoxia is defined as a state of reduced O2 supplied to cells or tissues when 
compared to their normal physiological levels. Hypoxia mimetic agents (HMAs) are 
chemical used to induce pharmacological hypoxia without affecting environmental oxygen 
levels per se. The name HMA is routinely applied as these agents will activate the family 
of transcription factors which respond to reduced oxygen availability, Hypoxia Inducible 
Factors (HIF), which is taken as a surrogate indicator for hypoxia. These agents have 
been proposed as a cheaper alternative to engineered oxygen control measures including 
tri-gas incubators and workstation approaches. Multipotent stem cells (e.g. neuronal PC12 
and human mesenchymal stem cells (hMSCs)) due their ability to differentiate into various 
cell types provide a means to develop better understanding of tissue development, repair, 
and protection. In addition, they provide better therapeutic perspectives and opportunities 
for the treatment of many diseases. Physiological oxygen plays a key role in the 
maintenance of cellular proliferation, behaviour and biology both in vivo and when 
mimiced in vitro. Physiological oxygen and hypoxia are routinely confused creating 
additional complexity in defining the role of oxygen in cell behaviours. This work has 
therefore evaluated the role of a panel of well-established HMAs (CoCl2, DFO, DMOG) 
and new agent (IOX2) vs. different reduced oxygen culture conditions. PC12 and hMSCs 
were both used to examinine the roles of HMAs on proliferation, metabolic activity, HIFs 
expression, nitroreductase activity, oxidative stress, apoptosis, death/necrosis and 
mitochondrial dynamic (burden, action potential and genome copy number) in comparison 
to physiological normoxia and intermittent hypoxia. HMAs induced HIF expression, 
apoptosis, trapped cell at G0/G1 phase and induced both ROS formation and 
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nitroreductase activity in a manner that was not consistent with a reduced oxygen culture 
condition alone. Mitochondrial burden, mitochondrial action potential, and mitochondrial 
genome number also changed in response to HMA exposure in a manner that was 
indenependent of the oxygen culture conditions tested. In summary, HMAs do not provide 
an accurate replication of engineered oxygen control measures in PC12 and hMSC 
biology. This is reflected in biological alterations impacting on cell yield, behaviour and 
biology. 
Key words: Hypoxia, hypoxia mimetic agents, PC12, hMSCs, HIF, apoptosis, cell cycle 
and ROS.
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1.1. Oxygen, hypoxia and hypoxia mimetic agents 
Oxygen can be thought of as the molecule of life. It is a vital molecule for all forms of life, 
excepting where prevalent conditions differed i.e. anaerobic bacteria, which evolved 
during a period when oxygen levels were very low on Earth. With increased availability of 
atmospheric O2 the evolution of the extraordinarily efficient mechanism of oxidative 
phosphorylation (OXPHOS) was seen; mitochondria generating energy that is stored as 
adenosine triphosphate (ATP) molecules. Oxygen itself is produced by plants, algae and 
cyanobacteria as a by-product from a reaction between carbon dioxide and water and is 
used by animals for a more efficient energy production. Oxygen is available in nature in 
different forms, gaseous diatomic oxygen (O2) is found in the atmosphere at a 
concentration of 21.1% and it can also exist as a triatomic molecule called ozone (O3). 
Water contains oxygen in the form of O2 with a concentration of 1-13 mg/L O2 depending 
on water temperature and salinity (Kildea & Andreacchio, 2012). Normoxia is defined as 
the oxygen partial pressure (pO2) that an organism can live healthily on. Any reduction in 
bioavailability of O2 due to partial lack of oxygen is called hypoxia (Loiacono et al., 2010) 
while a total lack of oxygen is called anoxia. Restricted oxygen supply to tissues due to 
blocked blood flow is called ischemia (Barnabas et al., 2013). Insufficient blood flow to the 
brain is collectively known as stroke or ischemic stroke. Adaptability to changes in oxygen 
supply varies markedly among organisms and the borders of hypoxia and normoxia are 
species or even population‐specific (Das et al., 2010).  
Oxygen is essential for a broad spectrum of physiological reactions that include, but are 
not restricted to cell metabolism, respiration and growth (Loiacono et al., 2010). All multi-
cellular organisms have mechanisms that regulate oxygen homeostasis which is very 
important to maintain cell viability (Semenza, 1999). Under physiological conditions, 
oxygen levels vary from one tissue to another, ranging from 0.002% to 10%, which is 
lower than the atmospheric oxygen level of 21 % (Stamati et al., 2011). Hypoxia is defined 
as a state of reduced O2 supply to cells or tissue that results in reduction of ATP 
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production in one state or condition compared with another. As such, the highly relative 
term “hypoxic status” differs from one cell type to another (Prabhakar & Semenza, 2012).  
Hypoxic cells depend on anaerobic glycolysis for ATP generation, and the low residual 
oxygen will participate in some level of ATP production through the tri-carboxylic acid 
cycle (TCA) and electron transport chain (ETC) (Duke, 1999). Mitochondria are the major 
consumer of oxygen (some 85–90%) in cells as they are responsible for oxidative 
phosphorylation (OXPHOS), the main metabolic pathway for ATP production (Clanton, 
2007). During hypoxia, there is increased reactive oxygen species (ROS) production, 
related to the excess electrons leaking from the mitochondrial ETC (Prabhakar & 
Semenza, 2012). ROS causes oxidative stress, which is defined as an imbalance 
between pro-oxidants and antioxidant substances (Griendling & Fitzgerald, 2003). ROS 
impairs cell function and results in decreased cell viability (Peterson et al., 2011). 
Many underlying pathogeneses of diseases include hypoxia as a feature, such as cancer, 
infections and inflammation-related conditions. Cancerous tissue has hypoxic regions due 
to abnormal cell proliferation, increased distances to vascular supply, and angiogenesis. 
Low oxygen levels in diagnostic tumour biopsies indicate a higher risk of mortality in 
cancers of the bladder, brain, breast, colon, cervix, endometrium, head/neck, lung, ovary, 
pancreas, prostate, rectum, and stomach (Semenza, 2010). 
Hypoxia plays a critical role in cancer biology by activating the transcription of genes that 
are included in glucose metabolism (Liu et al., 2009), genetic instability (Huang et al., 
2007), vascularisation (Liao & Johnson, 2007), stem cell maintenance (Spees et al., 
2015), cell immortalisation, epithelial-mesenchymal transition (Mak et al., 2010), pH 
regulation (Swietach et al., 2007), immune evasion (Lukashev et al., 2007), metastasis 
and invasion (Chan & Giaccia, 2007), and radiation resistance (Moeller et al., 2007). 
Hypoxia plays a role in infectious conditions such as bacillary angiomatosis that is caused 
by Bartonella henselae (Kempf et al., 2005), chronic hepatitis C (Ripoli et al., 2010) and 
cutaneous infections caused by Staphylococcus aureus, varicella-zoster virus, human 
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herpesvirus, or Candida albicans (Werth et al., 2010). In inflammatory conditions, it is 
associated with cellular hyperproliferation and infiltration by cells derived from the 
circulation, such as T cells and monocytes (Feldmann, 2002). The increase in tissue mass 
lead to an increase in oxygen consumption by inflamed tissue (Lee et al., 2007). 
 
1.2. Molecular response to hypoxia 
Hypoxic conditions can occur under several physiological conditions - for example during 
normal embryonic development and pathological conditions, including inflammation-
related settings like solid tumours, healing wounds, atherosclerotic plaque formation and 
rheumatoid arthritis. Cells respond by initiating adaptive mechanisms to maintain cell 
survival through the AMP-activated protein kinase (AMPK) pathway (Viollet et al., 2009) 
which shifts metabolism to glycolysis by increasing catalytic activity of a number of 
enzymes, including phosphofructokinase-1 and pyruvate kinase, but this is unsustainable 
for longer periods of time (Duke, 1999). The three phases theory for cell responses to 
hypoxia was postulated by Connett and colleagues in 1990 (Connett et al., 1990) where 
they described three phases in response to hypoxia. The first phase starts when oxygen 
decreases inside the cell, but ATP production is still sufficient to fulfil the energy demand. 
The second phase is where ATP is maintained by anaerobic glycolysis via the Embden-
Meyerhof pathway which generates only 2 molecules of ATP per 1 molecule of glucose 
metabolized. This pathway is not sufficient to satisfy the ATP demands of highly metabolic 
tissues such as the kidney, liver, and brain and these organs will develop ATP depletion 
rapidly under hypoxic conditions. The third and the last phase initiates when glycolysis 
becomes insufficient to produce enough ATP to maintain cell function and structural 
integrity (Connett et al., 1990).  
Many tissues develop ATP depletion after phase two and these tissues i.e. brain nerve 
cells, require high levels of ATP to operate the sodium-potassium 1 pump. If ATP 
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depletion reaches 50-60% of the demands, membrane depolarization and sodium and 
water retention occur (Loiacono et aI., 2010). Due to membrane depolarization calcium 
influx occurs through voltage-gated calcium channels leading to glutamate 
neurotransmitter release and which initiate a glutamate cascade (Dendorfer et al., 2004; 
Cook, 2010). Death of neurons from these insults can follow quickly by swelling and 
lysing, or through a complex process resembling apoptosis (Dendorfer et aI., 2004). 
However, many studies have shown that some neuronal cells under hypoxic conditions do 
survive (Cook, 2010). These surviving cells develop adaptive responses and express high 
levels of hypoxia inducible factor-1α (HIF-1α) (Chavez et al., 2006), which is a 
transcription factor and a major regulator of the cellular response to hypoxia (Semenza, 
2000). 
 
1.3. Hypoxia inducible factor (HIF) 
In 1992, Semenza and Wang investigated the promoter region of the erythropoietin (EPO) 
gene. Erythropoietin (EPO) is a glycoprotein hormone, which regulates red blood cell 
production; in hypoxia, the expression of this protein significantly increases to facilitate 
tissue re-oxygenation. They use electrophoretic mobility shift assay to determine a DNA 
/protein complex with reduced mobility. This identified a nuclear factor that was bound to 
the EPO promoter and the DNA-binding activity of this factor was tightly regulated by 
oxygen, therefore the protein was designated hypoxia-inducible factor (HIF-1) (Semenza 
& Wang, 1992). Further work revealed that the HIF protein has transcriptional activity and 
the ability to recognize and bind specific DNA sequence known as hypoxia response 
elements (HRE) (RCGTG) in target gene promoters (Wiesener et al., 1998). HIF consists 
of two subunits, α– and β- subunits, which show high structural similarity and both 
subunits contain three acting domains; N-terminal domain which is a basic helix-loop-helix 
(b-HLH) domain for DNA binding; the second domain is the central region which is PER-
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ARNT-SIM (PAS) domain, which facilitates hetero-dimerization of sub-units and the third 
one is the C-terminus which is responsible for recruiting transcriptional co-regulatory 
proteins (Zhulin et al., 1997). There are three HIF-α subunits isoforms. 
1.3.1. HIF-1α 
HIF-1α is a 826-amino acid protein encoded by the HIF-1A gene (Ponting & Aravind, 
1997) with a molecular weight of 120 k Da. HIF-1α is ubiquitously expressed in the body 
and is the main regulator of the cellular response to hypoxia (Ke & Costa, 2006). HIF-1α 
levels are significantly elevated at O2 concentrations below 6% (or 42 mmHg), and is 
rapidly degraded by re-oxygenation to 21% O2 (140 mmHg) with a half-life of about 5 min 
(Prabhakar & Semenza, 2012). HIF-1α mRNA is transiently expressed with high protein 
stability (Jiang et al., 1996; Ema et al., 1997; Makino et al., 2001). HIF-1α needs specific 
co-factors; hepatic nuclear factor 4 (HNF4), mothers against decapentaplegic homolog 3 
(Smad3), signal transducer and activator of transcription 3 (STAT3), and c-Myc 
(Aprelikova et al., 2006; Warnecke et al., 2008). The Lyer and Kotch groups determined 
that the knockout of HIF-1α is lethal for mice and the knockout mice had a specific 
phenotype that was characterized by cardiac malformation and vascular regression (Kotch 
et al., 1999). HIF-1α and 2α share common target genes such as Vascular endothelial 
growth factor (VEGF) and EPO, suggesting they may have a similar role in regulating 
processes including angiogenesis and erythropoiesis (Semenza et al., 1994; Warnecke et 
al., 2003; Raval et al., 2005; Zhu et al., 2006). In addition, HIF-1α has specific target 
genes like Glucose transporter 1 (GLUT-1), Bcl-2/adenovirus E1B 19d-interacting protein 
(BNIP-3), and carbonic anhydrase 9 (CA9) thus HIF-1α plays a vital role in metabolism, 
apoptosis, angiogenesis (Zhong et al., 1999; Greijer & van der Wall, 2004) and its 
associated with a majority of cancers (Zhong et al., 1999, Semenza, 2010). The structure 
of HIF-1α is showed in Figure 1.1A.  
1.3.2.  HIF-2α  
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HIF-2α is an 870-amino acid protein with a molecular weight of 115 kDa. It shares 48% 
amino acid homology with HIF-1α, with high identity in the b-HLH (85%), PER-ARNT-SIM 
(PAS)-A (68%), and (PAS)-B (73%) domains (Tian et al., 1997). HIF-2α is more tissue-
specific and is included in developing blood vessels and lung (Tian et al., 1997). It plays a 
vital role in embryonic heart development and it is essential for catecholamine 
homeostasis (Comino-Méndez et al., 2013). HIF-2α mRNA is more stable than HIF-1α 
mRNA and HIF-2α protein levels significantly increase in hypoxia. HIF-2α needs specific 
co-factors like NEMO, NFκB essential modulator, and CITED-2-CBP/p300-interacting 
modulator. Tian et al., (1997) and Scortegagna et al., (2003) identified that knockout of 
HIF-2α is lethal for mice and the knockout mice have a specific phenotype that is 
characterized by heart failure bradycardia, and impaired Reactive oxygen species (ROS) 
metabolism. In addition, HIF-2α has specific target genes like cyclin D, TGF-β, ANGPT2, 
and VEGFR1 (Raval et al., 2005; Aprelikova et al., 2006; Kasuya et al., 2011), thus HIF-
2α plays a role in vascular remodelling, haematopoiesis and cancer genesis and HIF-2α 
associates with renal cell carcinoma, and polycythaemia (Ang et al., 2002; Raval et al., 
2005). The structure of HIF-2α is showed in Figure 1.1B.  
1.3.3. HIF-3α  
HIF-3α is 662 amino-acids long with a molecular weight of 73K Da and has a 
transactivation domain (TAD-N) and oxygen dependent domain (ODD), but no TAD-C in 
its C terminus (Ravenna et al., 2016). It is involved in the negative control of HIF-1α-
mediated transcription by reducing the binding of HIF-1 to HRE, thus inhibiting HIF-1 
downstream gene transcription. Hypoxia induces the down-regulation of HIF-3α, leading 
to the activation of HIF-1 in hypoxia (Hu et al., 2013). While in re-oxygenation states, HIF-
3α expression is increased to promote the inhibition of HIF-1α activity. The sub-isoform 
HIF-3α 4 lacks ODD, TAD-N, and TAD-C and has a dominant-negative function of 
inactivating HIF-1-mediated transcription and is considered a new path for feedback 
mechanisms that control HIF-1 (Maynard et al., 2005). HIF-3α is mainly found in the 
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cornea, retina, brain, heart and lung (Makino et al., 2001; Kant et al., 2013; Ravenna et 
al., 2016). The novel hypoxia-inducible product of the HIF-3α gene is expressed 
predominantly during embryonic and neonatal stages and thereby designated NEPAS 
(neonatal and embryonic PAS) (Yamashita, 2008). The structure of HIF-3α is showed in 
Figure 1.1C.  
 
 
Figure 1.1. HIF structure 
The three human HIF-1α, HIF-2α and HIF-3α isoforms and binding partner HIF-β all contain the 
basic helix-loop-helix (b-HLH) domain that acts as a HRE binding site. The central region – Per-
ARNT-Sim (PAS) domain, facilitates heterodimerization of HIFs.  HIF-1α (A), HIF-2α (B) and HIF-
3α (C) contain an oxygen dependent domain (ODDD) which is responsible for protein stability as it 
contains Pro 402 and Pro 564 in HIF-1α, Pro 531 in HIF-2α and Por490 in HIF-3α (all indicated by 
red circles) which are the target for PHDs. The C-terminal recruit’s transcriptional coregulatory 
proteins via the Asparginyl residue in C-TAD (Asp813 in HIF-1 α and Asp 851 in HIF-2 α) (Red 
circles) represent the site of action of FIH and a revital for HIF-1α, HIF-2α transactivation 
(Prabhakar & Semenza, 2012). 
 
In normoxia conditions, HIF-α subunits are destabilized by hydroxylation of the two proline 
residues located in the ODDD region by prolyl-4-hydroxylase domain (PHD) (Ivan et al., 
2001), and acylation of lysine (Lys532) by the acetyl-transferase-arrest-defective-1 (ARD-
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1) enzyme activity (Masson et al., 2001). After hydroxylation and acetylation, HIF-α is 
recognized by von-Hippel-Lindau (p-VHL) tumour suppressor leading to poly-
ubiquitination by the action of E3 ubiquitin-ligase and this complex is subjected to 
degradation by proteasome 26S (Lando et al., 2002). There is another hydroxylation 
process that occurs on Asparagine 803 on the C-terminal domain of HIF-α. The 
hydroxylation is caused by factor inhibiting HIF (FIH) that inhibits the co-activation with 
p300, thus inhibits HIF transcriptional activation (Lando et al., 2002). Both prolyl-
hydroxylase and asparagine hydroxylase belong to oxygen dependent hydroxylase 
families that rely on oxygen to possess their catalytic activity, and are considered to be the 
cellular sensors for oxygen level (Schofield & Ratcliffe, 2004) (Figure1.2).  
In hypoxic conditions, the lack of oxygen, the substrate for PHDs and FIH, causes a cease 
of the hydroxylation process, resulting in no binding of HIF-α to the p-VHL. This results in 
the accumulation of HIF-1α in its stable form, translocation into the nucleus and binding to 
the β- subunit to form the active HIF dimer. This in turn binds to co-activators such as 
CREB-binding protein CBP/p300, transcription intermediary factor 2 and steroid–receptor 
activator activators to up regulate gene transcription (Kumar et al., 2003; Ke & Costa, 
2006; Luo et al., 2011) (Figure 1.2). 
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Figure 1.2. Hypoxia inducible factor pathway  
 HIF-1α contains oxygen degradation dependent domain (ODDD) that contains two proline 
residues (402 and 564) (yellow rectangle). Under air oxygen culture condition these ODDD are 
hydroxylated in the presence of oxygen (pink rectangle) by PHD enzyme (yellow rectangle) activity 
leading to the binding of the von Hippel-Lindau (p-VHL) E3 ubiquitin ligase component (blue circle) 
that earmarks HIF-α with polyubiquitin chains that are recognized by the 26S proteasome leading 
to HIF-α degradation. Many factors can inhibit PHDs enzyme activity as (ROS, NO, Fumarate, 
succinate and HMAs). Under hypoxia, PHD activity inhibited and HIF-1α accumulated in cytoplasm 
and bind to HIF-β both subunit enter the nucleus attached to CBP/p300 and bind HRE leading to 
upregulation of hundreds of genes responsible for hypoxia adaption. 
 
1.4. HIF hydroxylases: the cellular oxygen sensor  
Prolyl hydroxylase domain enzyme activity is the connects oxygen sensing and energy 
production by the TCA cycle (Figure 1.3). Intermediates of the TCA cycle are essential to 
the PHDs activity while end products of the TCA cycle such as succinate and fumarate 
inhibit enzymatic activity of PHDs (Isaacs et al., 2005; Lee et al., 2005; Koivunen et al., 
2007). Mutations of metabolic genes such as fumarate hydratase (FH) and the subunits of 
succinate dehydrogenase (SDH) as well as isocitrate dehydrogenase (IDH1 and IDH2) 
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can produce a condition called pseudo hypoxia by production of a reduced form of 2-OG, 
(R)-2HG, as an oncometabolite, where HIF-1 is activated despite normal oxygen 
conditions (Chowdhury et al., 2011; Xu et al., 2011; Koivunen et al., 2012). The APC/C-
Cdh1 E3 ubiquitin ligase link between glycolysis and gutaminolysis regulation and cell 
cycle as APC/C-Cdh1 E3 ubiquitin ligase modulate 6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase 3 (PFKFB3) and Glutaminase (GLS1) proteins thus affecting utilization 
of glucose and glutamine (Xu et al., 2011; Koivunen et al., 2012). 
 
Figure 1.3. 2-OG at the crossroads of metabolic pathways  
The TCA cycle intermediate 2-OG acts as a cofactor of PHD enzymes, the intermediates succinate 
and fumarate are known to inhibit enzymatic functions of PHDs (red box). The APC/C-Cdh1 E3 
ubiquitin ligase link between glycolysis and gutaminolysis regulation and cell cycle by modulate 
PFKFB3 and GLS1. 
 
1.4.1. HIF hydroxylases discovery 
Since the discovery of HIF transcription factors it was believed that they played the major 
role in oxygen sensing in response to hypoxia. Subsequent investigation changed this 
idea by focusing on a group of oxygen-dependent hydroxylases. Prior to this Hutton et al 
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(1967) reported on a prolyl-hydroxylase-catalysed reaction that requires 2-OG. Further 
work revealed that prolyl-hydroxylase mediated a wide variety of roles in plants and 
animals that include oxygen sensing (Jaakkola et al., 2001; Masson et al., 2001), DNA 
repair (Ringvoll et al., 2006; Sedgwick et al., 2007), biosynthesis (Jenkins & Raines, 2002; 
Myllyharju & Kivirikko, 2004), and metabolism (Snell et al., 2014). In the mid-1990s, Jiang 
et al., (1996) suggested a potential role for HIF as an oxygen sensor as HIF-1α protein 
concentration dramatically changes over a physiological oxygen range. Further work 
identified that prolyl-hydroxylase accelerated the process of HIF protein ubiquitylation and 
degradation by production of hydroxyprolines (Ivan et al., 2001; Jaakkola et al., 2001; 
Masson et al., 2001) which were approximately 100-fold more tightly bound by p-VHL than 
non-hydroxylated prolines (Chan et al., 2002). Post-translational modification of HIFs by 
oxygen-dependent HIF hydroxylases was clearly defined in 2002 (Bruick & Mc Knight, 
2001; Epstein et al., 2001; Lando et al., 2002). These enzymes catalysed the transfer of 
two electrons from an oxygen atom to 2-OG forming succinate and carbon dioxide and the 
other atom of oxygen being directly incorporated into the HIF-α unit as shown in Figure 
1.4. 
 
Figure 1.4. Prolyl-4 hydroxylase domain activity  
The catalytic activity of the PHD used proline as substrate. In addition, PHD activity need O2 and 2-
oxoglutarate as co-substrates, Fe
2+ 
and ascorbate as co-factors. The hydroxylation reaction 
produces hydroxyproline and succinate.  
 
Now there is the general acceptance that prolyl hydroxylases are the primary oxygen 
sensors as they are the main regulators of HIFs which respond to changes in oxygen 
levels. HIF-α is subjected to hydroxylation in prolyl residues Pro- 402 and Pro-564 in the 
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case of HIF-1α and Pro-405 and Pro-531 in the case of HIF-2α located within the ODD 
domain (Snell et al., 2014) This reaction also requires ferrous iron (from Fenton reaction) 
as a cofactor, and 2-OG and molecular oxygen as co-substrates (Gaber et al., 2005) 
(Figure 1.5).  
In mammalian cells, at least 4 isoforms of the prolyl hydroxyls domain (PHD1-4) have 
been discovered to date. The PHDs share a common motif of a double strand β-helix core 
fold, also known as jelly roll folds (Karuppagounder & Ratan, 2012). According to their 
high Km values (Hirsila et al., 2003), PHDs respond fairly linearly to the wide range of 
physiological oxygen levels and this make it well fitted to be the cellular oxygen sensors 
(Appelhoff et al., 2004). All the isoforms can hydroxylate the LXXLAP motif in HIF-α 
subunits and this sequence is also found in other substances such as IκBα, RNA 
polymerase and β-adrenergic receptor (Fong & Takeda, 2008). The HIF pathway is 
inactivated in normoxia by the inhibitory effect of PHD, while in hypoxia, the PHDs are not 
active so the HIF pathway is activated (Fong & Takeda, 2008). 
 
Figure 1.5. PHDs act as oxygen sensors  
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In the presence of oxygen, HIF pathway is inactivated by PHD inhibition, while in hypoxia, the 
PHDs are not active so the HIF pathway is activated. Both PHD and FIH inhibitors act as HIF-α 
stabilisers and increase HIF activity. On the contrary, blocking p300 and HIF interaction decreases 
HIF activity. Red arrows (+) ve indicate factors that could increase HIF activity. Red arrow (-) ve 
represents sites of inhibition, while black arrows point out factors that could decrease HIF activity. 
Red circle sits of hydroxylation.  
 
1.4.1.1. PHD-1 (EGLN-2) 
Prolyl hydroxylase domain-1 is found principally in the nucleus, with highest 
concentrations in the testis, moderate concentration in the liver and lower concentrations 
in heart, kidney and brain (Kant et al., 2013). PHD-1 is a constitutively expressed 407 
amino acid long protein with a molecular weight of 43 kDa (Erez et al., 2003). In normoxia, 
PHD-1 shows a higher affinity to HIF-2α than HIF-1α while in hypoxic conditions it 
possesses equal affinity to both HIF isoforms (Corcoran et al., 2013). Explorations of 
physiological PHD-1 functions have revealed that PHD-1 plays a role in the energy 
metabolism of muscle and liver as directing metabolism towards the TCA cycle (Aragones 
et al., 2008; Schneider et al., 2010), cell cycle progression as it regulates the abundance 
of cyclin D1 which is needed for proper cell cycle progression (Zhang et al., 2016), and 
control of the stability of centrosome component Cep192 (Moser et al., 2013). From 
previous work, PHD-1 affects centrosome duplication and maturation in G2 phase which 
allows cell cycle progression through cyclin D1 induction (Zeng et al., 2010) and 
hydroxylation of IкB kinase (IKK) (Cummins et al., 2006).  
1.4.1.2. PHD-2 (EGLN-1) 
Prolyl hydroxylase domain-2 is found predominately in the cytoplasm with features of 
nucleus shuttling. It consists of 426 amino acids with a molecular weight of 46 kDa (Fong 
& Takeda, 2008). The highest expression of PHD-2 is found in the heart and testis and is 
moderately expressed in the brain, kidney and liver (Fong & Takeda, 2008). Both mRNA 
and protein expression are up regulated by hypoxia, and it is considered to be the main 
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regulator of the HIF-α transcriptional factors (Fong & Takeda, 2008). PHD-2 targets 
proline 402 and 564 in HIF, and has a higher affinity to HIF-1α than HIF-2α in both 
normoxic and hypoxic conditions (Fong & Takeda, 2008). PHD-2 null homozygousity is 
lethal as it causes massive structural defects in the heart and placenta in mice (Takeda et 
al., 2006). In addition, PHD-2 mutations were linked to erythrocytosis in humans (Ladroue 
et al., 2012). PHD-2 expression may play a role in detecting aggressiveness and survival 
in many types of cancer; including breast cancer (Bordoli et al., 2011; Fox et al., 2011; 
Peurala et al., 2012), pancreatic cancer (Su et al., 2012), squamous cell carcinoma of 
head and neck (Jokilehto et al., 2006), prostate cancer (Boddy et al., 2005), and glioma 
(Henze et al., 2010). Nuclear localization of PHD-2 is associated with tumour 
aggressiveness and with radiation response (Jokilehto et al., 2006; Luukkaa et al., 2009), 
but in breast cancer it is associated with increased survival (Peurala et al., 2012). As a 
part of the PHD-2 role in hypoxia and HIF signalling, recent work has revealed the 
relationship between PHD-2 and adipose tissue metabolism (adipogenesis and fatty acid 
synthesis). In mice, the partial loss of PHD-2 gene function leads to less adipose tissue, 
smaller adipocytes and improvements in glucose tolerance and insulin sensitivity (Rahtu-
Korpela et al., 2014). 
1.4.1.3. PHD-3 (EGLN-3) 
Prolyl hydroxylase domain-3 is distributed equally between the cytoplasmic and nuclear 
compartments. PHD-3 consists of 239 amino acids with a molecular weight of 27.3 kDa 
(Fong & Takeda, 2008). It is highly expressed in the heart, placenta and liver, and 
moderately expressed in the brain and kidneys (Karuppagounder & Ratan, 2012). PHD-3 
mRNA and protein expression are strongly induced by hypoxia, hypoxia mimetic agents or 
by growth factor deprivation in sympathetic neurons (Karuppagounder & Ratan, 2012). 
PHD-3 targets proline 564 in HIF, and has an equal affinity to HIF-1α and HIF-2α in 
normoxia, while in the hypoxic condition it possesses a higher affinity to the HIF-2 than 
HIF-1 isoform (Fong & Takeda, 2008). In addition to the hydroxylation function, PHD-3 
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hydroxylation-independent functions by targeted proteins represent a variety of signalling 
pathways such as PK-M2 protein which plays a central role in metabolic reprogramming 
as it functions as a switch between glycolysis and oxidative phosphorylation (Wang et al., 
2014) by regulating the assembly of PK-M2 and acting as a co-activator in PK-M2-derived 
HIF-1 target transcription (Luo et al., 2011; Sun et al., 2011). PHD-3 also targets NF-κB 
signalling in carcinogenesis and also in hypoxia (Koong et al., 1994; Michiels et al., 2002; 
Karin & Greten, 2005). PHD-3 binds the signalling pathway that mediates apoptosis and 
cell death (Bcl-2 and hPRP19) (Lee et al., 2005; Peurala et al., 2012). 
1.4.1.4. PHD-4 
Recently discovered to regulate HIF by hydroxylation of proline in the (LXX-LAP) 
sequence at two separated sites in the α-subunit (Karuppagounderand & Ratan, 2012). 
PHD-4 is in the endoplasmic reticulum and is up regulated by hypoxia. It is related to 
procollagen hydroxylase and it has three subtypes which show 42-59% of structural 
sequence similarity to each other and contains three iron binding residues, where the 
lysine that binds 2-oxoglutarate is replaced by arginine (Koivunen et al., 2007).  
1.4.1.5. Factor inhibits HIF  
Factor inhibits HIF is an Asparagine hydroxylase, and is distributed evenly between the 
nucleus and cytoplasm. FIH consists of 348 amino acids with a molecular weight of 40.6 
kDa, with the highest expression in breast tissue, testis, ovaries and kidneys. FIH mRNA 
and protein does not change in hypoxia. FIH activity is reduced by hypoxia and targets 
asparagine 803 and 851 for HIF-1α and HIF-2α, respectively (Fong & Takeda, 2008). FIH 
consists of jellyroll-like β-barrels formed from 8 β-strand and iron binding sites that contain 
2-histidine (Laitala et al., 2012). NFκB and Notch systems both contain ankyrin repeat 
domain (ARD) proteins to compete with HIF-α for FIH-dependent hydroxylation and 
actually forms better substrates than HIF-α in vitro (Loenarz & Schofield, 2008). Deletion 
of FIH influences metabolism and insulin sensitivity, elevating metabolic rate and 
improving glucose and lipid homeostasis (Zhang et al., 2010).  
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1.4.2. PHD modulators as hypoxia mimetic agents 
Prolyl hydroxylase domains are considered to be the cellular oxygen sensor, as they have 
a high affinity to oxygen with a Km-value range from 230 to 250 μM in comparison to other 
hydroxylase enzymes e.g. Collagen hydroxylase (Cioffi et al., 2003; Hirsila et al., 2003). In 
order to retain their maximum activity, PHDs need oxygen molecules, as one oxygen atom 
will couple to proline to form hydroxyl-proline and another oxygen atom is used for de-
carboxylation of 2-oxoglutarate (2-OG) to succinate. In addition to this reaction, the PHDs 
require non-haem-Fe+2 for catalytic activity, which binds to the His-X-Asp/Glu-Xn-His motif 
to coordinate enzymatic activity (Gerald et al., 2004). Moreover, the PHD needs ascorbic 
acid for returning the Fe+2 to its active form (Gerald et al., 2004). PHDs activity is inhibited 
by hypoxia, nitric oxide, ROS, 2-OG analogues, and cobalt chloride (Maxwell & Salnikow, 
2004).  
Prolyl hydroxylase can be inhibited through multiple methods in normoxic conditions by 
disrupting the balance of Fe2+ using an iron chelator such as deferoxamine (DFO) or via 
competitive inhibition, with for example, cobalt chloride. These agents possess a lack of 
specificity and the risk of off-target effects are very high (Warnecke et al., 2003; Bernhardt 
et al., 2007). Another method for modulating PHDs activity is through the use of 2-
oxoglutarate analogues such as L-Mimosine (L-Mim), dimethyloxalyl-glycine (DMOG), 3,4-
dihydroxybenzoate (3,4-DHB), and N-[[1,2-dihydro-4-hydroxy-2-oxo-1-(phenylmethyl)-3-
quinolinyl] carbonyl]-glycine (IOX2). However, these agents have drawbacks because 
they may inhibit other 2-oxoglutarate oxygenases, as 2-oxoglutarate dependent histone 
demethylases, which could cause an undesirable effect on the epigenetics of the cells. A 
new member 2-oxoglutarate inhibitor, IOX2, is more potent than DMOG, with relative IC50 
values of 0.022 µM and 5 µM respectively (Chowdhury et al., 2013). IOX2 inhibits both 
PHD-2 and FIH with about 5000 times more selectivity for PHD-2 than histone 
demethylases (Chowdhury et al., 2013).  
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1.4.3. Clinical application of PHD inhibitors 
Prolyl hydroxylase domain inhibitors are used to increase HIF signalling, thus it can be 
used in the treatment of many pathological conditions (Heyman et al., 2011), for example, 
anaemia (Hsieh et al., 2007), ischaemic diseases (Ockaili et al., 2005; Fan et al., 2015), 
wound healing (Fan et al., 2015), stem cell preconditioning and other conditions (Hsieh et 
al., 2007). 
1.4.3.1. Anaemia  
The main therapeutic implication of hypoxia mimetic agents (HMAs) is to treat anaemia by 
enhancing EPO secretion via up-regulation of HIF-1α. In addition, activation of various 
downstream genes that may have beneficial effects. Several review papers thoroughly 
cover the recent advances in the development of PHD inhibitors targeting anaemia (Hsieh 
et al., 2007; Muchnik & Kaplan, 2011). The superiority of HMAs over iron repletion and 
administration EPO analogues, which are used to treat anaemia, are due to the high cost 
of EPO analogues their associated resistance, and side effects.  
1.4.3.2. Ischemic Disease 
When ischemic injury occurs, damage to the tissue associated with both initially limits 
oxygen supply and reperfusion leading to rapid restoration of oxygen (Hausenloy et al., 
2013) as the rapid re-oxygenation of injured tissues is usually associated with a profound 
inflammatory response. HIF plays an important role in the treatment of ischemic disease 
and this can have summarised in three main functions. First, when injured tissue is pre-
exposed to non-lethal ischemia, in a process known as preconditioning, the injured tissue 
region will significantly reduce. HIF stabilisation is important for this effect (Eckle et al., 
2008). Secondly, the interaction between HIF and the circadian rhythm protein period 2 
(PER2) is critical for the regulation of the metabolic pathway during ischemia, by adjusting 
the glycolytic enzyme production of the ischemic region, especially in the heart (Eckle et 
al., 2014). Lastly, HIF stabilisation in remote ischemic preconditioning will lead to 
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enhancement in plasma interleukin-10 transcription, thereby reducing the size of the 
myocardial infarct (Cai et al., 2013). Protecting neurons and repairing the brain after 
stroke was another potential function of HMAs (Karuppagounder & Ratan, 2012). Recent 
works from different research centres revealed that direct inhibition of PHDs by small 
molecule inhibitors rather than HIF stability plays a role in neuroprotection (Baranova et 
al., 2007; Nagel et al., 2011). 
1.4.3.3. Inflammatory Disease 
Inflammatory hypoxia is a characteristic of inflamed tissues, inflamed regions usually have 
a high metabolism accompanied with low levels of oxygen and glucose (Fraisl et al., 2009; 
Bartels et al., 2013; Eltzschig et al., 2014). HIF-1 can be stabilized by both a low oxygen 
supply under hypoxia and pro-inflammatory molecules in the inflamed region and hypoxia 
can be considered as an inflammatory stimulus by enhancing pro-inflammatory cytokines 
(Schwartz et al., 2011). HIF signalling pathways are involved in many human inflammatory 
diseases such as inflammatory bowel disease, Crohn’s disease, acute lung injury, and 
infectious diseases (Fraisl et al., 2009; Schwartz et al., 2011). Stabilized HIF-1α signal 
activated anti-inflammation responses via induction of adenosine A2A receptor and netrin-
1, inhibit excessive inflammation and reduces cellular apoptosis thus participating in tissue 
repair (Schwartz et al., 2011). 
1.4.3.4. Tissue Injury  
The use of HMAs to stabilize HIF-1α can be used effectively in the treatment of wounds 
and other tissue injuries; this is due to fact that HIF signalling is involved in the regulation 
of various processes including inflammation, angiogenesis, and vasculogenesis (Kalucka 
et al., 2013; Kant et al., 2013; Zhang et al., 2013). Ruthenborg et al., (2014) provided 
more detailed information about the therapeutic potentials of HMAs in the treatment of 
pathogenic wound repair (e.g., diabetic wounds). 
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1.4.3.5. Asthma 
Hypoxia is recognized during the asthma associated allergic inflammatory reaction. Cells 
respond to low oxygen by activation of the HIF pathway, which extend proinflammatory 
reactions and aggravation of the disease condition by constitutively express 
inflammasome proteins and are a potent source of the pro-inflammatory cytokines pro-
IL1α and pro-IL1β (Huerta-Yepez et al., 2011). Bronchial biopsies from patients with 
asthma show increased HIF pathway activity leading to the activation of genes, such as 
vascular VEGF that plays a role in airway remodelling and increased collagen synthesis 
and fibrosis (Ahmad et al., 2012). Many works revealed that nonspecific HIF-1 inhibition 
leads to a reduction in the allergic inflammation and lung remodelling in animal models 
(Huerta-Yepez et al., 2011). In addition, PHD-2 inhibitors such as ethyl 3,4-
dihydroxybenzoic acid, an oxoglutarate analogue, increase airway responsiveness, cell 
infiltration, mucus production, and collagen deposition in the basal membrane of the 
epithelium in a mouse model of asthma (Ahmad et al., 2012). This result shows the 
protective role of PHD-2 in the development of asthma (Huerta-Yepez et al., 2008). 
1.4.3.6. Obesity 
The oxygen level reduction associated with obesity leads to increased adipose tissue 
expansion due to multiple factors such as inadequate vascular response, local 
inflammation, fibrosis, and metabolic dysfunction, all these effect results in a bad 
prognosis of condition (Crewe et al., 2017). The changes in PHD-2 activity in obesity have 
a detrimental effect. In support, Matsuura et al., (2013) revealed that PHD-2 deletion from 
adipocytes resulted in reduced weight gain, glucose intolerance, fat mass and lower 
macrophage infiltration that are associated with a high-fat diet model. In contrast 
Michailidou et al., (2015) showed that PHD-2 knockout murine model displayed an 
increased adipose mass. However, despite the difference in adipose mass results, this 
group also observed a normal glucose tolerance in these mice, with reduced levels of 
circulating fatty acids and no increase in macrophage levels in white adipose tissue 
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(Michailidou et al., 2015). The available body of data on the role of PHD-2 in obesity is, 
however, scarce and further work needs to be pursued to underlie the mechanisms 
responsible for this outcome. 
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1.5. Mitochondria, origin, stracture and functions   
The mitochondrion is a cytoplasmic organelle embedded in a reticular network in the cell 
cytoplasm. This double-membrane structured organelle contains the machinery that is 
needed for the mitochondria to produce adenosine triphosphate (ATP), and to fulfil their 
roles in apoptosis, calcium homeostasis and the formation of iron sulphur clusters along 
with many other functions. Mitochondria contain their own DNA encoding a number of vital 
proteins for mitochondria function, but the vast majority of mitochondrial proteins are 
nuclear encoded (Anderson et al., 1981). As mitochondria encode their own proteins this 
also means that they are susceptible to diseases that are caused by mutations in 
mitochondrial DNA (mtDNA) which not only affect mitochondria but also cellular function 
(Park and Larsson, 2011). Recently mtDNA has found use as tool for diagnosis of many 
disease conditions e.g. mt-ND1 gene encodes the ND1 protein, a subunit of NADH 
dehydrogenase, used in diagnosis of mitochondrial disorders including Leigh's syndrome 
(Thorburn and Rahman, 1993). There are two theories hypothesis mitochondria origin 
“endosymbiotic theory” was proposed by Margulis (1971) and hydrogen theory (Martin & 
Muller, 1998). 
Mitochondria are elongated rod-shaped structures with a double membrane. Mitochondria 
have diameter of ~2.5 μm in length ~0.5 μm, with a highly folded inner membrane, called 
cristae, all enveloped by an outer membrane (Palade, 1952) as depicted in Figure (1.6) 
with Transmission electron microscopy (TEM). 
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Figure 1.6. Mitochondria morphology and structure  
Mitochondrion ultrastructure (TEM image) mitochondrion has double membranes outer and inner 
mitochondrial membrane (OMM and IMM) with internal matrix, each of which contains highly 
specialized proteins. The outer membrane contains many channels serve as sieve consist of 
protein porin. the inner membrane, which is highly folded membrane with large infoldings called 
cristae. IMM utilizes a group of transport proteins that will allow transport those materials essentials 
to the matrix only.  
 
The outer mitochondrial membrane (OMM) contains high densities of mitochondrial 
voltage dependent anion channels (VDAC) which facilitate the passage of 10 kDa size 
molecules to the inter-membrane space (Shoshan-Barmatz et al., 2014). The cardiolipin 
rich inner mitochondrial membrane (IMM) separates the inter-membrane space from the 
mitochondrial matrix and contains many transport proteins that act as a scaffold for the 
respiratory complexes where oxidative phosphorylation (OXPHOS) occurs, and provides 
an ideal environment that is essential for ATP formation (Paradies et al., 2014). The highly 
folded IMM, provides an effectively large surface area for maximum respiratory complex 
protein integration to produce ATP via OXPHOS (Paradies et al., 2014). 
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Many of the enzymatic processes take place in the mitochondrial matrix such as those 
required for oxidative metabolism such as the TCA cycle and β-oxidation of fatty acids. 
The matrix also contains mtDNA and is the site of replication, transcription and translation 
of this genome (Hawlitschek et al., 1988; Pfanner et al., 1989; Pfaff & Klingenberg, 1968; 
Liu & Chen, 2013). 
Mitochondrial biogenesis is tightly regulated according to the energy requirements of the 
cell in order to provide an adequate amount of ATP. The first mechanism to respond to an 
increasing ATP demand is the increase of mitochondrial mass by activation of AMP 
activated protein kinase (AMPK) (Dominy & Puigserver, 2013), and Sirtuin 1 (SIRT1) 
(NAD+ sensor). This trigger activation of peroxisome proliferator activated receptor γ 
coactivator-1α (PGC-1α) which is the main regulator of mitochondrial biogenesis. It 
initiates the transcription of nuclear encoded mitochondrial proteins such as nuclear 
respiratory factors 1 and 2 (NRF1 and NRF2), oestrogen related receptor α (ERRα), 
forkhead box class-o (Foxo-1), and peroxisome proliferator activated receptors (PPARs) 
(Puigserver & Spiegelman, 2003) where expression of these proteins leads to the 
eventual increase in mitochondrial mass (Dillon et al., 2012). The second mechanism is 
activated by low temperatures in brown adipose tissues by activation of β3 adrenergic 
receptor via the sympathetic nervous system as a measure of non-shivering 
thermogenesis involving proton uncoupling protein UCP-1 (Puigserver et al., 1998).  
Cell health is directly related to the mitochondria as intact cells have intact mitochondrial 
biogenesis and bioenergetic functions (Liesa & Shiriha, 2013). Mitochondria are a highly 
dynamic organelle which displays constant movement and changes in shape and size by 
fusion and fission processes, which are guided by a number of dynamin-like GTPases 
(Bürmann et al., 2012). The processes of fusion and fission ensure correct membrane 
(inner and outer) fusion and distribution of mitochondrial contents like mtDNA, proteins 
and soluble factors (Scott & Youle, 2010). Fusion and fission processes play vital role in 
many cellular functions such as mitosis, energy sensing, ATP turnover, calcium 
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homeostasis, autophagy and apoptosis (Hyde et al., 2010; Tait & Green, 2012). In 
addition, fusion and fission processes are the main regulator of the morphology of 
mitochondria. The balance between the two processes will determined if the mitochondria 
have correct-shape or are fragmented or elongated. The importance of these 
mitochondrial morphology changes is clear in many pathological conditions related to 
neurodegeneration (Markham et al., 2014). Moreover, the fusion process take part in 
regulating mitochondrial respiration (Roy et al., 2015). 
Mitochondrial functions can have summarized by: 
1.Oxidative Phosphorylation 
2. Generation of reactive oxygen species  
3. Calcium Handling 
4. Iron-sulphur cluster biogenesis  
Mitochondria encode 37 genes, 13 of which contribute protein subunits towards the 
OXPHOS complexes and 22 tRNAs and 2 rRNAs which enable OXPHOS subunit 
expression (Taanman, 1999). There are ≤10 copies of the 16,569 bp circular mtDNA 
genome per mitochondrion located within the mitochondrial matrix. Nuclear genome 
encodes the remaining 77 proteins required for OXPHOS which are translated within the 
cytoplasm and passed to the mitochondria. The mitochondrial genome does not contain 
introns (Anderson et al., 1981). mtDNA copy number in each cell varies from 100,000 
copies of mtDNA in female germline oocytes (Shoubridge & Wai, 2007) to ~250 mtDNA 
molecules in adult stem cells related to their small size and high nuclear cytoplasmic ratio 
(Coller et al., 2001). mtDNA content inside the cell is related to energy expenditure. High 
energy demanding cells such as muscle and nerve require more mtDNA than other types 
(Shoubridge & Wai, 2007). Brown et al., (2011) have suggested that single genomes are 
packaged together in complexes called nucleoids that contain protein machinery essential 
for the replication and transcription of mtDNA.  
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From above, the number of mitochondria can be roughly estimated from the amount of 
mtDNA noting that each mitochondrion has multiple copies of mtDNA (Phillips et al., 
2014). Southern blot analysis is traditional method for mtDNA quantification (Tang et al., 
2012), but nowadays, quantitative polymerase chain reaction (qPCR) techniques are more 
commonly used as they provide a relative number of mitochondrial genomes per cell by 
comparing mtDNA copy number to that of nuclear DNA (Phillips et al., 2014). NADH 
dehydrogenase subunit I (ND-1) can be used along with specific nuclear-encoded 
housekeeping genes for normalization purposes (Phillips et al., 2014). 
 
1.5.1.  Effect of reduced oxygen level and HMAs on mitochondria 
1.5.1.1.  Effects of hypoxia on mitochondrial structure and dynamics 
Mitochondria are highly dynamic organelles; mitochondrial morphology is regulated by 
fission / fusion machineries which is modulated in response to changes in oxygen 
availability. Under hypoxia, faster glucose consumption occurs in an attempt to retain ATP 
production using less efficient anaerobic glycolysis (Lum et al., 2007). Under hypoxic 
conditions, shortage of supplementation of substrates like acetyl-CoA and O2 to 
mitochondria inducing major structural, functional, and dynamical changes. The structural 
and dynamical changes are characterized by impairment of fusion process that leads to 
mitochondrial depolarization, loss of mtDNA that may associated with altered respiration 
rates, and uneven distribution of the mitochondria within cells (Jezek et al., 2009). Under 
continuous hypoxia neurons cells reduce mitochondrial size and change mitochondrial 
morphology and this may be related to changes in nitric oxide synthase activity (Guo et 
al., 2008). HIF stabilization under hypoxia or by HMAs play a role in changing 
mitochondrial morphology and function through affecting cellular signals which are 
transduced within the cell in order to affect mitochondrial morphology and function (Chen 
et al., 2005). 
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1.5.1.2.  Effects of hypoxia on the respiratory chain complexes 
Hypoxia and HMAs through stabilizing HIF play vital role in changing OXPHOS machinery 
such as stabilizing HIF induce of pyruvate dehydrogenase kinase, which inhibits pyruvate 
dehydrogenase activity leading to shift pyruvate away from TCA thus reduced respiration 
due to limitation of substrate and inducing expression of LDH-A that shift pyruvate a way 
from TCA toL-lactate (Kim et al., 2006). HIF also changes subunit composition of 
cytochrome c oxidase subunit 4 isoform via increased COX4-1 destruction and increase 
COX4-2 expression (Brunori et al., 2004). Moreover, HIF-1 mediates expression of BNIP3 
which is a pro-apoptotic BH3-only protein associated with mitochondrial dysfunction acting 
as a potent inducer of autophagy (Hamacher-Brady et al., 2007). In addition, hypoxia 
elevates NO levels via increased activity of nitric oxide synthases and NO will compete 
with cytochrome c oxidase for O2 thus reducing respiratory chain activity (Galkin et al., 
2007). 
1.5.1.3.  Effects of hypoxia on ROS production by Complex I &III 
ROS form from the leak of 1-2% of electrons that pass through the mitochondrial 
respiratory chain under air oxygen culture conditions where complex I and to lesser extent 
complex III are considered the main sites for ROS formation (Poyton et al., 2009). Under 
hypoxia or after HMAs, controversy has arisen around whether ROS formation increases 
or decreases, and this may be related to fact that HIF participates in ROS regulation while 
ROS itself plays a role in HIF expression and activity (Kotake-Nara & Saida, 2007; 
Owusu-Ansah et al., 2008; Zeng et al., 2011). The mtDNA encoded complex III and other 
respiratory chain proteins are crucial in ROS formation (Poyton et al., 2009).  
1.5.1.4.  Effects of hypoxia on ATP synthase 
ATP synthase (or F1:F0 ATPase) is a reversible rotary motor enzyme which uses proton 
movement across the mitochondrial IMM to synthesis of ATP from ADP under normoxic 
physiological conditions. Under hypoxia mitochondrial action potential decreases below 
the physiological steady-state reversing ATPase activity and using the produced energy to 
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pump out the protons from the matrix to the intermembrane space in synchronization with 
the adenine nucleotide translocator which maintains the physiological membrane potential 
(Bosetti et al., 2002). So, under hypoxic condition the drop in cytoplasmic high energy 
phosphates is mainly related to reversion of ATP synthase activity requiring a strictly 
regulated mechanism to stop ATP waste. This is achieved by H+/Δψm dependent IF1, 
protein binding to the catalytic F1 site at low pH and low Δψm resulting in a rapid - 
reversible dropping of the enzyme activity. In addition, H+/Δψm dependent IF1 is also 
related to elevation ROS formation and induce mitophagy which are correlated to many 
pathological conditions as myocardial infarction, Alzheimer's disease and inflammatory 
diseases (Baracca et al., 2002).  
1.5.1.5.  Effects of hypoxia on mitochondrial genome 
Mitochondria are the main energy producing, oxygen consuming organelle and it 
responsible of ROS formation (Poyton et al., 2009). Mitochondria participate and respond 
to HIF stabilization in hypoxia or after HMAs treatment. Mitochondria respond by 
reprogramming of the energy production by shifting metabolism to the anaerobic pathway. 
Moreover, mitochondria undergo successive fission and fusion to repair damage mtDNA 
and this mechanism allows for separation of mitochondria with damaged DNA via fission, 
and have healthy material from healthy mitochondria via fusion and this process is 
regulated by group of proteins that include mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), 
dynamin-related protein 1 (Drp1), human fission factor-1 (FIS1) and optic atrophy factor 1 
(OPA1). In addition, hypoxia increase mtDNA copy number and this may be related to the 
ability of HIF induce mRNA levels of PGC-1α, TFAM and SSBP genes (Chuang et al., 
2012). 
 
1.6.  Apoptosis 
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Apoptosis (programmed cell death) is controlled by an extrinsic pathway mediated by cell 
receptors or an intrinsic pathway mediated by cell damage. Cytochrome c is an important 
factor in apoptosis as cytochrome c release from mitochondria enables the apoptosome 
formation along with Apoptotic protease activating factor 1 (Apaf-1) which activates pro-
caspase-9, leading to apoptosis (Parrish et al., 2013). Cytochrome c release is a tightly 
regulated process that requires the binding of pro-apoptotic Bc-l2 family proteins Bax and 
Bak to the outer mitochondrial membrane leading to increase permeability of the 
membrane (Shamas-Din et al., 2013). Under physiological conditions, Bcl-2 homolgy-3 
(BH3) family of proteins inhibit Bcl-2 proteins from triggering apoptosis via cytochrome c 
release (Willis et al., 2007). Stabilization of HIF-α (by hypoxia or after HMAs treatment) is 
involved in the regulation of many members of Bcl-2 family both pro-apoptotic (BNIP3 and 
Noxa) and antiapoptotic (Bcl-2, Bax, Bad, Bid, Mcl-1 and Bcl-xL). Proapoptotic activity 
induced by HIF-1α includes downregulation of Bcl-2, induction of BNIP3, and BH3-only 
domain protein Noxa. In contrast, HIF-1α can also protect from apoptosis by elevating Bcl-
2 and Mcl-1 levels, Bcl-xL induction, and decreasing pro-apoptotic Bid, Bax, and Bak 
levels (Santore et al., 2002).  
 
1.7. Cell cycle 
The cell cycle is a highly regulated series of events involving cell growth and division into 
two new daughter cells, to do so the cell undergo a series of events that are both 
accurately timed and precisely regulated involving cell growth, DNA replication, and 
division to produces two identical cells. Cell cycle consist of four distinct stages; Gap 
phase 1 (G1), DNA replication phase (S), and Gap phase 2 (G2), and mitotic division (M). 
under stressful growth conditions cells can exit G1 into G0 where they become quiescent 
and do not progress to G1 phase, remaining metabolically active and maintaining the 
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ability for subsequent re-entry into the cell cycle. Each stage regulated by highly ordered 
processes pushing cells from one phase to the next (Antico Arciuch et al., 2012).  
 
The cell cycle is connected to what called metabolic cycle; as during cell division cells 
switch between an oxidative phase; which involve the biosynthesis of many cellular 
components (G1 phase) utilising energy derived from mitochondria, followed by a 
reductive phase; with DNA-replication and biosynthesis of mitochondria (S/G2/M phases) 
where energy is sourced from non-respiratory energy production methods (Martínez-Diez 
et al., 2006). If there is insufficient energy to complete the cycle, the cells become trapped 
at the G1 (restriction point) of the cell cycle. Metabolic stress triggers G1 arrest and it 
control by AMP-activated protein kinase (AMPK) activity. AMPK is considered as a 
metabolic sensor of energy demand in higher eukaryotic cells (Cantó & Auwerx, 2010). 
Activated AMPK promotes the phosphorylation of p53 on Ser15 (Wu et al., 2014), this 
step prevents p53 degradation leading to the accumulation of p53 which induces the 
expression of p21 gene. p21 act as cyclin-dependent kinase inhibitor, that induce cell-
cycle arrest at either of G1 or G2 (Finn et al., 2016). Owusu-Ansah et al., (2008) revealed 
that mutations in genes encoding complex IV and complex I components will activate the 
G1/S checkpoint via decreased ATP production and a rise of AMP levels resulting in 
activation of AMPK or by increases in ROS formation resulting in activation of c-Jun N-
terminal kinases (JNK) and Foxo. In mammalian cells cyclin D1 phosphorylates and 
inactivates retinoblastoma protein (pRB) indicating entry of cells into the S phase of the 
cycle, inhibiting mitochondrial function (Sakamaki et al., 2006) and repressing the activity 
of nuclear respiratory factor-1 (NRF1) (Wang et al., 2006). The studies of mechanisms 
that control mitochondrial biogenesis during the cell cycle have revealed that there is 
synchronized increase in mitochondrial mass and membrane potential throughout the 
progression from G1 to mitosis and after cell division these parameters will return back to 
normal (Wang et al., 2006). Moreover, mtDNA contents increased from S to G2 phase 
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with a harmonized increase of NRF1 levels (Wang et al., 2006). The relation between 
mitochondrial function control and NRF-1 was revealed by a Scapula et al., (2012). Other 
study showed that defects in NRF1 associated with a defect in the maintenance of the 
mitochondrial membrane potential and very low mtDNA contents (Morrish & Hockenbery, 
2014).  
 
Figure 1.7. The cell cycle is divided into a number of stages.  
The eukaryotic cell cycle is divided into a number of stages. Two gap phases (G1 and G2) allow 
cell growth in preparation for DNA duplication and chromosome segregation during interphase. 
DNA duplication is triggered after G1-phase and finished by the end of the S/G2 border lastly, M-
phase. The green circles represent cyclin-dependent kinase (CDK), the red circles represent cyclin. 
The green arrow represent cell go to G0 and the red arrow represent the cell back to G1. 
 
Peroxisome proliferator-activated receptor-gamma co-activator (PGC) is a member of a 
family of transcription co-activators that plays a central role in the regulation of cellular 
energy metabolism. PGC-1α and PGC-1β induce Mfn-2 expression via transcriptional 
mechanisms. PGC-1β induces morphological changes in mitochondria during the cell 
cycle (Zorzano & Claret, 2015). High energy demands lead to induction of PGC-1α that in 
turn will induce and stimulate many functions like mitochondrial biogenesis, Mfn-2 
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expression, and mitochondrial function modulation (Zorzano & Claret, 2015). Mitochondria 
follow a highly concerted behaviour when passing through the different stages of the cell 
cycle (Hyde et al., 2010). Mitochondria at G0 are found in filamentous and fragmented 
forms. In the mitotic phase, fragmented mitochondria are positioned opposite telomeres of 
daughter cells in M phase which ensure concerted movement and dispersion between 
daughter cells. Mitochondria form an extended tubular network and tubular elements that 
undergo fission and fusion at G1/S (Gupte, 2015). This mitochondrial network at G1/S 
serves many cellular functions such as the production of increased mitochondrial ATP to 
compensate for the reduction in ATP production due to glycolysis produced ATP during 
G1/S, playing a vital role to ensure that a homogenized distribution of mitochondrial DNA 
in the continuous matrix is maintained, and that cells are protected from apoptosis at this 
crucial cell cycle stage (Mitra et al., 2009). Inhibition of Drp1 induces mitochondrial hyper 
fusion which leads to increased cyclin-E levels initiating cell replication at G1/S phase 
(Mitra et al., 2009). 
Oxygen is one of the most demanded nutrients required by the cells in the cell cycle and   
lack or reduction in its concentration can lead to cell cycle arrest at G1 phase with 
reduction in S phase. It is postulated that hypoxia induce protein phosphatase 1 (PP1) 
activity a specific CDKs phosphatase that related to the reduction in CDK activity 
associated with an accumulation of hypo-phosphorylated-pRb (Krtolica et al., 1998).  
Hypoxia associated reduction in CDK activity is related to increases in p21 and p27 levels 
(CDK inhibitor). The exact role of HIF-1α in induction of p27 is still an area of debate, but 
the role of p27 is critical in the cell cycle arrest under hypoxic condition. HIF1α induction 
disrupts c-Myc-Max complex formation leading to decreased c-Myc transcription which 
induces p21 expression causing cell cycle arrest. In contrast, induction of HIF2α can 
facilitate c-Myc and Max complex formation with increased c-Myc transcription which in 
turn increases cyclin D2 expression and reduces p21 leading to activate cell proliferation 
(Krtolica et al., 1998). 
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In addition to above HIFs play a role in regulation of transcription of several microRNAs 
particular miR210 which play role in regulates E2F3, a transcription factor causing severe 
downregulation in protein levels leading to cell cycle progression arrest (Medina et al., 
2008). HIF1α have the ability to block DNA replication under hypoxic condition by 
activation of ATR and its downstream target checkpoint kinase 1 (Chk1) leading to 
trapped cell at G1 phase (Hammond et al., 2003). Minichromosome maintenance (MCM) 
proteins are main the components of the DNA helicase, which mediate DNA replication, 
an essential process prior to cell division. HIF-1a to the complex decreased 
phosphorylation and activation of the MCM complex by the kinase Cdc7. As a result, HIF-
1a inhibited firing of replication origins, decreased DNA replication, and induced cell cycle 
arrest (Hubbi et al., 2011). 
1.8.  Cells models 
1.8.1. PC12 cell 
In the early 70s, PC12 was described as cells derived from pheochromocytoma of rat 
adrenal medulla and have an embryonic origin from the neural crest with a mixture of 
neuroblastic and eosinophilic cells (Greene and Tischler, 1976). These cells are round; 
small (6-14μm diameter) can be cultured in serum-containing medium with a doubling time 
ranging from 2-3 days. They can survive after 30 passages in culture; no significant 
chromosomal changes were found (Brynczka et al, 2007).  PC12 is used as a tool to 
overcome problems that associated with neuronal cell culturing and harvesting as it does 
not need growth factors and considered to be the best model for nerve cell differentiation 
(Fujita K et al, 1989). Importantly, PC12 are widely used to study hypoxia, receptor 
pharmacology and nerve cell differentiation. They are like the neoplastic adrenal 
chromaffin cells, after treatment with NGF they possess a neuronal phenotype (Greene & 
Tischler, 1976). The ease culture of PC12 provide large amount of information about cell 
proliferation and differentiation. Treating PC12 cells with nerve growth factor or 
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dexamethasone shift cell out of the cell cycle and induce terminally differentiate This 
makes PC12 cells very useful model for neuronal differentiation and neurosecretion. NGF 
treatment for 10–14 days cause aggregation of vesicles in the ends of the neurites. PC12 
used in hypoxia research, as duration of hypoxia induces dramatic change in exocytosis. 
prion protein fragments and vesicle release in Parkinson's disease.  
 
 
1.8.2. BM-MSCs  
Friedenstein et al was the first to demonstrate that bone marrow contains two populations 
of cells: hematopoietic stem cells (HSCs) and a rare population of plastic-adherent 
stromal cells, which were referred to mesenchymal stromal cells (MSCs) (Williams and 
Hare et al, 2011). In the early 21st century, many studies demonstrated that human MSCs 
have the ability to transdifferentiate into endoderm-derived cells and cardiomyocytes 
(Toma et al, 2002). These cells have many important characteristics such as 
multipotency, migration, long term transduction stability and no immunogenicity thus it 
provides an interesting research tool which can be used in investigations of organ and 
tissue development and different pathological processes that occur during human 
development and drug discovery and development (Lee et al, 2004; Song et al, 2006).  
Clinically, MSCs is used in kidney regeneration (Hopkins et al, 2009), blood precursor 
transplantation (Billet et al, 2008), cardiac repair (Nesselmann et al, 2008); wound healing 
(Fu et al, 2006) and treatment of arthritis (Chen and Tuan, 2008). The HIF pathway affects 
MSCs in many ways, such as modifying energy metabolism, iron metabolism, intracellular 
pH, vasomotor activity, migration, motility and modification of the extracellular matrix. 
However HIF can also induce apoptosis (cell death mechanisms via increased 
mitochondrial membrane permeability), increase ROS and RNS, and increase intracellular 
acidity that leads to significant increase in caspases activities (Csete; 2005). 
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1.9.  Aim 
The importance of multipotent stem cells applications in regenerative medicine raises the 
need to define a strategy to produce metabolically flixiablecells cells that can adapite to 
further insults and increase their number that represent the main problem facing 
multipotent stem cells such as MSCs applications. HMAs and engineered control oxygen 
technique used to produce the in vitro cell expanded-metabolic flexibile of multipotent 
stem cells. This work aims to define the impact of HMAs on multipotent stem cells. This 
study aims to compare the cell behavior changes in multipotent cells (both neural PC12 
and hBM-MSCs) after incubation under different oxygen culture condition using control 
oxygen engineering and after drug-induced hypoxia using different types and 
concentrations of HMAs and check if control oxygen engineering produce additional effect 
on cell behavior after treats both types of cells with HMAs. In both cell types; our 
hypothesis of this study is, that there would be a distinct change in cell proliferation (cell 
count, MTT, cell cycle and apoptosis), cell differentiation, HIF expression and 
Mitochondrial dynamic (burden, action potential and mitochondrial genome copy number) 
under pharmacological induce hypoxia as well as oxygen engineering. 
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Chapter 2 : Materials & Methods 
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2.1. Materials 
Table 2.1. List of materials, catalogue number and supplier 
Chemical name Catalogue number Supplier 
(3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl 
tetrazolium bromide 
M2128 Sigma-Aldrich 
3-isobutyl-1-methylxanthine  I7018 Sigma-Aldrich 
4′,6-Diamidino-2-phenylindole  D9542 Sigma-Aldrich 
Agarose BP1356-500 Fisher Scientific 
Alcian blue A3157 Sigma-Aldrich 
Alizarin red S A5533 Sigma-Aldrich 
Annexin V Binding Buffer 130-092-820 Miltenyi Biotec 
Annexin V-FITC 130-092-052 Miltenyi Biotec 
Ascorbic acid phosphate A8960 Sigma-Aldrich 
β-glycerophosphate G9422 Sigma-Aldrich 
Bovine serum albumin  BP9703-100 Fisher Scientific 
Collagen IV from human placenta C5533 Sigma-Aldrich 
Cryopreserved human bone marrow 
mononuclear cells  
2M-125C Lonza 
Cobalt Chloride C8661 Sigma-Aldrich 
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DAPI D9542 Sigma-Aldrich 
Dexamethasone D2915 Sigma-Aldrich 
Deferoxamine mesylate  D9533 Sigma-Aldrich 
Diglycidyl-ether of Polypropylene-glycol R1072 Agar Scientific 
Direct Load Wide Range DNA Marker D7058 Sigma-Aldrich 
Dimethyl Sulfoxide  D2650 Sigma-Aldrich 
Dimethyloxalylglycine D3695 Sigma-Aldrich 
Dimethylaminoethanol AGR1067 Agar Scientific 
DNeasy Blood & Tissue Kit  69504 Qiagen 
Donkey anti-mouse IgG-FITC antibody SC-2099 
Santa Cruz 
biotechnology 
DyLight® 488 goat anti-mouse IgG (H+L) ab96879 Abcam 
Dulbecco’s Modified Eagle Medium  BE12-707F Lonza 
Ethanol (absolute) E0650/17 Fisher Scientific 
ERL 4221 AGR1047R Agar Scientific 
Fetal bovine serum, South America origin  DE14-801F Biosera 
Fibronectin F0895 Sigma-Aldrich 
Flow cytometry staining buffer FC001 
R&D system 
biotechne 
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Fresh human bone marrow aspirate ABM001-1 ALLCELLS 
Gel Loading Buffer (0.05% bromophenol 
blue, 40% sucrose, 0.1 M EDTA, 0.5% 
SDS) 
G2526 Sigma-Aldrich 
Glycine 50046 SIGMA-ALDRICH 
Horse serum  H 1270 Sigma-Aldrich 
GAP-43 Antibody NB300-143 Novus Biologicals 
Glutaraldehyde solution 25% G5882 Sigma-Aldrich 
IOX2 SML-0652 Sigma-Aldrich 
Indomethacin I7378 Sigma-Aldrich 
Insulin I9278 Sigma-Aldrich 
Insulin, Transferrin, Selenium (ITS) I3146 Sigma-Aldrich 
Industrial methylated spirits (IMS) I99050 Genta Medical 
Isopropanol P/7500/17 Fisher Scientific 
L-Glutamine BE17-605E Lonza 
L-Proline P5607 Sigma-Aldrich 
Methanol M/3900/17 Fisher Scientific 
Cryopreserved human bone marrow 
mononuclear cells (MNCs) 
2M-125B Lonza 
Magnesium sulphate M-5921 Sigma-Aldrich 
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Nerve Growth Factor 7S (NGF 7S, murine, 
natural) 
13290-010 Thermo-fisher 
Non-essential amino acids BE13-114E Lonza 
Nonenyl Succinic Anhydride AGR1054 Agar Scientific 
Magnesium chloride M-8266 Sigma-Aldrich 
Oil Red O O-0625 Sigma-Aldrich 
Osmium Tetroxide AGR1015 Agar Scientific 
RNase, DNase-free 11119915001 Sigma-Aldrich 
Paraformaldehyde P-0840-53 Fisher Scientific 
Penicillin, streptomycin, amphotericin B BE17-745E Lonza 
Phosphate buffered saline BE17-516F Lonza 
Phycoerythrin-conjugated CD105 antibody 130-098-845 Miltenyi Biotec 
Phycoerythrin-conjugated CD14 antibody 130-098-167 Miltenyi Biotec 
Phycoerythrin-conjugated CD19antibody  130-098-168 Miltenyi Biotec 
Phycoerythrin-conjugated CD34 antibody 130-098-140 Miltenyi Biotec 
Phycoerythrin-conjugated CD45 antibody  130-098-141 Miltenyi Biotec 
Phycoerythrin-conjugated CD73 antibody  130-097-932 Miltenyi Biotec 
Phycoerythrin-conjugated CD90 antibody 130-098-906 Miltenyi Biotec 
66 
 
Phycoerythrin-conjugated HLA-DR 
antibody  
130-098-177 Miltenyi Biotec 
Phycoerythrin-conjugated IgG1 antibody  130-098-849 Miltenyi Biotec 
Potassium chloride P9333 Sigma-Aldrich 
Potassium phosphate PHR 1330 Sigma-Aldrich 
Propidium iodide 81845 Sigma-Aldrich 
Quantifast SYBR green RT-PCR kit 204141 Qiagen 
Synapsin I Antibody PPS062 R&D Systems 
Sodium bicarbonate S-7277 Sigma-Aldrich 
TAE Buffer  B49 Thermo-fisher 
Taq PCR Master Mix Kit 201443 Qiagen 
Transforming growth factor β3 100-36E Peprotech 
Tris HCl T3253 Sigma 
Tris Base 93352 Sigma 
Triton X-100 9002-93-1 Sigma-Aldrich 
Trypan blue T8154 Sigma-Aldrich 
Trypsin 15090 Life Technologies 
Tween 20 66368 Analar 
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Ultrapure distilled water DNAse RNAse 
free 
10977-035 Gibco 
 
 
2.2. General cell culture and experiments 
2.2.1. PC12  
2.2.1.1. PC12 thawing and culture  
PC12 cells were obtained commercially from (Sigma Aldrich-88022401-1VL). PC12 
culture medium comprised DMEM (Sigma-Aldrich, Cat. No. D5796), 5% horse serum 
(Sigma-H1270), 5% foetal bovine serum (FBS), and 1% Penicillin-Streptomycin (BE17-
745E). To establish culture a cryopreserved vial of PC12 cells were rapidly thawed in a 
37oC water bath for 2 minutes, decanted into 15 ml of fresh media, then cells spun down 
for 3 minutes at 300 x g, the supernatant removed, and the cell pellet resuspended in 7.5 
ml media which was decanted into a T25 flask and the flask placed into a humidified 37oC 
incubator with a 5% CO2.  
 
2.2.1.2. Cryopreservation of PC12 
For cryopreservation PC12 cells were first counted, centrifuged at 300 x g for 3 minutes, 
supernatant removed, and the cell pellet resuspended at 1x106 cells/ml freezing solution. 
The freezing solution was composed of 10% (v/v) DMSO, 70% DMEM and 20% FBS. The 
cell/freezing solution was then decanted into a 1.5 ml cryovial before being placed in a Mr 
Frosty TM (Nalgene®), a vessel filled with isopropanol, for controlled cooling to – 80oC 
overnight, before transferring into liquid nitrogen storage. The following day the cryovial 
was transferred into liquid nitrogen for long term storage. 
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2.2.1.3. PC12 media changes and passaging 
Media was changed every 48 hrs by first performing centrifugation of cells and media at 
300 x g for 3 minutes followed by removal of 1/3 supernatant and replacement with fresh 
culture medium. For passage cell pellets were resuspended in fresh media, counted, and 
seeded at a density of 4x104 cell/ ml into either a standard 21% oxygen incubator, a 2% 
oxygen incubator, or a 2% oxygen workstation (see Section 2.2.1.5). 
 
2.2.1.4. PC12 cell counting  
The PC12 cell suspension was centrifuged for 3 minutes at 300 x g, reconstituted with 1ml 
of fresh media, 10 µl of cell suspension removed, mixed with 10 µl of trypan blue and 
counted with the Countess® Automated Cell Counting Platform system (Figure 2.1). This 
system provides an automated cell count and viability measurement using trypan blue 
staining combined with advanced image analysis. Following cell suspension mixing with 
trypan blue cells were loaded onto the chamber slide. Prior to use the Countess required 
optimisation for each cell type with reference to sensitivity, minimal size, maximal size and 
circularity parameters. The optimisation process was started by first choosing the cell 
count mode on the setting screen (Figure 2.2.A) followed by selection of the parameters 
button (Figure 2.2.B). With the parameters screen open the above parameters can be 
adjusted, the protocol named, and saved. The protocol can then be readily recalled and 
applied (Figure 2.2.C). Loaded slides were then inserted into the machine and the cell 
count button pressed on the touch screen. 
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Figure 2.1. Countess® Automated Cell Counting Platform system  
Countess Cell counter Invitrogen (MP10227) is equipped with a camera (2.3X objective and 3.1 
mega pixel) for image acquisition and Countess™ Software to for subsequent analysis. (A). 
Countess Cell counter chamber slide is a plastic disposable that holds the sample in two separate 
chambers for replication. The counting process occurs in the central location of the counting 
chamber. The entire volume of cells counted is 0.4 μl, the same as counting four (1 mm × 1 mm) 
squares in a standard haemocytometer (B) (Invitrogen Catalogue number C10227).  
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Figure 2.2. Optimisation of Countess® Automated Cell Counting Platform system 
After switching on the home screen appears (A), the setting button is selected opening the setting 
screen (B), the parameters button is then selected (C), which contains the sensitivity, minimal size, 
maximal size and circularity options. Once determined the save button records the protocol for 
further use (Invitrogen Catalogue number C10227). 
 
As outlined above automatic image acquisition was used to generate cell count and 
viability data. Cell number/ml, Live and dead cell number/ml, and Viability (% live/dead) 
data is generated (Figure 2.3). 
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Figure 2.3. Countess Cell counter result screen 
After optimisation of machine and chamber slide loading the Count cell button is pressed and the 
results screen generated showing the total number of the cells / ml, live and dead cells/ml, and 
viability (%). Picture edited from Invitrogen (Catalogue number C10227). 
 
To standardise a PC12 cell suspension was centrifuged for 3 minutes at 300 x g, 
reconstituted with 1 ml of fresh media and 20 µl of cell suspension removed and mixed 
with 20 µl of trypan blue. 10 µl of the cell/trypan blue mixture was counted using a 
Neubauer haemocytometer by placing 10 µl of cell-trypan blue suspension under the 
coverslip of the haemocytometer via capillary action. Cells were then counted under a 
light microscope         (x 10 lenses) (Figure 2.4). A mean cell count was calculated by 
counting cell numbers in the 4 x 4 corner regions to indicate cell numbers in each 0.1 µl of 
suspension, divided by 4 to generate an average, cell number multiple by 104 followed by 
the dilution factor for trypan blue to identify cells/ml. The remaining 10 µl of cell/trypan 
blue solution was counted using the Countess® Automated Cell Counting Platform 
software. The Countess was standardisation via comparison to the standard 
haemocytometer counting technique. 
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Figure 2.4. Neubauer haemocytometer 
Neubauer haemocytometer is an enclosed chamber with two ports for sample introduction. The 
chamber contains precisely spaced lines in a grid pattern. There are two counting chambers per 
slide for replicates (A). Diagram count chamber of haemocytometer indicating the set of 16 squares 
that should be used for counting (B). 
 
Cell counts obtained with the haemocytometer revealed no significant differences to those 
obtained with the Countess at any time point over a 96 hrs growth period. 
Haemocytometer-derived cell counts increased from 4 x 104/ml at 0 hrs to 6.7 x 104/ml at 
24 hrs, and 9.5 x 104/ml, 18.6 x 104/ml, and 20 x 104/ml at 48 hrs, 72 hrs, and 96 hrs, 
respectively. Similarly, Countess-derived cell counts increased from 4 x 104/ml at 0 hrs to 
6.9 x 104/ml at 24 hrs, and 11 x 104/ml, 18 x 104/ml, and 20.6 x 104/ml at 48 hrs, 72 hrs, 
and 96 hrs, respectively. Rates of increase and final cell numbers were broadly similar 
(Figure 2.5).  
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Figure 2.5. Standardisation of Countess® Automated Cell Counter to the standard 
haemocytometer counting technique 
PC12 cells were seeded in T25 flasks at a density of 4x10
4 
and cells counted every 24 hrs using 
both cell counting techniques. (A) Cell count using haemocytometer. (B) Cell count using 
Countess
®
 Automated Cell Counter. x-axis represents time (hrs), y-axis represents cell x10
4
 / ml. 
n=3, error bars indicate ± standard deviation. 
 
2.2.1.5. Alternate oxygen level culture conditions 
Alternate oxygen conditions were supplied by seeding cells into a standard cell culture 
incubator (Panasonic MCO-18AC-EP) which represents air oxygen, for intermittent 
hypoxia (2% O2) a tri-gas incubator was used (Panasonic MCO-19M-PE) and the oxygen 
change as result of the incubator door opening (not more 5 min./ open). This condition 
aimed to mimic hypoxia/reoxygenation found after ischaemia in vivo. finally, a continuous 
normoxic environment (2% O2) was created via a hermetic workstation with controllable 
oxygen levels (SCI-TIVE, Baker Ruskinn) (Figure 2.6). 
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Figure 2.6. Oxygen level control methods 
Different oxygen levels and control was achieved using different type of incubators. Air oxygen(A), 
intermittent hypoxia (2% O2) (B) and a continuous normoxic environment (C). 
2.2.1.6. PC12 metabolic activity  
To determine metabolic activity the MTT (3-(4,5-dimethylthiazol-2yl)-
2,5diphenyltetrazolium bromide) assay was performed. PC12 cells were first mixed by 
pipetting, and then centrifuged for 3 minutes at 300 x g, and cells re-suspended in 1 ml of 
fresh medium before being counted and diluted to allow a seeding density of 6 x103 cells / 
150 μl in a 96 well plate in fresh medium. PC12 cells were then incubated at each oxygen 
level for 24, 48, 72 and 96 hrs. Following incubation media was replaced with fresh 
containing 10 µl of MTT solution (5mg /ml) and incubated at 37 oC for 3 hrs in the 
incubator. After incubation 50 µl of 1:1 DMSO: Isopropanol solution was added to each 
well followed by incubation for a further 45 minutes. Following on from the second 
incubation the contents of the well were mixed well by pipetting up and down before being 
placed into Synergy HT Multi-Detection Microplate Reader (BioTek Instruments) and read 
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at 570 nm (Figure 2.7). MTT controls included media only, media and cells, solubilising 
buffer. 
 
2.2.1.7. PC12 cell cycle  
To measure the cell cycle PC12 cells were seeded at a density of 4x104 cell/ml, flasks 
positioned vertically, and incubated for 24, 48, 72 and 96 hrs. Following incubation, cells 
were centrifuged for 3 minutes at 300 x g at 4°C. The supernatant was aspirated from the 
pellet of cells and 2ml of ice cold 70% ethanol added slowly to the sample with vortexing. 
Samples were either used immediately or stored at - 20°C till needed. Before use cells 
were spun down for 5 minutes at 500 x g, ethanol aspirated from the cells and then 
washed with 1ml PBS, vortexed gently and then washed and centrifuged again for 5 
minutes at 500 x g at 4°C. This was repeated twice. Following centrifugation cells were re-
suspended in 200 µl solution of 50 µg/ml propidium iodide (PI) with 50µl of ribonuclease 
solution (100 µg/ml in distilled water) solution, incubated in the dark for 30-45 minutes 
before having fluorescence measured via a Cytomics FC500 flow cytometer (Beckman 
Coulter). The machine was started, software opened, cell sample placed in 10 ml flow 
tube after filtration with a muslin cloth. Voltages for fluorescence channels were set using 
an unstained sample and forward scatter (FS) and side scatter (SS) adjusted to clearly 
delineate the cell population. Dead cells, clumps and debris were excluded by gating. 
Doublets were then excluded through a gating in a dot plot of FL3 versus Log forward 
scatter, so that only the gated population was visible in the histogram. 10,000 events were 
acquired on flow cytometer. Data was analysed with FCS Express 5 (De Novo Software). 
DNA histograms were then generated for each sample and data presented as a 
percentage of cell in each phase (Figure 2.7).  
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Figure 2.7. Cell cycle analysis for the PC12 cell line 
(A) Representative flow cytometry analysis of the cell-cycle displaying the initial dot plot of FS 
versus FL3 where red dots represent gate cells. (B) Histogram represents cells at different cell 
cycle phases; G1, S and G2.  
 
2.2.1.8. PC12 apoptosis 
PC12 cells were seeded at a density of 4x104 cell/ml, flasks positioned vertically, and cells 
incubated for 24, 48, 72 and 96 hrs (Figure 2.6). Following incubation cells were collected, 
centrifuged for 3 minutes at 300 x g, supernatant removed, and the cell pellet washed with 
PBS, before being centrifuged for a further 3 minutes at 300 x g. Cells were then re-
suspended in Annexin-V binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2), 
cells centrifuged again for 3 minutes at 300 x g, the supernatant removed and 10 µl of 1 
µg/ml Annexin-V added before a 15 minutes incubation at room temperature in the dark. 
After incubation cells were washed with 500 µl of Annexin-V binding buffer, cells 
centrifuged at 300 x g for 3 minutes, supernatant removed, and another 500 µl of annexin-
V binding buffer added before mixing with 10 µg/ml propidium iodide. Subsequently, the 
Cytomics FC500 flow cytometer (Beckman Coulter) machine was started, software 
opened, and the cell sample placed into a 10 ml flow tube following filtration with muslin 
cloth. Voltages for fluorescence channels were set using an unstained sample where FS 
and SS were adjusted to clearly delineate the cell population. A dot plot of FL3 (for PI) 
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versus FL1 (for Annexin-V) was then drawn (Figure 2.8). At least 20,000 events were 
collected per sample. Data was analysed with Flowing (Turku Centre for Biotechnology). 
Data is presented as a percentage of live, early apoptosis, late apoptosis, and necrotising 
cells. Negative controls were unstained cells, positive control cells were obtained by 
incubating cells at 55°C for 10 minutes.  
 
Figure 2.8. Annexin-V scatter plot 
A representative scatter plot of PC12 cells stained with Annexin-V and PI measured with the 
Cytomics FC500 flow cytometer (Beckman Coulter). Data analysis performed with Flowing 
software (Turku Centre for Biotechnology). 
2.2.1.9. Neurite outgrowth differentiation  
PC12 cells were plated at a seeding density of 104 cells/ml into 24-well plates coated with 
collagen type IV. Coating was achieved by mixing lyophilised collagen type IV with 5 ml 
PBS until dissolved. 200 µl of the collagen solution was then placed in each well and 
allowed to sit for 1 hr at room temperature; wells were then washed three times with PBS. 
For the first 24 hrs adherent cells were grown in DMEM after which media was replaced 
with DMEM containing 5% FBS and 1% horse serum and incubated for a further 24 hrs. 
Fresh media supplemented with 100 ng/ml NGF7S was then added and over the next 7-
10 days media changed every 48 hrs. Images were recorded using the Nikon Eclipse Ti 
microscope via a D5-Fil camera on NIS Elements software (Nikon). 
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2.2.1.10. Immunohistochemistry staining of PC12 differentiated using Synapsin-1 
and GAP-43 
Cells were washed with PBS, fixed with cold 4% paraformaldehyde for 25 minutes, and 
permeabilised with 0.1% PBS-Tween for 20 minutes before incubation in 1% bovine 
serum albumin blocking solution (Sigma, UK). Following incubation cells were again 
washed with PBS and fixed cells exposed to either 100 µl of synapsin1 primary antibody 
(R&D system) (1:2000) dilution or 100 µl of GAP-43 primary antibody (Novus Bio) (1:1000 
dilution). Cells were then incubated in the dark for 3 hrs at room temperature. Following 
incubation cells were first washed with PBS and then incubated with 100 µl secondary 
antibody (donkey anti-mouse IgG-FITC and donkey anti-rabbit IgG-FITC for Synapsin-1 
and GAP-43 respectively) (1:200 dilution) overnight in the dark before being washed with 
PBS. Cells were then stained with DAPI (50 ug/ml in PBS) for 5 minutes, DAPI removed, 
and cells washed with PBS 3 X 3 minutes each. The plate was then covered with 
aluminium foil until ready for imaging. Images were recorded on a Nikon Eclipse Ti 
inverted fluorescence microscope using a D5-Fil camera (Nikon) and NIS Elements 
software manufacturer (Nikon). 
 
2.2.1.11. Mitochondrial burden and Action potential 
PC12 cells were seeded into T25 flasks at density of 4x104 cells/ml for 24, 48, 72 and 96 
hrs. For experimental use cells were first mixed well by pipetting up and down before 
being transferred into a 15 ml tube and centrifuged for 3 minutes at 300 x g. After 
centrifugation media was aspirated off and replaced by fresh media supplemented by 
different concentrations of either MitoTracker® Green FM (Thermo Fisher) (5, 10, 50, 100, 
200, 400 and 800 nM) or MitoTracker® Red FM (Thermo Fisher) (2.5, 5, 10, 25, 50, 100 
and 200 nM) and cells incubated for 20 minutes. After incubation cells were washed with 
PBS and analysed on the Cytomics FC500 flow cytometer (Beckman Coulter). A minimum 
of 10,000 events were collected per sample. Data was analysed with Flowing software 
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(Turku Centre for Biotechnology). Analysis showed that 100 nM of MitoTracker® Green 
FM (Thermo Fisher) (mitochondrial burden) and 25 nM of MitoTracker® Red FM (Thermo 
Fisher) (mitochondrial membrane action potential), represented the values where a 
labelling plateau was encountered. (Figure 2.9).  
The next step was ensuring that compensation could be performed where dual 
MitoTracker sample labelling was applied to avoid bleeding across channels. This was 
performed by ensuring that the median of the negative population was equal to the 
median of the positive population in the spill over channels. Voltage channels were first 
set for fluorescence channels using an unstained sample and FS/SS adjusted to clearly 
delineate the cell population clearly, gating was then applied to exclude dead cells, 
clumps and debris. Compensation was started from the red fluorochrome step-wise down 
to the green fluorochrome while checking the compensation in all channels. 
 
  
Figure 2.9. Standardisation of MitoTracker® Green FM and MitoTracker® Red FM 
concentrations 
PC12 cells were used to determine the optimal concentration of both MitoTrackers. (A) 
Fluorescence intensity after treating cells with different concentrations of MitoTracker
®
 Green FM 
(B) Fluorescence intensity after treating cells with different concentrations of MitoTracker
®
 Red FM. 
The blue box represents the values where a labelling plateau was encountered. X-axis represent 
MitoTracker concentration (nM). Y-axis represents fluorescence intensity. Data represented as 
mean± SD.  
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2.2.1.12. Reactive oxygen species and nitroreductase activity measurement 
Cells were seeded at 4x104 cells /ml and incubated for 24, 48, 72 and 96 hrs for 
experimental use. For positive control purposes, the ROS inducer Pyocyanin (250 µM) 
and hypoxia mimetic (DFO) (200 μM) were introduced to cells followed by incubation 
under normal tissue culture conditions (37ºC, 5% CO2). Pyocyanin and DFO were 
incubated for 30 minutes and 3.5 hrs, respectively. Unstained cells were used as negative 
controls. Cells were then resuspended (5x 105 cells) in 200 µL of ROS-ID® 
Hypoxia/Oxidative Stress Detection mixture comprising 6 µl of oxidative stress reagent (5 
mM), 10 µl of nitroreductase detection agent (1 mM) in 10ml of 1x PBS for 30 minutes at 
37oC. After incubation, cells were washed with PBS and stored in the dark prior to 
analysis via Cytomics FC500 flow cytometer (Beckman Coulter). At least 10,000 events 
were collected per sample. Data was analysed using Flowing software (Turku Centre for 
Biotechnology). 
 
2.2.1.13. Hypoxia inducible factor-1α and -2α subunit expression analysis 
PC12 cells were seeded at 4x104 cells /ml for and incubated for 24, 48, 72 and 96 hrs. 
Following incubation, the cells were fixed with 80% ice cold methanol for 5 minutes 
centrifuged for 3 minutes at 300 x g, and the methanol removed. Followed by 
permeabilisation with 0.1% PBS/Tween for 20 minutes cells were again centrifuged for 3 
minutes at 300 x g, the permeabilisation solution removed and samples incubated in 
blocking solution consisting of 10% bovine serum albumin (Sigma, UK), 0.3 M glycine 
(Sigma, UK) supplemented with primary monoclonal antibodies for HIF-1α or HIF-2α 
(Abcam, USA) at concentration of 2 µg/1x106 cells and incubated for 30 minutes at 22ºC. 
The primary antibody-blocking solution was then removed via centrifugation at 300 x g for 
3 minutes. The cells were then washed with PBS, centrifuged for 3 minutes at 300 x g, 
and then incubated with 500 µl of secondary antibody DyLight® 488 goat anti-mouse IgG 
(H+L) (Abcam, USA) (1/500 dilution) for 30 min at 22ºC. The isotype control antibody was 
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mouse IgG1. FC500 flow cytometer (Beckman Coulter) was used to analyse the samples. 
At least 10,000 events were collected per sample (Figure 2.10). Data was analysed using 
Flowing software (Turku Centre for Biotechnology). 
 
Figure 2.10. DyLight® 488 gating 
Flow cytometer dot plot and histogram representing PC12 cells incubated with IgG1 control and 
primary monoclonal antibodies for HIF-1α or HIF-2α and secondary antibody DyLight
®
 488. (A) Dot 
plot of FS versus Log FL1. The red dots in R-1 gate represent the selected population. (B) 
Histogram represents FL1 where red indicates the fluorescence intensity of IgG1 (negative control) 
and grey represent cells positively stained with DyLight
®
 488. Data obtained from FC500 flow 
cytometer (Beckman Coulter) was used to analyse the samples. At least 10,000 events were 
collected per sample. Data was analysed using Flowing software (Turku Centre for Biotechnology). 
 
2.2.2. hMSCs 
2.2.2.1. hMSC isolation and culture from fresh bone marrow and cryopreserved 
mononuclear cells. 
Human bone marrow cells were isolated from commercially sourced bone marrow 
(Caltag- Medsystems Ltd) following a modification of the plastic adherence technique 
described by D’lppolito et al., (2006) and refined by Kay et al., (2015). Whole human bone 
marrow aspirate collected from the bilateral iliac crests of healthy donors was mixed with 
approximately 100 U of heparin/ml bone marrow aspirate and shipped. As soon as the 
bone marrow aspirate was received (usually between 48-72 hrs after aspiration) it was 
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seeded into flasks previously treated with 10 ng/ml fibronectin for 1hr at room temperature 
prior to being washed twice with complete media. Marrow was seeded at a density of 
1x105 mononuclear cells (MNC) /cm2 based on the total cell number stated by the 
company (MNC equal 25-33% of total cell count). After calculating the required volume of 
bone marrow aspirate, the volume was completed to the desired volume with complete 
media composed of DMEM 4.5 g/L glucose with 5%(v/v) FBS, 2 mM L-glutamine (L-Glut), 
1%(v/v) non-essential amino acids (NEAA) and 1%(v/v) penicillin, streptomycin and 
amphotericin B (100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B). 
After one week of culture 50% of media was gently removed and replaced with fresh 
antibiotic free media and after a further week 100% media change into antibiotic-free 
medium was performed, removing the majority of the remaining non-adherent leukocytes 
and erythrocytes. Following isolation, the media changes were carried out twice weekly 
with fresh media.  
Commercially sourced MNC vials from Lonza Company were obtained from density 
separated cryopreserved, human bone marrow MNCs and stored in liquid nitrogen until 
required. Cell vials were rapidly thawed at 37°C in a water bath, contents transferred to a 
centrifuge tube of complete media (as for hMSC isolation from bone marrow) and 
centrifuged for 5 minutes at 250 x g. The supernatant was then aspirated, and cells re-
suspended in complete media, counted and plated at 1x105 MNCs /cm2 and treated as for 
human bone marrow aspirate. 
2.2.2.2. Cell Splitting and passaging 
hMSCs were passaged by washing cells with PBS followed by the addition of 1-2.5 ml of 
10% trypsin-EDTA (depend on flask size) and incubation in a 37oC incubator until cells 
adopted a rounded-up morphology and were detached easily from the bottom of the flask 
by either gentle agitation or by a sharp knock to the side of the flask. Once detached the 
volume a five-fold excess of fresh media was added to inactivate trypsin and cells were 
centrifuged at 250 x g for 5 minutes. After centrifugation, the supernatant was aspirated, 
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and cells reconstituted with 1 ml fresh medium, 20 µl removed for counting and cells 
reseeded at the required density in fresh medium. hMSC were counted following 
enzymatic detachment from the flask surface with the Countess (see Section 2.2.1.4). 
2.2.2.3. Cryopreservation 
Cells were detached using trypsin-EDTA, centrifuged for 5 minutes at 250 x g, 
supernatant removed, and cells re-suspended in 1 ml of fresh media, 20 µl removed for 
cell count, centrifuged again for 5 minutes at 250 x g, supernatant again removed and 
cells re-suspended with freezing solution (1x106 cell/ml) and transferred into the cryovial. 
The freezing solution composed of 90% FBS and 10% (v/v) DMSO. The labelled cryovials 
were placed in a Mr Frosty TM (Nalgene®) for controlled cooling to – 80oC overnight, before 
transferring into liquid nitrogen storage. 
2.2.2.4. hMSCs metabolic activity  
hMSCs were cultured in 24-well plates at a density of 6 x103 cell/well and incubated for 14 
days 37oC in each oxygen condition with and witout HMAs treatment. After 14 days, cells 
were detached and the content of the well transferred into a sterile 1.5 ml sterile tube, 
centrifuged for 5 minutes at 250 x g, supernatant removed, and cells resuspended with 
150 µl fresh media contain 10 µl of MTT solution (5mg /ml), transferred into to a 96 well 
plate and incubated for 3 hrs in a 37oC incubator. After incubation, MTT precipitate was 
solubilised using 50 µl of DMSO: isopropanol 1:1 mixture and samples incubated for a 
further 45 minutes at 37oC. After the last incubation period, the contents of the wells were 
mixed well by pipetting up and down before placing into the Synergy HT Multi-Detection 
Microplate Reader (BioTek Instruments) and read at 570 nm.  
2.2.2.5. Colony forming unit firoblast assay 
The number of colony was obtained by plating marrow into T25 flasks which previously 
treated with 10 ng/ml fibronectin for 1hr at room temperature prior to being washed twice 
with complete media. Aspirate was seeded at a density of 1x105 mononuclear cells (MNC) 
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/cm2 based on the total cell number stated by the company (MNC equal 25-33% of total 
cell count).  Cells then leave to grow in standard MSCs culture media (section 2.2.2.2) for 
one week, then 50% of media was gently removed and replaced with fresh antibiotic free 
media and after a further week 100% media change into antibiotic-free medium was 
performed, removing the majority of the remaining non-adherent leukocytes and 
erythrocytes. Following isolation, cells washed with PBS, then 10 mL of a 0.5% crystal 
violet solution (Sigma) with methanol was added for 30 minutes. The cells washed with 
PBS and leaved to dryed over night then Images were recorded on a Nikon Eclipse Ti 
inverted fluorescence microscope using a D5-Fil camera (Nikon) and NIS Elements 
software manufacturer (Nikon). 
2.2.2.6. hMSCs Cell cycle  
hMSCs were cultured for 14 days at each oxygen condition (Figure 2.6). Following 
incubation period, cells detached and centrifuged at 250 x g for 5 minutes at 4°C. The 
supernatant was aspirated, and cells washed with 1 ml of ice cold 70% ethanol. These 
samples were either used directly or stored at - 20°C. For use ethanol was first aspirated 
after 5 minutes centrifugation at 300 x g at 4°C. A 200 µl solution of 50 µg/ml propidium 
iodide with 50 µl of ribonuclease solution (100 µg/ml in distilled water) was added and 
samples incubated in the dark for 30-45 minutes after which fluorescence measured via 
Cytomics FC500 flow cytometer (Beckman Coulter) as described in section 2.2.1.6. Data 
is presented as a percentage of cells in each phase. 
2.2.2.6. hMSCs apoptosis  
hMSCs were seeded and left to grow for 14 days at each oxygen condition. Cells were 
harvested and centrifuged for 5 minutes at 250 x g, PBS removed, and cell pellet re-
suspended in 500 µl Annexin-V binding buffer, cells centrifuged for 5 minutes at 250 x g, 
supernatant removed and 10 µl of 1 µg/ml Annexin-V added and incubated for 15 minutes 
at room temperature in the dark. Cells were then washed with 500 ml of Annexin-V 
binding buffer and cells centrifuged at 250 x g for 5 minutes, supernatant removed, 500 µl 
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of Annexin-V binding buffer added, mixed with 10 µg/ml propidium iodide and measured 
with the Cytomics FC500 flow cytometer (Beckman Coulter) as described in section 
2.2.1.8.  
2.2.2.7. MSCs tri-lineage differentiation and characterisation  
To determine differentiation potential, hMSCs were seeded at 2.5 x104/cm2 in standard 
proliferation media overnight to allow attachment after which media was changed to 
differentiation media. Cells were then cultured in the appropriate differentiation media for 
21 days with media changes every 3 days.  
2.2.2.7.1. Chondrogenic differentiation  
Monolayer chondrogenic differentiation was induced using media which consisted of low 
FBS 1% (v/v) DMEM supplemented with 1% (v/v) ITS, 1% (v/v) sodium pyruvate, 100 nM 
dexamethasone, 50 μM ascorbic acid phosphate, 40 μg/ml L-proline (Sigma-Aldrich) and 
10 ng/ml TGF-β3. For staining cells were fixed with 95% methanol for 10 minutes, washed 
with PBS and stained with Alcian blue, as described in section 2.2.2.7.4. 
2.2.2.7.2. Osteogenic differentiation  
Osteogenic differentiation was induced using media supplemented with 50 μM ascorbic 
acid phosphate, 10 mM β-glycerophosphate and 100 nM dexamethasone for 21 days 
before monolayers were fixed with 95% methanol for 10 minutes, washed with PBS and 
stained with Alizarin Red S as per section 2.2.2.7.5. 
2.2.2.7.3. Adipogenic differentiation  
Adipogenesis was induced using media containing 500 nM dexamethasone, 500 μM 3-
isobutyl-1-methylxanthine, 10 μg/ml insulin and 100μM indomethacin. Cells were fixed 
with 4% (w/v) paraformaldehyde in PBS for approximately 20 minutes washed with PBS 
and stained with Oil Red O for intracellular lipid droplets as described in section 2.2.2.7.6. 
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2.2.2.7.4. Alcian blue monolayer staining  
Alcian blue 1% (w/v) was used to detect sulphated glycosaminoglycans on fixed 
monolayers. Alcian blue was prepared in 0.1 M HCl and passed through filter paper. To 
stain monolayers, fixed cells were washed with PBS before being covered with the Alcian 
blue stain overnight. The next day, the stain was removed and washed gently under 
running tap water until clear. Then stained monolayers were imaged.  
2.2.2.7.5. Alizarin red S monolayer staining  
Alizarin red S was used to detect mineralised calcium nodules in fixed monolayers. 
Alizarin red S of 2% (w/v) solution was prepared in distilled water (dH2O) and filtered by 
filter paper. To stain monolayers, the fixed cells were washed with PBS before being 
covered with alizarin red S solution for 10 minutes. Then stain was removed, and 
monolayers washed gently under running tap water until clear. Wells were left to dry 
before imaging. 
2.2.2.7.6. Oil Red O monolayer staining  
Oil Red O stain was used to detect intracellular lipid droplets in the fixed monolayers. A 
saturated solution of Oil Red O was prepared as a stock solution using 300 mg of Oil Red 
O in 100 ml of 99% (v/v) isopropanol, this ensured maximum saturation of the solution and 
it was left at least 12 h before use. The working solution was prepared by mixing 40% of 
stock solution with 60% dH2O (v/v) and filtered using a 0.22 µm syringe filter. The cell 
monolayer was washed with 350 µL of 60% isopropanol and then covered with the filtered 
Oil Red O working solution for 5 minutes after which the stain was removed, and the well 
rapidly washed once with PBS before imaging.  
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2.2.2.7.7. Immunostaining of BM-hMSCs tri-lineage differentiation after incubation at 
three oxygen culture conditions after treatment with HMAs 
For detection of adipocytes differentiation goat anti-mouse FABP4 Antigen. Goat anti-
human Aggrecan antigen used to detect chondrocytes differentiation, and a mouse anti-
human Osteocalcin was used to detect osteocytes differentiation for confirm the 
differentiation status. The chondrocyctes and osteocytes were stained using the Northern 
LightsTM 557-conjugated Donkey anti-goat (Catalog #NL001; red) while adipocytes were 
stained with Anti-Mouse (Catalog #NL007; red) IgG secondary antibodies, and the nuclei 
were counterstained with DAPI (blue). 
2.2.2.8. Characterisation of MSCs (Flow cytometry)  
hMSCs were grown for 14 days at each oxygen conditions, cells washed with PBS and 
detached using 10% trypsin- EDTA at 37oC incubator until cells were rounded up and 
detached easily. Media was added, and the cell suspension centrifuged for 5 minutes at 
250 x g, counted, and re-suspended in flow cytometry buffer (0.5% (w/v) BSA and 2 mM 
EDTA in PBS) and aliquoted in 1.5 ml micro-centrifuge tubes at 1 x 105 cells/ tube, 
centrifuged again at 250 g for 5 minutes and the supernatant discarded. Phycoerythrin 
(PE) conjugated antibodies (CD14, CD19, CD34, CD45, CD73, CD90 and CD105, HLA-
DR, IgG1 and IgG2a isotype controls) were diluted in 1:11 with flow cytometry buffer to a 
total volume of 1 ml and cell pellets re-suspended in the appropriate antibody solution and 
incubated in the dark for 15 minutes at 4 °C. Buffer was then added to stained cells to a 
total volume of 1 ml and cells centrifuged at 250 g for 5 minutes, supernatant s discarded 
and the cells re-suspended in 300 μL of flow cytometry buffer. At least 5000 events were 
acquired on a Cytomics FC500 flow cytometer (Beckman Coulter). Cell samples were 
placed into a 10 ml flow tube after filtration with muslin cloth. Voltages were set for 
fluorescence channels using an unstained sample and FS/SS adjusted to make clearly 
delineate the cell population. An PE versus Log FS dot plot was then gated to exclude 
dead cells, clumps and debris. Data were analysed using Flowing software (Turku Centre 
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for Biotechnology). Gates were used to exclude 99% of the appropriate isotype control 
events and determined the percentage positive events.  
2.2.2.9. Mitochondrial burden and Action potential  
hMSCs seeded 15 x 104 cell / flask were seeded and incubated for 14 days at the three 
oxygen conditions. After 14 days media was removed, and mitochondria labelled with a 
mixture of 100 nM MitoTracker® Green FM (Thermo fisher) and 25 nM MitoTracker® Red 
FM (Thermo fisher) in fresh culture medium. Cells were then incubated for 20 minutes at 
37oC covered with aluminium foil before fixing with 4% paraformaldehyde in PBS for 20 
minutes at room temperature (RT). Fixed cells were washed with PBS, detached using 
cell scraper, and kept in the dark until analysis on the Cytomics FC500 flow cytometer 
(Beckman Coulter). Cell samples were placed into a 10 ml flow tube after filtration with 
muslin cloth. Voltages for fluorescence channels were adjusted using an unstained 
sample; FS and scatters determined for cell population visualisation. An FL1 or FL2 
versus Log FS dot plot was drawn and data analysed using Flowing software (Turku 
Centre for Biotechnology). At least 10,000 events were collected per sample.  
2.2.2.10. Reactive oxygen species and nitroreductase activity measurement 
hMSCs were cultured and detached as described above. Cells were then resuspended in 
fresh media supplemented with 200 µL of ROS-ID® Hypoxia/Oxidative Stress Detection 
mixture (6 µl of oxidative stress reagent (5 mM), 10µl of nitroreductase detection agent 
(1mM) in 10ml PBS) for 30 minutes at 37oC. After incubation, cells were washed with 
PBS, detached and kept in the dark until ready for analysis on the Cytomics FC500 flow 
cytometer (Beckman Coulter). Cell samples were placed in a 10 ml flow tube after filtration 
with muslin cloth. Voltages for fluorescence channels adjusted using an unstained 
sample; FS and FS for cell population visualisation. An FL1 or FL3 versus Log FS dot plot 
was drawn and data analysed using Flowing software (Turku Centre for Biotechnology). 
At least 10,000 events were collected per sample. 
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2.2.2.11. Hypoxia inducible factor-1α and -2α subunit expression analysis 
hMSCs were cultured for 14 days in the three oxygen conditions. Cells were washed with 
PBS, detached transferred to a 15 ml tube and centrifuged for 5 minutes at 250 x g. 
Supernatant was then removed and cells fixed with 80% ice cold methanol for 5 minutes, 
centrifuged again for 5 minutes at 250 x g, methanol removed, permeabilised with 
0.1% PBS-Tween for 20 minutes, and permeabilisation solution removed after 
centrifugation for 5 minutes at 250 x g. Cells were incubated in blocking solution 
(10% bovine serum albumin (Sigma, UK), 0.3 M glycine (Sigma, UK)) supplemented with 
mouse monoclonal HIF-1α or HIF-2α (Abcam, USA) antibody (2 µg/1x106 cells) and 
incubated for 30 minutes at 22ºC. Then primary antibody solution was removed, cells 
washed with PBS, and then incubated with 500 µl of secondary antibody DyLight® 488 
goat anti-mouse IgG (H+L) (Abcam, USA) (1:500 dilution in PBS) for 30 min at 22ºC in the 
dark. Isotype control antibody was mouse IgG1 used under the same conditions. 
Acquisition of 10,000 events was performed. Data was analysed using Flowing software. 
 
2.3. Preparation of hypoxia mimetic agents  
A CoCl2 stock solution (100 mM) was prepared by mixing 238 mg of CoCl2 with 10 ml of 
deionised water. Two working solutions (10 and 1 mM) were prepared by further dilution. 
DFO stock solution (100 mM) was prepared by mixing 65.6 mg of DFO with 10 ml of 
deionised water, two working solutions (10 and 1 mM) were prepared by further dilutions. 
DMOG stock solution (100 mM) was prepared by mixing 50 mg DMOG powder with 2.8 ml 
of deionised water. Further dilutions of DMOG were freshly made with DW to prepare a 
working solution (10 mM) where 1 ml of stock solution was mixed with 9 ml of DW. IOX2 
stock solution (10 mM) was prepared by mixing 0.35234 µg of IOX2 in 100 µl of warm 
DMSO and diluted with DW to the working solution concentration directly before use. All 
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solutions were filtered through a 0.2 μm filter and stored at 2-8°C. Toxicity testing for all 
was performed via MTT and cell counts across a range of dilutions. MTT. 
 
2.4. Mitochondrial genome copy number (qPCR) 
2.4.1. Extraction and quantification of mitochondrial DNA 
Total DNA was isolated using the DNeasy Mini kit (Qiagen, UK). 1x 106 cell/ sample 
(PC12 or hMSCs) were lysed with 10% Proteinase K in PBS, 200 μl of buffer-AL, 
thoroughly vortexed and incubated for 10 minutes at 56 oC in a water bath. Following on 
from incubation 200 μl of molecular grade ethanol was added, samples thoroughly mixed 
and the resulting solution transferred to a DNeasy Mini spin column which was then 
centrifuged for 1 minute at 3500 x g. After centrifugation, the flow through was discarded 
leaving total DNA bound to the column membrane. Then column membrane was then 
washed with 500 μl of AW1 washing buffer and the column centrifuged at 3500 x g for 1 
minute. The flow through was again discarded and 500 μl of AW2 washing buffer was 
added. The column was again centrifuged at 1100 x g for 3 minutes. The flow through was 
discarded. The column was then placed in a 1.5 ml tube. DNase & RNase-free water (50 
μl) was carefully added to the centre of the spin column membrane and allowed to soak 
for 2 minutes. The column was then centrifuged for 1 min at 56 x g and the eluted DNA 
transferred to ice. DNA concentration was quantified using a Nano drop 2000 (Thermo 
Scientific, UK) and stored at -80°C until required. 
 
2.4.2. Semi-quantitative polymerase chain reaction (PCR) 
DNA was diluted before use with nuclease-free distilled water to a final concentration of 
100 ng/μl. One step PCR was performed with Taq PCR Master Mix (Qiagen, UK). 
Following manufacturer's instructions, a master mix was first prepared which comprised of 
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6.25 μl reaction mix, 1.25 μl of each relevant primer (10 µmol), and 3.25 μl free nuclease 
water, per sample. Then 1 µl of diluted DNA was aliquoted into a 0.2 ml PCR tube on ice. 
Master mix was then added to each sample to give a final reaction volume of 12 μl. A no 
template negative control was included for all experiments. 
PCR primers were designed using rat gene and human gene sequences from NCBI map 
viewer and designed using Primer3 open-source PCR primer design software and 
obtained from Invitrogen Ltd. (Paisley, UK). Designed primers were evaluated in NCBI 
Primer-BLAST to check specificity before being purchased from Invitrogen. Primer 
sequences and product sizes are listed in Table 2.2.  
Table 2.2. PCR Primer sequences and product sizes 
Primers Sequence 
Product 
size 
Rattus Act b  
Sense TTGCCCTAGACTTCGAGCAA 
213 
R AGACTTACAGTGTGGCCTCC 
Rattus Gapdh 
F ACATGCACAGGGTACTTCGA 
163 
R TTACCCCAGCCTTCTCCATG 
Rattus mt-ND1 
F AGGACCATTCGCCCTATTCT 
183 
R GGGTAGGATGCTCGGATTCA 
Homosapiens 
ACTB 
F AACAGACTCCCCATCCCAAG 
202 
R CCAGAGGCGTACAGGGATAG 
Homo sapiens 
GAPDH  
F CGGGTCTTTGCAGTCGTATG 
168 
R CTGTTTCTGGGGACTAGGGG 
Homo sapiens 
mt-ND1 
F ATTATCGCCCCAACCCTCTC 
191 
R GCTCGTAGGGCTCCGAATAG 
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PCR tubes and sample strips were then briefly centrifuged before being transferred to a 
Senso Quest Lab cycler (Geneflow) thermal cycler. The thermal cycler was programmed 
as listed in Table 2.3. 
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Table 2.3. Thermocycler programme 
STEP 
Thermal cycler programme 
1 
One cycle of 94 °C for 3 minutes (reverse transcription step). 
2 
Three cycles of 94 °C for 1 minutes (denature hot start antibodies and DNA 
melting). 
3 
35 cycles. 
4 
94 °C for 1minute (DNA melting). 
5 
Annealing temperature as appropriate for primer pair for 1 minute. 
6 
72 °C for 1 minute (DNA extension). 
7 
One cycle of 72 oC for 10 minutes. 
8 
15 °C ∞ 
 
2.4.3. Agarose Gel Electrophoresis 
Following on from PCR amplification samples were fractionated on 2% agarose gel (4 g of 
agarose powder was dissolved in 200 ml 1x tris-acetate-EDTA (TAE) buffer (40 mM Tris 
Acetate, 2 mM Na2 EDTA). Agarose was boiled in a microwave oven until clear and the, 
agarose solution immediately poured into a casting frame and a gel comb added. 
Ethidium bromide (0.7 μg/ml) was added to the dissolved agarose solution and mixed by 
swirling before being poured. After 1hr at room temperature, the gel had set and was 
ready to use. The gel was placed into the gel tank (Bio-Rad DNA Sub cell) and 5 μl of 
each PCR sample mixed with 5 μl of gel loading buffer (Sigma, UK) and then pipetted into 
the correct well. For comparison of fragment size, direct load wide range DNA marker 
(Sigma, UK) was also run. All gels were run for one hour at 100 V and were viewed using 
an Ultraviolet Trans illuminator using Syngene gel documentation system (Cambridge, 
UK). 
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2.4.4. Quantitative polymerase chain reaction (qPCR) 
Relative gene expression was assessed using the QuantiTect SYBR Green PCR kit 
(Qiagen, UK). Replicate reactions for each gene of interest and for housekeeping genes 
were performed for each sample. To compare the gene expression difference among our 
samples the ∆∆Ct were calculated. ∆Ct value was calculated for each sample as the 
difference between the Ct for the gene of interest and the house keeping gene. ∆∆Ct was 
measured as the difference between ∆Ct values of an experimental sample and the 
control sample, the fold-change in gene expression was measured as 2-(∆∆Ct). 
Samples were prepared by adjusting the concentration of DNA to 100 ng/ml in a final 
volume of 3.5 µl of in nuclease free water and this volume placed into each experimental 
well of a chilled 96 PCR plate (Sigma, UK) and kept on ice till use. A master mix of 6.5 µl 
SYBR green, 0.5 µl of each relevant primer and 4 µl of Ultrapure distilled water DNAse 
RNAse free was prepared. Immediately before the transfer to the PCR machine 
1 µl/sample of enzyme was added to the master mix thoroughly mixed, an optical 
adhesive cover (Thermo fisher, UK) used to seal the plate and then transferred to a 
Stratagene Mx3005P real time thermal cycler (Agilent Technologies, UK) using MxPro-
3005P qPCR Software (Agilent Technologies, UK) The thermal cycler was programmed 
as shown in (Figure 2.11). 
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Figure 2.11. qPCR thermal cycle programme 
Segment 1 corresponds to amplification of the product and segment 3 to the melt curve. Graph 
obtained from Stratagene Mx3005P real time thermal cycler (Agilent Technologies, UK) using 
MxPro-3005P qPCR Software (Agilent Technologies, UK) 
 
2.5. Transmission Electron Microscope (TEM) study of MSCs 
ultrastructures 
The cells were cultured under the three-oxygen condition for 14 days, washed with 2% 
(v/v) Glutaraldehyde in cacodylate buffer (pH 7.4) containing 2 mM CaCl2 for half an hour 
at room temperature. Next cell samples were washed with 0.1 M cacodylate and then 
fixed in 1% (v/v) osmium tetroxide in 0.1 M cacodylate buffer for 1 hour before being 
washed in cacodylate buffer (pH 7.4) containing 2 mM CaCl2. Cell samples were then 
dehydrated with different concentration of ethanol (70%, 80%, 90% and 100% 
respectively), put into epoxy resin (Alan Laboratories Ltd, Reading, UK), and implanted 
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into moulds. The resin was then polymerised at 60oC for one day. Sectioning of 
polymerised resin was performed with a Reichert-Jung Ultra-cut E ultra-microtome (Leica 
Microsystems Nussloch GmbH Wetzlar, Germany).  
The ultra-thin sections were stained in uranyl acetate made in ethanol (50% (v/v)), and 
then in Reynold's lead citrate. JEOL JEM-1230 transmission electron microscope (USA) 
was used for the visualisation of ultrathin sections. Images analysis using analysSIS® 
software (Olympus Soft Imaging Systems GMBH, Germany). 
 
2.6. Statistical analysis 
All data were expressed as mean ± SD, One-way ANOVA and post-hoc (Bonferroni) 
analysis were used to define changes in cell count and MTT activity after drug treatment 
at each time point. In addition, to examine the effect of concentration, time and the 
interaction between concentration and time on cell count. The mean difference is 
significant at the 95% level (p <0.05). 
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Chapter 3 : Effects of hypoxia mimetic agents on 
PC12 
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3.1. Introduction 
PC12 cell is a pheochromocytoma cell line derived from Rattus norvegicus. It is a 
catecholamine-producing cell that synthesises, stores and releases dopamine and 
norepinephrine, similar to the chromaffin cells of the human adrenal medulla. PC12 has 
been extensively used as a neuronal model in neurochemical and neurobiological studies 
along with neuroblastoma SH-SY5Y cell line, ALS NSC-34 and NT2 cells (Greene & 
Tischler, 1976; Langlois & Duval, 1997; Madji Hounoum et al., 2016; Xicoy et al., 2017). 
PC12 cells differentiate in the presence of nerve growth factor (NGF) into neuronal cells 
that have properties of sympathetic neurons. Differentiated PC12 cells have axons and 
dendrites which are useful for neurite outgrowth assessment. PC12 cells grow rapidly in 
vitro and can be produced in large amounts, making them useful for studies where large 
quantities of cellular material may be required, for example protein-based assays. Of 
relevance to this thesis, PC12 cells have been used extensively to study oxygen-induced 
cellular changes due to their ease of culture (suspension), differentiation capacity, and 
appropriateness for stroke-related investigations. PC12 will proliferate or differentiate 
according to the mitogen stimulation that they receive. For example, epidermal growth 
factor (EGF) stimulates cells proliferation (Pennock & Wang, 2003), whereas nerve growth 
factor (NGF) tends to promote differentiation to sympathetic-like neurones (Aloe et al., 
2016). The longevity of the ERK stimulation is the main determinant for cellular fate where 
short ERK stimulation tends to promote continued cell division while more sustained ERK 
stimulation tends to encourage cellular differentiation (Kao et al., 2001). Hypoxia is 
defined as an oxygen level less than that normally encountered by any given cell type 
(Semenza, 2010). Changes in oxygen levels, and specifically hypoxia, occur in many 
physiological and developmental processes, like in embryonic development. In addition, 
hypoxia can be considered to be both cause and effect for many pathological processes 
such as myocardial infarction and infection (Semenza, 2012). Changes in oxygen levels 
are typically reflected by changes in cellular events and processes. For example, hypoxia 
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has been shown to directly impact on various mitochondrial activities such as ATP 
production, ROS formation and enzyme activities. This is thought to be due to significant 
changes that occur at a gene expression level, in response to alterations in oxygenation 
(Solaini, 2010). Many studies suggest that cells respond to hypoxia through an 
evolutionary mechanism that is regulated, at least in part, by hypoxia-inducible factor 
(HIF-1α) (Majmundar et al., 2010). HIF-1α appears to play a significant role in the 
regulation of many metabolic activities such as glucose haemostasis and lipid and amino 
acids metabolism. There is accumulating evidence, particularly in PC12 cells, that hypoxia 
and hypoxia-mimetic agents cause significant increases in the intracellular concentration 
of mitochondria-derived reactive oxygen species (ROS) (Crispo et al., 2011; Lan et al., 
2011; Guo et al., 2012). Hypoxia-mimetic agents exert their action by inhibiting prolyl-
hydroxylase, an enzyme that regulates degradation of HIF-1α, which in turn regulates 
various transcription factors (Dengler et al., 2014). The increased activity of HIF-1α has a 
positive effect on PC12 cell survival under hypoxic conditions. In this case, survival is 
thought to be facilitated by decreased inflammatory signalling, shifts in metabolism to 
glycolytic pathways, and activation of antioxidant mechanisms such as Nuclear factor E2-
related factor 2 (Nrf2) (Kolamunne et al., 2013; Zheng et al., 2015). However, it is still 
unclear how hypoxia-mimetic agents affect mitochondrial function in PC12 cells. Indeed, 
few studies have investigated the effect of HMAs used concentrations on cell proliferation, 
metabolic activity, apoptosis, cell cycle ROS formation and nitroreductase activity in PC12 
cells. The primary aim of this study is therefore to assess the in vitro effect of hypoxia-
mimetic agents on PC12 cell viability under air oxygen culture conditions (21% O2), 
intermittent 2% oxygen and continuous 2% culturing conditions (both at 2% O2). 
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3.2. Methods 
3.2.1. Materials 
Molecular grade reagents and deionised water (Sigma, UK) were used. All chemicals 
used are listed in Chapter 2, Section 2.1. 
 
3.2.2. Cell models  
The PC12 cell line was cultured, maintained and passaged in suspension form as outlined 
in Chapter 2. Cells were maintained in a tissue culture incubator (as described in Chapter 
2) using the following conditions: 37 °C, 5% CO2 and 21% O2 for air oxygen, and 37 °C, 
5% CO2 and 2% O2 for intermittent hypoxia (IH) and continuous normoxia (CN) culture 
conditions. 
 
3.3. Results 
3.3.1. Effect of hypoxia mimetic agents on PC12 cell count and metabolic 
activity 
Cell counts and metabolic activity (MTT) of PC12 cells were explored in the presence of 
HMAs. In this instance, cell count and MTT assay were being used as surrogate markers 
of cell viability. The aim of these experiments was to optimise HMA concentrations to a 
non-toxic dose for use in subsequent experiments. Cell count data is presented as 
number of cell x 104 and MTT data is presented as normalized to the corresponding 
experimental control. Cells were grown under air oxygen, intermittent hypoxia and 
continuous normoxic conditions in the presence or absence of hypoxia mimetic agents. 
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3.3.1.1. Determination of PC12 cell viability after treatment with different 
concentrations of CoCl2 at different oxygen conditions. 
Different oxygen conditions showed no significant effect on cell count over the 96 hrs. 
CoCl2 induced no significant reductions in PC12 numbers at all concentrations tested in 
both AO and IH over 96 hrs. CN displayed increased sensitivity to CoCl2 toxicity with 
significant reductions cell count was noted for concentrations ≥75 µM only. However, cells 
exposed to 50 µM CoCl2 displayed the lowest reductions in cell counts across all oxygen 
conditions and time points. At this concentration (50 µM), cell count reductions were 
measured as 17%, 14%, 7% and 2% for air oxygen culture, 5%, 1%, 10% and 3% for IH 
culture, and 10%, followed by significant increase 21%, 37% and 40% for CN culture (at 
24, 48, 72 and 96 hrs respectively) (Figure 3.1).  
Different oxygen conditions showed no significant change on MTT activity over the 96 hrs. 
CoCl2 induced significant reductions in MTT activity across all time-points and conditions 
tested except for 50 µM in CN (Figure 3.2). However, again similar to above cells exposed 
to 50 µM displayed the overall lowest levels of reductions in MTT activity of 8%, 9%, 8% 
and 14% for air oxygen, 13%, 15%, 25% and 29% for IH, and 3%, 4%, 5% and 5% for CN 
(at 24, 48, 72 and 96 hrs respectively) (Figure 3.2). 
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Figure 3.1. Effect of CoCl2 on PC12 cell counts in different oxygen conditions 
Cell counts of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of CoCl2 across a 96 hrs time-course. X-axis 
indicates different CoCl2 concetration. Y-axis indicates cell number x10
4 
/ ml. Data are presented as 
mean ± standard deviation (SD). n=1 triplicate, * indicates significant change in comparison to 
control at each time point (p<0.01). 
  
103 
 
 
 
Figure 3.2. Effect of CoCl2 on MTT activity of PC12 cultured in different oxygen 
conditions.  
MTT activity of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of CoCl2 across a 96hrs time-course. X-axis 
indicates different CoCl2 concetration. Y-axis indicates Abs. value normalized to Abs. of control at 
each time point. Data are normalized to untreated controls at each time point. n=1 triplicate, * 
indicates significant change in comparison to control at each time point (p<0.01). 
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3.3.1.2. Determination of PC12 cell viability after treatment with different 
concentrations of DFO in different oxygen conditions 
DFO induced significant reductions in PC12 numbers at all concentrations tested in both 
AO and CN over 96 hrs. IH displayed reduced sensitivity with significant reductions noted 
for concentrations ≥75 µM only (Figure 3.1). However, cells exposed to 50 µM DFO 
displayed the lowest reductions in cell counts across all oxygen conditions and time 
points. Cell count reductions were measured as 4%, 14%, 18% and 2% for AO culture, 
3%, 6%, 3% and 14% for IH, and 23%, 17%, 37% and 26% for CN (at 24, 48, 72 and 96 
hrs respectively) (Figure 3.3). Similarly, DFO significantly decreased metabolic activity, as 
measured by MTT assay, over the three oxygen conditions (p<0.05), at all time-points (24, 
48, 72 and 96 hrs), and at all concentrations tested. However, similar again to above MTT 
activity displayed the least reductions at 50 µM with 5%, 14%, 21 and 17% for AO, 8%, 
14%, 15% and 19% for IH, and 8%, 7%, 9% and 23% for CN (at 24, 48, 72 and 96 hrs 
respectively) (Figure 3.4). 
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Figure 3.3. Effect of DFO effects on cell counts of PC12 cells cultured in different 
oxygen conditions 
Cell counts of PC12 cells at air oxygen (AO) (A), intermittent hypoxia (IH) (B), and continuous 
normoxia (CN) following exposure to different concentrations of DFO across a 96 hrs time-course. 
Y-axis indicates cell number x10
4
/ ml. X-axis indicates different DFO concentrations. Data are 
presented as mean ± standard deviation (SD). n=1 triplicate, * indicate significant difference 
compared to control at beach time point (p<0.01).  
 
 
 
 
 
 
 
106 
 
 
 Figure 3.4. Effect of DFO on MTT activity of PC12 cells cultured in different oxygen 
conditions 
MTT activity of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of DFO across a 96 hrs time-course. Y-axis 
indicates Abs. value normalized to Abs. of control at each time point. X-axis indicates different DFO 
concentrations. Data are normalized to untreated controls at each time point. n=1 triplicate, * 
indicates significant change in comparison to control at each time point (p<0.01).  
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3.3.1.3. Determination of PC12 cell viability after treatment with different 
concentrations of DMOG at different oxygen conditions 
DMOG induced significant reductions in PC12 numbers at all concentrations tested in IH 
over 96 hrs (Figure 3.5). AO and CN displayed reduced sensitivity with significant 
reductions noted for concentrations ≥250 µM only (Figure 3.5). However, cells exposed to 
100 µM DMOG displayed the lowest reductions in cell counts across all oxygen conditions 
and time points. Cell count reductions were measured as 10%, 23%, 14% and 29% for 
AO, 14%, 11%, 16.6% and 20% for IH, and 13%, 26%, 21% and 34% for CN for CN (at 
24, 48, 72 and 96 hrs respectively) (Figure 3.5). DMOG significantly decreased metabolic 
activity, as measured by MTT assay, in AO and IH (p<0.05), at all time-points (24, 48, 72 
and 96 hrs), and at all concentrations tested (Figure 3.6). The exception to this was CN at 
values ≤100 µM (Figure 3.6). Reductions in MTT at 100 µM were 4%, 13%, 30% and 17% 
for AO, 7%, 13%, 14% and 19% for IH, and 7%, 6%, 9% and 22% for CN (at 24, 48, 72 
and 96 hrs respectively) (Figure 3.6).  
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Figure 3.5. Effect of DMOG on PC12 numbers in different oxygen conditions 
Cell counts of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), or continuous normoxia 
(CN) following exposure to different concentrations of DMOG across a 96 hrs time-course. Y-axis 
indicates cell number 10
4
/ ml. X-axis indicates different DMOG concentrations. Data are presented 
as mean ± standard deviation (SD). n=1 triplicate, * indicates significant changes in comparison d 
to control at each time point (p<0.01). 
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 Figure 3.6. Effect of DMOG on MTT activity of PC12 cells cultured in different 
oxygen conditions 
MTT activity of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), or continuous normoxia 
(CN) following exposure to different concentrations of DMOG across a 96 hrs time-course. Y-axis 
indicates Abs. value normalized to Abs. of control at each time point. X-axis indicates different 
DMOG concentrations. Data are normalized to untreated controls at each time point. n=1 triplicate, 
* indicates significant change in comparison to control at each time point (p<0.01).  
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3.3.1.4. Determination of PC12 cell viability after treatment with different 
concentrations of IOX2 in different oxygen conditions 
IOX2 induced significant reductions in PC12 numbers at all concentrations tested in both 
AO and IH over 96 hrs (Figure 3.7). CN displayed reduced sensitivity with significant 
reductions noted for concentrations ≥100nM only (Figure 3.7). However, cells exposed to 
50 nM displayed the lowest reductions in cell counts across all oxygen conditions and time 
points. Cell count reductions were measured as 12%, 6%, 20% and 19% for AO, 3%, 
11%, 20%and 17% for IH and 23%, 17%, 38% and 17% for CN (at 24, 48, 72 and 96 hrs 
respectively) (Figure 3.7). IOX2 significantly decreased metabolic activity, as measured by 
MTT assay, in all conditions (p<0.05), at all time-points (24, 48, 72 and 96 hrs), and at all 
concentrations tested (Figure 3.8). Reductions in MTT at 50 nM were 9%, 17%, 29 % and 
17% for AO, 14%, 20%, 15% and 16 % for IH, and 5%, 6%, 10% and 13% for CN (at 24, 
48, 72 and 96 hrs respectively) (Figure 3.8). 
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Figure 3.7. Effect of IOX2 effects on cell counts of PC12 cells cultured in different 
oxygen conditions 
Cell counts of PC12 cells at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of IOX2 across a 96 hrs time-course. Y-axis 
indicates cell number x10
4
. X-axis indicates different IOX2 concentrations. Data are presented as 
mean ± standard deviation (SD). n=1 triplicate, *indicates significant change in comparison d to 
control at each time point (p<0.01).  
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Figure 3.8. Effect of IOX2 on MTT activity of PC12 cells cultured in different oxygen 
conditions 
MTT activity of PC12 cells in air oxygen (AO), intermittent hypoxia (IH) (B), or continuous normoxia 
(CN) following exposure to different concentrations of IOX2 across a 96 hrs time-course. Y-axis 
indicates Abs. value normalized to Abs. of control at each time point. X-axis indicates different 
IOX2 concentrations. Data are normalized to untreated controls at each time point. n=1 triplicate, * 
indicates significant change in comparison to control at each time point (p<0.01). 
 
The reduction in cell count and MTT activity after ≥75 µM CoCl2 and ≥75 µM (iron 
dependent HMAs) may related to ability to competing or chelating iron from binding site 
PHD enzyme (respectively) leading to induce hypoxia response by reduce HIF1-α 
degradation which affecting cell cycle and apoptosis (Zeng et al., 2011). In addition, these 
agents may be affecting cytoplasmic enzymes as nitroreductases and mitochondrial 
enzymes as NAD(P)H dehydrogenase activity that lead to increase sensitivity of PC12 to 
CoCl2 and DFO toxicity and ROS formation. 
This reduction in cell count and MTT after ≥100 µM DMOG and ≥100 nM IOX2 may 
related to the fact that DMOG and IOX2 inhibit PHD enzyme by act as a substrate leading 
to indice hypoxia response and this may be affecting cell cycle and cell survival. These 
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agents have significant effect on mitochondrial metabolism and function by changing 
intracellular acidification, rapidly inhibits mitochondrial respiration which even precedes 
activation of HIF pathways (Zhdanov et al., 2015). The difference in cell count and MTT 
activity between the two agents may be related to the lack of selectivity for PHD and FIH 
in DMOG. 
Following on from definition of the HMA dose that minimally affected PC12 cell viability 
(50 µM for CoCl2 and DFO, 100 µM for DMOG and 50 nM for IOX2) we sought to confirm 
that these agent at used doses still have ability to induce of HIF-1α and HIF-2α. 
 
3.3.2. Effect of hypoxia mimetic agents on HIF expression 
Hypoxia inducible factors (HIFs) are proteins that serve as heterodimeric transcription 
factors responsible for regulation of oxygen homeostasis. They are stabilised under 
hypoxia due to a lack of activity of enzymes from the prolyl-hydroxylase family. PHDs 
when active hydroxylate HIFs at specific residues directing them for subsequent 
ubiquitination and degradation (Semenza, 2007). HIFs stability is therefore regulated 
mainly by post-translational prolyl hydroxylation catalysed by the HIF prolyl hydroxylase 
domain proteins (PHDs) (Fan et al., 2014). There are three known HIF-α isoforms (HIF-
1α, HIF-2α, and HIF-3α). HIF-1α is ubiquitously expressed; HIF-2α expression is specific 
to endothelia, parenchyma, and interstitial cells, and finally HIF-3α of which less is known. 
Studies described the effects of hypoxia and HMA on HIF-1α and HIF-2α expression, in 
which HMAs were applied at high concentrations associated with reduced cell viability and 
short-term exposures (Rodríguez-Jiménez et al., 2008; Cartee et al., 2012; Giansanti et 
al., 2013). We sought to determine whether HIF-1α and HIF-2α expression was induced in 
either AO, IH, or CN cultured PC12 cells and whether the HMA doses we had identified 
induced HIF-1α expression to levels comparable with AO, IH, or CN culture. 
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Using FACS analysis of immuno-labelled suspension cultured PC12 we established that 
AO cultured cells displayed a consistent baseline expression of 33.85± 8.77%. PC12 
stocks used to initiate all experiments were measured to establish control levels and are 
represented as the X-axis intersection with the Y-axis (Figure 3.9).  
In this work, we find that IH cultured cells displayed an immediate upregulation of HIF-1α 
after 24 hrs to 64% which was down regulated to 55% by 48 hrs and maintained thereafter 
at 49% at 72 hrs and 55% at 96 hrs. In contrast to IH, CN displayed a consistently low 
expression profile over the entire time course (29% at 24 hrs, 35% at 48 hrs, 35% at 72 
hrs, and 33% at 96 hrs). Taken together this demonstrated that IH and CN culture induced 
distinct HIF-1α stabilisation profiles (Figure 3.9).  
Having established the baseline HIF-1α profiles for each oxygen condition we next sought 
to determine the role of the HMA at the previously identified minimal concentrations over 
96 hrs of culture. In AO culture, significant upregulation was noted with all HMAs, after 24 
hrs, to levels comparable to those noted for IH; CoCl2 65%, DFO 62%, DMOG 61%, and 
IOX2 77% (Figure 3.9.A). HIF-1α levels were substantially reduced for all HMAs by 48 hrs 
(CoCl2 50%, DFO 46%, DMOG 48% and IOX2 52%) to levels still consistent with IH. At 72 
hrs CoCl2 levels had reduced to baseline 35% whereas the remaining HMAs continued to 
display consistency with IH (DFO 53.5%, DMOG 48.8%, IOX2 56.8%). At 96 hrs, HIF-1α 
had dropped to a consistent elevated above baseline level with all HMAs tested. The 
overall profile of HMAs in AO was that they bore a close resemblance to IH cultured cells 
but not CN. IH cultured PC12 cells were also supplemented with HMAs to establish if an 
additive or negative feedback loop could be identified. HIF-1α expression levels in HMA 
supplemented media were comparable to IH throughout the 96 hrs period indicating an 
absence of an additive or negative effect (Figure 3.9.B). CN cultured cells displayed a 
distinct HIF-1α profile where marginal upregulation was noted after 48 hrs (43.45%), but 
low levels of expression at all other time-points, with levels comparable to AO (Figure 
3.9.C). The presence of HMAs again resulted in distinct responses where CoCl2 
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supplementation marginally upregulated HIF-1α at 24 hrs to 40%, not at 48 hrs, and was 
comparable at all other points. DFO and IOX2 supplementation resulted in HIF-1α levels 
consistent with CN throughout whereas DMOG supplemented PC12 displayed 
comparable levels at all time-points apart from 96 hrs where some up regulation was 
noted. To sum up at used concentrations HMAs (except DMOG and IOX2 at 96 hrs) have 
no additive effect on HIF-1α expression over both IH and CN culture condition. 
 
Figure 3.9. Effect of hypoxia mimetic agents on HIF-1α expression in different 
oxygen conditions 
The percentage of anti-HIF-1α (ab16066) labelled cells is shown. PC12 were exposed to (50 µM 
CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs in AO, 
IH and CN. Data are presented as mean of % of HIF-1α positive ± standard deviation (SD). n=1 
triplicate, * indicates significant difference in comparison to the % of HIF-1α positive cells at each 
time point. 
 
HIF-1α expression over the 96 hrs showed reduction in magnitude with time and this 
finding reflect that the cells develope adaptation to oxygen levels and this correct for both 
IH and after treatment with HMAs and this may relate to activation of negative feedback 
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genes that regulate HIF-1α expression by increase HIF-3α4 expression which weaken the 
HIF-1α / DNA binding (Drevytska et al., 2012). 
 
HIF-2α displayed an expression profile distinct to that seen with HIF-1α. The experimental 
seeding population displayed a baseline expression of 60% which is indicated by the 
intersection of the x-axis with the y-axis (Figure 3.10). AO cultured cells were as expected 
consistent with baseline at 24 hrs (61.36%) but levels decreased to 53.33 at 48 hrs, 
50.35% at 72 hrs and 48.57% at 96 hrs; CN cultured cells were consistent with baseline 
through to 72 hrs with a sharp down-regulation to 48% noted thereafter while IH cultured 
cells displayed some up regulation at 24 hrs to 75% followed by down regulation to levels 
comparable with AO and CN at 96 hrs (Figure 3.10). In AO, CoCl2 induced an initial up 
regulation at 24 hrs to levels comparable with IH, followed by downregulation to levels 
comparable with baseline at 72 hrs and slight upregulation above baseline at 96 hrs. DFO 
induced slight upregulation at 24 and 48 hrs, down regulation below baseline at 72 hrs, 
followed by upregulation to levels comparable with CoCl2 at 96 hrs. AO cultured DMOG 
supplemented cells displayed an upregulation at 24 hrs comparable to CoCl2 which had 
dropped by 48 hrs to a position of marginal upregulation and was maintained at that levels 
through to 96 hrs. IOX2 displayed a similar upregulation profile to CoCl2 and DMOG at 24 
hrs followed by downregulation to baseline levels through to 72 hrs and marked 
upregulation at 96 hrs. The overall profile of HMA driven HIF-2α regulation over 96 hrs 
was distinct from AO, IH, and CN cultured cells. Supplementation of IH cultured PC12 with 
HMAs again resulted in a shared response profile with IH for CoCl2, DFO, and DMOG at 
24 hrs (Figure 3.10.B). For CoCl2 this was reduced to baseline levels by 48 hrs and 
thereafter. DFO maintained upregulation at 48 hrs, was markedly decreased at 72 hrs, 
followed by upregulation at 96 hrs. HIF-2α levels were reduced in DMOG at 48 hrs and 
were below baseline at 72 hrs and thereafter. IOX2 induced baseline levels of HIF-2α 
expression throughout the 96 hrs timeline. CN cultured cells displayed a constant HIF-2α 
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profile over 72 hrs comparable to baseline expression followed by down regulation after 
96 hrs. The presence of HMAs again resulted in distinct responses where CoCl2 
supplementation up regulated HIF-2α at 24 hrs 77%, at 48 hrs and 72 hrs HIF-2α profile is 
comparable to CN with higher expression observed after 96 hrs. DFO and DMOG 
supplementation resulted in HIF-2α levels constantly higher than CN throughout whereas 
DFO supplemented PC12 displayed higher level at 96 hrs where some up regulation was 
noted. IOX2 induced baseline levels of HIF-2α expression throughout the 72 hrs with 
higher expression level was observed after 96 hrs. 
 
Figure 3.10. Effect of hypoxia mimetic agents on HIF-2α expression in oxygen 
conditions 
The percentage of anti-HIF-2α (ab8365). PC12 cells were exposed to (50 µM CoCl2, 50 µM DFO, 
100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs in AO (A), IH (B) and CN 
(C). Data are presented as % of HIF-1α positive ± standard deviation (SD). n=1 triplicate, * 
indicates significant difference in comparison to the % of HIF-2α positive cells at each time point. 
 
Again HIF-2α expression showed reduction to the level less than baseline expression with 
time and this finding reflect that HIF-2α no longer orchestrates adaptive responses may 
related to the switch in HIF-1/HIF-2 signaling over 96hrs under hypoxia that involve in cell 
118 
 
survival in energy crisis by regulating balance between energy saving and reduction in 
PC12 proliferation on one hand and active cell growth and tumor expansion, on the other 
hand (Zhdanov et al., 2013).  
3.3.3. Effect of hypoxia mimetic agents on PC12 cell differentiation capacity. 
A core feature of PC12 is their neural differentiation capacity following exposure to the 
correct conditions. These are achieved by encouraging adhesion of the suspension 
culture cells via provision of a Collagen IV coated substrate. Differentiation is then 
spontaneous at low levels but can be enhanced via provision of NGF. We sought to 
determine if AO, IH, and CN would induce comparable levels of differentiation, quantify 
the enhancement induced by NGF, and determine if HMAs would mirror IH and/or CN 
responses. Differentiation was quantified by counting cells with neurite extensions (See 
Section 2.2.1.9). 
To confirm neurogenic differentiation, we next performed immunofluorescence for both 
GAP-43 and Synapsin-1; neurogenic differentiation markers (Rossoll & Bassell, 2009). 
SH-SY5Y is a human derived cell line isolated from neuroblastoma biopsy from bone 
marrow used as an in vitro model of neuronal function and differentiation. These cells 
possess an adrenergic phenotype, express neurogenic markers GAP-43 and Synapsin-1 
(Zhang et al., 2008), and SH-SY5Y was included as a control. 
There were no significant effects for different oxygen culture condition on PC12 cells 
neurite development capacity without induction by NGF (Figure 3.11 and 12). In addition, 
all oxygen condotions elevated GAP-43 while synapsin-1 elevated only under IH culture 
condition in comparison to base line expression of SH-SY5Y (Figure 3.13 and 14 
respectively).  
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Figure 3.11. Neuronal differentiation is enhanced by NGF in an oxygen-independent 
manner 
PC12 cell were cultured in collagen IV pre-coated 24-well plate with and without NGF stimulation 
for 7-10 days at three different oxygen culture conditions. Histogram shows the percentage of 
neurite bearing PC12. X-axis indicates the oxygen and NGF treatment. Y-axis indicates the 
percentage of neurite bearing cells. Error bars indicates standard deviation. * indicates significant 
difference in comparison to control (without and with NGF treatment respectively) p< 0.01. 
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Figure 3.12. Neurite outgrowths of PC12 
PC12 were plated at a seeding density of 10
4
 cells/ml into 24-well plates coated with collagen type IV and incubated for 7-10 days at AO +/- NGF, PC12 
incubated at IH +/- NGF, PC12 incubated at DMOG +/- NGF, Scale bar equal 100 µm. 
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Figure 3.13. Effect of different oxygen culture conditions on GAP-43 expression 
PC12 cultured under different oxygen conditions with and without addition of NGF.The cell labelled with anti-GAP-43 primary antibody and then incubated 
with anti-rabbit IgG-FITC secondary antibody. GAP-43 expression in PC12 without NGF treatment (Blue indicates DAPI, Green indicates GAP-43). 
expression in PC12 without NGF treatment (Blue indicates DAPI, Green indicates GAP-43). SH-SY5Y used as positive control. Scale bar indicates 100 
µm.  
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Figure 3.14. Effect of different oxygen culture conditions on Synapsin-1 expression 
PC12 cultured under different oxygen conditions with and without addition of NGF. The cell labelled with anti-synapsin-1 primary antibody and then 
incubated with anti-mouse IgG-FITC secondary antibody.  Synapsin-1 expression in PC12 without NGF treatment (Blue indicates DAPI, Green indicates 
Synapsin-1). (Blue indicates DAPI, Green indicates Synapsin-1). SH-SY5Y used as positive control. Scale bar indicates 100 µm. 
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After NGF induction, significantly increased neurite outgrowth of PC12 cell was observed 
after incubation in IH and CN in comparison to NGF induced cells (Figures 3.11 and 3.15). 
In addition, all oxygen condotions elevated GAP-43and synapsin-1 elevated only under IH 
culture condition in comparison to base line expression of SH-SY5Y (Figures 3.16 and 
3.17 respectively).  
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Figure 3.15. Neurite outgrowths of PC12 
PC12 were plated at a seeding density of 10
4
 cells/ml into 24-well plates coated with collagen type IV and incubated for 7-10 days at AO + NGF, PC12 
incubated at IH + NGF, PC12 incubated at DMOG +- NGF, Scale bar equal µm 100. 
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Figure 3.16. Effect of different oxygen culture conditions on GAP-43 expression 
PC12 cultured under different oxygen conditions with and without addition of NGF.The cell labelled with anti-GAP-43 primary antibody and then incubated 
with anti-rabbit IgG-FITC secondary antibody. GAP-43 expression in PC12 with NGF treatment (Blue indicates DAPI, Green indicates GAP-43. SH-SY5Y 
used as positive control. Scale bar indicates 100 µm.  
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Figure 3.17.Effect of different oxygen culture conditions on Synapsin-1 expression 
PC12 cultured under different oxygen conditions with and without addition of NGF. The cell labelled with anti-synapsin-1 primary antibody and then incubated 
with anti-mouse IgG-FITC secondary antibody. (A) Synapsin-1 expression in PC12 with NGF treatment (Blue indicates DAPI, Green indicates Synapsin-1). 
SH-SY5Y used as positive control. Scale bar indicates 100 µm. 
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Only DMOG culture under AO significantly increase percentage of neurite bearing cells 
(8%) in comparison to control AO (p<0.05) (Figure 3.18A and 19). HMAs alone showed no 
remarkable effect on GAP-34 and synapsin-1 expression in comparison to AO (Figure 3. 
20 and 3.21). 
 
Figure 3.18. HMAs display distinct impacts on neuronal differentiation without NGF 
response 
PC12 cell were cultured in collagen IV pre-coated 24-well plate with and without NGF stimulation 
for 7-10 days after treatment with hypoxia mimetic agents at air oxygen (AO). Histogram shows the 
percentage of neurite bearing PC12 after treatment with HMAs alone (A) and after combination of 
NGF+ HMAs (B). X-axis indicates the oxygen and HMAs. Y-axis indicates the percentage of 
neurite bearing cells. Error bars indicates standard deviation. * indicates significant difference in 
comparison to control (p< 0.01).  
 
After NGF supplementation at AO, CoCl2, DMOG and IOX2 significantly increase 
percentage of neurite bearing cells (9, 11 and 10%) in comparison to control AO+NGF 
(p<0.05) (Figure 3.18.B and 19). At AO, iron dependent HMAs (CoCl2 and DFO) 
remarkably reduced GAP43, 2 oxoglutrate HMAs showed no significant effect on GAP43 
expression (Figure 3.20). HMAs (except CoCl2) caused obvious elevation in synapsin-1 
expression (Figure 3.21). 
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Figure 3.19. Neurite outgrowths of PC12 at AO  
PC12 were plated at a seeding density of 10
4
 cells/ml into 24-well plates coated with collagen type IV and incubated for 7-10 days (A) PC12 supplemented 
with CoCl2 +/- NGF, (B). PC12 supplemented with DFO +/- NGF, (C). PC12 supplemented with DMOG +/- NGF, (D). PC12 supplemented with IOX2 +/- 
NGF. Scale bar equal 100 µm. 
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Figure 3.20. Effect of HMAs on GAP-43 expression in PC12 at AO 
PC12 cultured under air oxygen condition with and without addition of NGF.The cell labelled with anti-GAP-43 primary antibody and then incubated with 
anti-rabbit IgG-FITC secondary antibody. (A) GAP-43 expression in PC12 with NGF treatment (Blue indicates DAPI, Green indicates GAP-43). (B) GAP-43 
expression in PC12 without NGF treatment (Blue indicates DAPI, Green indicates GAP-43). Scale bar indicates 100 µm
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Figure 3.21. Effect of HMAs on Synapsin-1 expression in PC12 in AO 
PC12 cultured under air oxygen condition with and without addition of NGF the cell labelled with anti-synapsin-1 primary antibody and then incubated with 
anti-mouse IgG-FITC secondary antibody. (A) Synapsin-1 expression in PC12 with NGF treatment (Blue indicates DAPI, Green indicates GAP-43). (B) 
Synapsin-1 expression in PC12 without NGF treatment (Blue indicates DAPI, Green indicates Synapsin-1). Scale bar indicates 100 µm. 
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neurite outgrowth at IH, significant effect elevated after supplementation with DFO and 
IOX2 while CoCl2 and DMOG have no effect of neurite outgrowth (Figure 3.22A and 23). 
DFO, DMOG and IOX2 remarkably increase in GAP-43 (Figure 3. 24). No change in 
synapsin-1 expression was noticed after HMAs supplementation (Figure 3.25). 
IH and NGF exposure stimulated a 3X increase in PC12 cell differentiation (Figure 3.22B 
and 23). while IH + NGF only CoCl2 and IOX2 caused significant reduction in neurite 
formation capacity in comparison to IH + NGF treated cells (Figure 3.19.B). GAP-43 
expression reduced after CoCl2 and DMOG with no obvious effect for DFO and IOX2 
(Figure 3.23). Synapsin-1 showed no obvious change after treatment with all HMAs 
(Figure 3.24 and 25). 
 
Figure 3.22. PC12 neurite outgrowth quantification in IH 
PC12 cell were cultured in collagen IV pre-coated 24-well plate with and without NGF stimulation 
for 7-10 days after treatment with hypoxia mimetic agents at intermittent hypoxia oxygen (IH). 
Histogram shows the percentage of neurite bearing PC12 cell after treatment with HMAs alone (A) 
and after combination of NGF+ HMAs (B). X-axis indicates the oxygen and HMAs. Y-axis indicates 
the percentage of neurite bearing cells. Error bars indicates standard deviation. * indicates 
significant difference (p< 0.01). 
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Figure 3.23. Neurite outgrowths of PC12 at IH  
PC12 were plated at a seeding density of 10
4
 cells/ml into 24-well plates coated with collagen type IV and incubated for 7-10 days. (A) PC12 supplemented 
with CoCl2 +/- NGF, (B). PC12 supplemented with DFO +/- NGF, (C). PC12 supplemented with DMOG +/- NGF, (D). PC12 supplemented with IOX2 +/- 
NGF. Scale bar equal 100 µm. 
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Figure 3.24. Effect of HMAs on GAP-43 expression in PC12 at IH 
PC12 cultured under intermittent hypoxia condition with and without addition of NGF. The cell labelled with anti-GAP-43 primary antibody and then 
incubated with anti-rabbit IgG-FITC secondary antibody. (A) GAP-43 expression in HMA supplemented PC12 with NGF. Blue indicates DAPI nuclei, Green 
indicates GAP-43. (B). GAP-43 expression in HMA supplemented PC12 without NGF. Scale bar indicates 100 µm. 
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Figure 3.25. Effect of HMAs on Synapsin-1 expression in PC12 at IH 
PC12 cultured under intermittent hypoxia condition with and without addition of NGF. The cell labelled with anti-synapsin-1 primary antibody and then 
incubated with anti-mouse IgG-FITC secondary antibody (A) Synapsin-1 expression in HMA supplemented PC12 with NGF (Blue indicates DAPI nuclei, 
Green indicates Synapsin-1). (B). Synapsin-1 expression in HMA supplemented PC12 without NGF. Scale bar indicates 100 µm. 
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CN + NGF exposure stimulated an 80% increase in PC12 cell differentiation in 
comparison to non NGF treated cells. DFO and IOX2 significantly elevated neurite 
outgrowth (Figure 3.26A and 27). All HMAs remarkably reduced GAP-43 expression while 
they have no effect on synapsin-1 (F igure 3.28 and 29). 
CN + DFO significantly increase neurite formation in comparison to CN +NGF (Figure 
3.26A and 27). CN + NGF + CoCl2 and DMOG displayed a marked and significant 
reduction in differentiated cell number vs. CN+ NGF treated cells (Figure 3.26B). HMAs 
showed no obvious effect on GAP-43 and synapsin-1 expression while only DMOG can 
induce some elevation in syanpsin-1 (Figure 3.28 and 29).  
 
Figure 3.26. Neurite outgrowths of PC12 at CN 
PC12 cell were cultured in collagen IV pre-coated 24-well plate with and without NGF stimulation 
for 7-10 days after treatment with hypoxia mimetic agents at continuous normoxia (CN). Histogram 
shows the percentage of neurite bearing PC12 cell after treatment with HMAs alone (A) and after 
combination of NGF+ HMAs (B). X-axis indicates the oxygen and HMAs. Y-axis indicates the 
percentage of neurite bearing cells. Error bars indicates standard deviation. * indicates significant 
difference (p< 0.01).
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Figure 3.27. Neurite outgrowths of PC12 at CN 
PC12 were plated at a seeding density of 10
4
 cells/ml into 24-well plates coated with collagen type IV and incubated for 7-10 days. (A) PC12 supplemented 
with CoCl2 +/- NGF, (B). PC12 supplemented with DFO +/- NGF, (C). PC12 supplemented with DMOG +/- NGF, (D). PC12 supplemented with IOX2 +/- 
NGF. Scale bar equal 100 µm. 
151 
 
 
 
152 
 
 
Figure 3.28. Effect of HMAs on GAP-43 expression in PC12 at CN 
PC12 cultured under continuous normoxia condition with and without addition of NGF. The cell labelled with anti-GAP-43 primary antibody and then 
incubated with anti-rabbit IgG-FITC secondary antibody (A) GAP-43 expression in HMA supplemented PC12 with NGF. Blue indicates DAPI nuclei, Green 
indicates GAP-43. (B). GAP-43 expression in HMA supplemented PC12 without NGF. Scale bar indicates 100 µm. 
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Figure 3.29. Effect of HMAs on Synapsin-1 expression in PC12 at CN 
PC12 cultured under continuous normoxia condition with and without addition of NGF. The cell labelled with anti-synapsin-1 primary antibody and then 
incubated with anti-mouse IgG-FITC secondary antibody. (A) Synapsin-1 expression in HMA supplemented PC12 with NGF. Blue indicates DAPI nuclei, 
Green indicates Synapsin-1. (B) Synapsin-1 expression in HMA supplemented PC12 without NGF. Scale bar indicates 100 µm. 
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In vitro model is vtial in screening of huge number of chemicals thet have potential 
pharmacological use. PC12 cell is one of the most known model to study the 
developmental neurotoxicants, assessment of critical neurodevelopmental processes and 
neuronal differentiation. neurotrophic factor NGF induce signaling pathways that control 
differentiation, and effect of chemicals on neurite outgrowth. NGF treated PC12 cells 
cease to proliferate, extend multiple neurites, and possess sympathetic neurons 
properties. Differentiation and neurite outgrowth can be quantitative assessment using 
simple contrast microscopy in live cells, or by fluorscene imaging after 
immunocytochemistry staining. 
The results of this work showed that there is no significant effect for different oxygen 
culture conditions on neurite outgrowth when cells un induced by NGF in contrast NGF 
induced cells showed significant elevation when incubated at IH (3 fold) and CN (80%) 
and this may be related to the fact that HIF-) Is a transcriptional activator of the 
tropomyosin receptor kinase A and B (Trk A and B) neurotrophin receptor gene thus have 
synergistic effect with NGF elevated (Martens et al., 2007). our findings suggest that 
hypoxia induces neurite outgrowth in PC12 cells via a pathway different from that 
activated by NGF. Expose to IH at critical stages of development may contribute to 
aberrant neurite outgrowth and could be a factor in the pathogenesis of certain delayed 
developmental neurological disorders. 
HMAs companied by a signiﬁcant decrease in the expression of the neuronal speciﬁc 
axonal marker of differentiation, GAP-43, as determined by immunoﬂuorescence and 
these results support the finding that HMAs uncoupled GAP-43 expression from neurite 
outgrowth and that hypoxia-induced neurite outgrowth is mediated by activation of 
adenosine A2A receptors coupled to adenylate cyclase (O’D riscoll and Gorman, 2005). 
HMAs under all oxygen culture conditions showed no obvious change in synapsin-1 
expression. 
 
156 
 
 
 
3.3.4. Effect of hypoxia mimetic agents on PC12 cells apoptosis 
During embryonic development, tissue maintenance and stress conditions like hypoxia 
and apoptosis occur as physiological processes. Apoptosis is characterised by certain 
morphologic changes which include changes in the plasma membrane, cytoplasm and 
nucleus condensation, and DNA cleavage. Changes in plasma membrane structure are 
amongst the earliest criteria. During apoptosis, phospholipid phosphatidylserine (PS) in 
the cell membrane is translocated to the outer side of the plasma membrane from the 
inner side, exposing PS to the external cellular environment. Annexin V is a 35-36 kDa 
Ca2+ dependent phospholipid-binding protein that has a high affinity for exposed PS. To 
retain affinity and sensitive, Annexin V conjugated to fluorochrome including 
Allophycocyanin (APC). Exposed PS in apoptotic cells bind APC Annexin V in 
combination with the membrane impermeable DNA dye propidium iodide (PI) used to 
differentiate between viable, apoptotic and secondary necrotic cells. 
To establish if the reduction in cellular viability was due to programmed cell death 
(apoptosis), the Annexin V assay was performed as outlined in Chapter 2, Section 2.2.1.8. 
PC12 cells incubated at AO, IH and CN culture shows that there was significant increase 
in early apoptosis and necrosis after incubation, while at IH only significantly increase late 
apoptosis with no significant effect was noticed at CN culture condition in comparison to 
AO culture condition.  
Under AO culture, all HMAs induced early apoptosis in comparison to control AO at nearly 
at all time points (p<0.01). No significant effect was noticed in late apoptosis after 
treatment with HMAs over 96 hrs. After treatment with DMOG and IOX2 significant 
increase in necrotic cells percentage after first 48 hrs and 24 and 48 hrs respectively. 
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While after 96 hrs all HMAs significantly reduced necrotic cells percentage in comparison 
to control AO at each time points (Figure 3.30). 
Under IH culture condition, CoCl2 and DFO significantly increase early apoptosis at 24, 72 
and 96 hrs with significant increase was noticed on early apoptosis after treatment with all 
DMOG after 96 and IOX2 at 24 hrs. No significant effect was noticed on late apoptosis 
(Figure 3.31).  
The percentage of necrotic cells significantly reduced after treatment with DFO, DMOG 
and IOX2 after 96 hrs, while it increased after 24 and 48 hrs after necrosis in co DFO, 
DMOG ans IOX2 in comparison to control IH at each time point (p<0.01 (Figure 3.29). 
Finally, under CN culture HMAs significantly elevate early apoptosis and late apoptosis 
over the 96 hrs. Necrosis significantly elevated over 96 hrs (Figure 3.30). To sum up 
HMAs cause significant elevation in early apoptosis and necrosis in PC12 under all 
oxygen culture conditions (Figure 3.32).   
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Figure 3.30. PC12 apoptosis/necrosis under air oxygen  
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs, the percentage of early, late apoptotic and apoptotic PC12 at AO was 
plotted. Data are presented as mean ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to AO at each time point (p<0.01). 
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Figure 3.31. PC12 apoptosis/necrosis under intermittent hypoxia  
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs, the percentage of early, late apoptotic and apoptotic PC12 at IH was 
plotted. Data are presented as mean ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to AO at each time point (p<0.01). 
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Figure 3.32. PC12 apoptosis/necrosis under continuous normoxia  
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs, the percentage of early, late apoptotic and apoptotic PC12 at CN was 
plotted. Data are presented as mean ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to AO at each time point (p<0.01). 
 
Intermittent hypoxia significantly elevated early apoptosis by increased p53 and oxidative 
stress lead to activation of caspase-3. Chemical hypoxia may induce inflammatory 
reactions by increasing in NO production and IL-6 secretion from PC12 cells. NO is a one 
of the most toxic substance several proinflammatory factors. HMAs may upregulated the 
expression levels of NOS by activation of mitogen-activated protein kinase (MAPK) family, 
which is contain three main members: extracellular signal-regulated protein kinase 1/2 
(ERK1/2), C-Jun-N-terminal kinase (JNK) and p38-MAPK. MAPK family plays a critical 
role in the regulation of growth and differentiation. HMAs +CN culture elevated all stages 
of cell death and this may have related to direct effect of oxygen changes on 
mitochondrial functions (Guo et al., 2006; Iglesias et al., 2013; Chen et al., 2017).  
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3.3.5. Effect of hypoxia mimetic agents on PC12 cell cycle progression 
The previous results showed that hypoxia mimetic agents affected cell growth and 
induced cell apoptosis. We next sought to determine if HMAs impacted on the cell cycle. 
Cell cycle is an energy demanding and very highly regulated process. Oxygen is an 
essential nutrient for the oxidative phosphorylation process considered as greatest net 
energy producing process, when compared with glycolysis. As such, for a cell to commit 
to cell division, it must overcome energy checkpoints (Moniz et al., 2015). Therefore, it 
would make sense that the components of the oxygen-sensing system directly influence 
cell cycle progression. The four steps of cell cycle involve different phases: cell growth, 
replication of DNA, transfer of duplicated chromosomes to daughter cells and cell division. 
These phases are controlled by different proto-oncogenes and tumour suppressors which 
regulate DNA repair of genetic damage and prevent tumorigenesis (Figure1.7). 
Propidium iodide (PI) is the most commonly used dye for DNA content and cell cycle 
analysis. The PI intercalates into the major groove of double-stranded DNA producing a 
highly fluorescent signal when excited at 488 nm with a broad emission centred around 
600 nm. PI also binds to RNA, it is mandatory to treat the cells with RNase for optimal 
DNA resolution. The excitation of PI at 488 nm facilitates its use on the flow cytometers 
(Figure 3.33. A, B and C). 
This work revealed that in control cells G0/G1 phase of cell cycle significantly increase 
(p<0.01) after IH and CN culture in comparison to AO, in contrast significant reduction in S 
phase under IH and CN conditions in comparison to AO (p<0.001). G2-M phase 
significantly decrease after 24 hrs at both IH and CN in comparison to AO (p<0.01) with 
no significant effect was noticed after 48 to 96 hrs. 
Under AO culture condition only IOX2 causes significant increase in G0/G1 phase after 24 
hrs and and 48 hrs in comparison to AO control (p<0.05) (Figure 3.34). HMAs reduced S 
phase at 24 and 48 hrs while after 72 and 96 hrs IOX2 in comparison to control AO 
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(p<0.01) while DMOG significantly increase cell population at S phase after 72 and 96 hrs 
in comparison to control AO (p<0.01) (Figure 3.35). DMOG and IOX2 significantly 
decrease G2-M phase after 72 and 96 hrs in comparison to control AO (p<0.01) (Figure 
3.36).  
Under IH culture condition, CoCl2, DMOG and IOX2 significantly reduced G1 phase after 
24 hrs while IOX2 significantly elevated G0/G1 phase, but after DMOG and IOX2 reduced 
G0/G1 phase after 48 hrs with no significant effect was noticed after 72 hrs. After 96 hrs 
CoCl2 reduced with significant increase with IOX2 (Figure 3.34). CoCl2 significantly 
reduced S phase after 24 and 96 hrs in comparison to control IH (p<0.01) (Figure 3.35). 
G2-M phase significant increase after 24 and 96 hrs of CoCl2 treatment in contrast IOX2 
significantly reduced G2-M population after 24, 72 and 96 hrs in comparison to control IH 
(p<0.01) (Figure 3.36). 
Under CN culture condition, G0/G1 phase population increase after 24 and 96 hrs of 
CoCl2 treatment, after 48 hrs DFO, DMOG and IOX2 significantly reduced G0/G1 
population in comparison to control CN (p<0.01) (Figure 3.34). where all HMAs 
significantly increase S phase population after 24 hrs it follow by significant reduction after 
72 hrs in comparison to control CN (p<0.01). CoCl2 and DMOG elevated S phase 
population after 48 hrs. DMOG and IOX2 continue to reduce S phase after 96 hrs with no 
significant effect for the other HMAs (Figure 3.35). Under all culture conditions, G2-M 
phase showed significant reduction HMAs after 96 hrs (Figure 3.36). 
To sum up IH and CN trapped cell in G0/G1 phase and reduced S phase in contrast 
HMAs induce pattern different completely from that was seen under the IH and CN culture 
conditions. 
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Figure 3.33. Cell cycle analysis 
Representative DNA fluorescence histograms of PI stained cells and the peaks indicated G0/G1, S 
and G2-M as shown in Figure 2.7. PC12 cells cultured under air oxygen (A), intermittent hypoxia 
(B) and continuous normoxia (C) culture conditions follow by exposure to (50 µM CoCl2, 50 µM 
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DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. The untreated PC12 
cells were consider as control. PC12 then stained with PI and assessed by flow cytometry (FACS).  
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Figure 3.34. Effect of hypoxia mimetic agents on the G0/G1 phase cell cycle of PC12 
cells cultured at three different culture conditions 
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs under air oxygen (AO), intermittent hypoxia (IH) and continuous normoxia 
(CN) culture conditions the percentage of cells in each cycle phase were analysed using flow 
cytometer. X-axis represents different treatments respectively. Y-axis represents percentage of 
cells in G0/G1 phase. Data are presented as mean of percentage of cells in this phase ± standard 
deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at each time 
point and at each oxygen culture condition (p<0.01). 
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Figure 3.35. Effect of hypoxia mimetic agents on the S–phase cell cycle of PC12 
cells cultured at three different culture conditions 
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs under air oxygen (AO), intermittent hypoxia (IH) and continuous normoxia 
(CN) culture conditions the percentage of cells in S phase were analysed using flow cytometer. X-
axis represents different treatments respectively. Y-axis represents percentage of cells in S phase. 
Data are presented as mean of percentage of cells in this phase ± standard deviation (SD). n=1 
triplicate, * indicates significant difference in comparison to control at each time point and at each 
oxygen culture condition (p<0.01). 
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Figure 3.36. Effect of hypoxia mimetic agents on the G2-M phase cell cycle of PC12 
cells cultured at three different culture conditions 
Following exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 
hrs, 72 hrs and 96 hrs under air oxygen (AO), intermittent hypoxia (IH) and continuous normoxia 
(CN) culture conditions the percentage of cells in G2-M phase were analysed using flow cytometer. 
X-axis represents different treatments respectively. Y-axis represents percentage of cells in S 
phase. Data are presented as mean of percentage of cells in this phase ± standard deviation (SD). 
n=1 triplicate, * indicates significant difference in comparison to control at each time point and at 
each oxygen culture condition (p<0.01). 
 
The cell cycle analysis revealed that PC12 treated with hypoxia and hypoxia mimetic 
agents were trapped in G0/G1 phase of cell cycle (Avramovich-Tirosh et al., 2007; Chen 
et al., 2014; Marin et al., 2016).  
This is the first report discuss the effect of IOX2 on cell cycle under three oxygen culture 
conditions. AO culture condition, IOX2 trapped cells in G0-G1 with no significant effect on 
S phase and reduce G2-M phase with variable changes was noticed with IH and CN. This 
effect may have related activation of HIF-1 that associated with arrest in G 1 or early S 
phase, the progression of cells through the cell cycle is regulated by a series of proteins 
known as the cyclins, and their associated partners enzymes cyclin-dependent kinases 
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(CDK) (Swanton, 2004). The major proteins associated with the G 1 /S boundary are the 
cyclin D family (D1, D2 and D3), their respective CDKs, CDK4 and CDK6, and cyclin E, 
with its respective CDK, CDK2 (Ekholm et al, 2000). The G 1 /S cyclin/CDKs function to 
control the phosphorylation of the retinoblastoma protein (pRb) (Bartek et al., 1996). 
 
3.3.6. Effect of hypoxia mimetic agents on ROS production and 
nitroreductase activity of PC12 cells 
Various stimuli during normal physiological functions produce reactive oxygen (ROS) and 
reactive nitrogen species (RNS) species (Newsholme et al., 2012; Bolisetty & Jaimes, 
2013). ROS, include superoxide anion (O2), hydroxyl radical (
-OH) and hydrogen peroxide 
(H2O2). ROS play vital roles in physiological activities which including intracellular 
signalling, host defence and redox regulation (Finkel, 2011). Over-production of ROS can 
be triggered by endogenous and exogenous factors (Bhattacharyya et al., 2014) in order 
to adapt the stressful changes, organisms developed a variety of mechanisms that 
prevent the formation of ROS or convert them to inactive derivatives these mechanisms 
include both enzymatic and non-enzymatic mechanisms. The enzymes involve superoxide 
dismutase, catalase and glutathione-related enzymes) and non-enzymatic mechanisms 
involve glutathione and vitamin E antioxidant systems (Rahman, 2007). Oxidative stress 
occurs when an imbalance occurs between oxidants and antioxidants in favour of the 
oxidants which leads to cellular damage responsible for degenerative conditions like those 
that occur in Alzheimer’s, Parkinson’s and atherosclerosis, among others (Rahal et al., 
2014). 
There are controversial reports about ROS formation in different cell lines under CN 
culture conditions (Bogdanova et al., 2016; Di Meo et al., 2016). The experimental 
seeding population displayed a baseline ROS formation and all values normalized to this 
value and it which is indicated by the intersection of the x-axis with the y-axis and all 
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values normalized to this value. The results of this work showed that there were significant 
increases in ROS formation after 48 and 72 hrs of incubation under all oxygen culture 
conditions in comparison to ROS formation under AO culture condition (p<0.01) (Figure 
3.36). 
After 24 hrs under AO, CoCl2, DFO, DMOG and IOX2 caused significant reduction in ROS 
formation (30%, 30%, 36%and 35% respectively) (p<0.01). After 48 hrs, HMAs possess 
no significant effect on ROS formation while at 72 hrs, CoCl2, DMOG and IOX2 elevated 
ROS formation (11%, 9% and 14%) (p<0.05) followed by drop in ROS formation levels 
(30%, 59%, 47% and 34%) after 96 hrs in comparison to control at each time point 
(p<0.01) (Figure 3.37). 
After 24 hrs under IH culture, CoCl2 showed no significantly change in ROS formation. In 
contrast, DFO, DMOG and IOX2 significantly increase (18%, 16% and 28%) in 
comparison to control IH. CoCl2 after 48 hrs significantly elevated (15%) in comparison to 
IH (p<0.001). while DFO, DMOG and IOX2 decrease (37%, 29% and 27%) in comparison 
to control IH (p<0.01). After 72 hrs, HMAs reduced ROS formation (50%, 65%, 75% and 
73%) in comparison to IH (p<0.01). After 96 hrs under IH culture with CoCl2, DFO, DMOG 
and IOX2 treatment reduced (122%, 143%, 128% and 129%) after (p<0.001) (Figure 
3.38). 
Finally, incubation of PC12 for 24 hrs at CN culture condition supplemented with HMAs 
elevated (13%, 10%, 18% and 92%) in comparison to CN (p<0.01). after 48 hrs, CoCl2 
and DMOG reduced ROS formation while DFO and IOX2 elevated ROS formation (28% 
and 70%) in comparison to control CN (p<0.01). After 72 hrs, CoCl2 reduced (27%) ROS 
formation in contrast IOX2 elevated (106%) ROS formation in comparison to IH (p<0.01). 
CoCl2, DFO and DMOG reduced ROS formation (69%, 83% and 77%) in comparison to 
control CN (p<0.001) (Figure 3.39).  
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Figure 3.37. Effect of hypoxia mimetic agents on the ROS formation of PC12 
cultured in AO culture condition 
Histogram of normalized fluorescence intensity of PC12 after stain with ROS-ID
®
 
Hypoxia/Oxidative stress detection reagent. PC12 cells exposure to (50 µM CoCl2, 50 µM DFO, 
100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as 
mean of normalized value ± standard deviation (SD). n=1 triplicate, * indicates significant difference 
in comparison to control at each AO at each time point (p<0.01). 
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Figure 3.38. Effect of hypoxia mimetic agents on the ROS formation of PC12 
cultured in the IH culture condition 
Histogram of normalized percentage of positive cells of PC12 after stain with ROS-ID
®
 
Hypoxia/Oxidative stress detection reagent. PC12 cells exposure to (50 µM CoCl2, 50 µM DFO, 
100 µM DMOG and 5 0nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as 
mean of normalized value ± standard deviation (SD). n=1 triplicate, * indicates significant difference 
in comparison to control IH at each time point (p<0.01). 
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Figure 3.39. Effect of hypoxia mimetic agents on the ROS formation of PC12 
cultured in CN culture condition 
Histogram of normalized percentage of positive cells of PC12 cells after stain with ROS-ID
®
 
Hypoxia/Oxidative stress detection reagent. PC12 cells exposure to (50µM CoCl2, 50 µM DFO, 100 
µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as mean of 
normalized value ± standard deviation (SD). n=1 triplicate, * indicates significant difference in 
comparison to control CN at each time point (p<0.01). 
 
Nitroreductase activity (NTR) of PC12 cells incubated under AO, IH and CN showed that 
there was no significant for oxygen culture condition after 24 hrs in comparison to AO 
followed by elevation (35% and 101%) after 48 and 72 hrs incubation at IH culture 
condition in comparison to control AO (p<0.01), but after 96 hrs IH and CN reduced (110% 
and 44%) in comparison to control AO (Figure 3.40). 
After 24 hrs incubation of PC12 with CoCl2, DFO, DMOG and IOX2 at AO, significant 
reduction in NTR activity was noticed (26%, 27%, 35% and 34%) compare to 24hrs AO. 
After 48 hrs, the NTR activity showed no significant change. After 72 hrs, CoCl2, DMOG 
and IOX2 elevated NTR activity (14%, 7% and 34%) in comparison to AO. In contrast, 
DFO reduced NTR activity (10%) in comparison to AO (p<0.01). HMAs reduced 
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nitroreductase activity after 96 hrs (21%, 53%, 42% and 41%) in comparison to AO 
(p<0.01).  
HMAs possess no significant effect on NTR activity after 24 hrs, DFO, DMOG and IOX2 
reduced nitroreductase activity (33%, 14% and 18%) after 48 hrs in comparison to IH 
(p<0.01). After 72 hrs reduced nitroreductase activity (45%, 58%, 67% and 56%) in 
comparison to control IH (p<0.01). HMAs elevated NTR activity after 96 hrs (108%, 127%, 
113 and 110%) in comparison to control IH (p<0.01) (Figure 3.41). 
Under CN culture condition, NTR activity showed no significant effect after 24 hrs. After 48 
hrs, CoCl2 reduced NTR activity (23%, 14% and 8%) in comparison to control CN 
(p<0.05). After 72 hrs, CoCl2 significantly reduced nitroreductase activity vs. control CN 
(p<0.01). After 96 hrs, HMAs significantly decreased nitroreductase activity when 
compared to control CN at 96 hrs (64%, 77%, 65% and 19% respectively) (p<0.01) 
(Figure 3.42). 
 
Figure 3.40. Effect of hypoxia mimetic agents on the nitroreductase activity of PC12 
cells cultured in AO culture condition 
Histogram of normalized fluorescence intensity of PC12 after stain with ROS-ID
®
 
Hypoxia/Oxidative stress detection reagent. PC12 exposure to (50 µM CoCl2, 50 µM DFO, 100 µM 
DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as mean of 
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normalized value ± standard deviation (SD). n=1 triplicate, * indicates significant difference in 
comparison to control at each time point (p<0.01). 
 
Figure 3.41. Effect of hypoxia mimetic agents on the nitroreductase activity of PC12 
cultured in IH culture conditions 
Histogram of normalized percentage of positive cells of PC12 after stain with ROS-ID
®
 
Hypoxia/Oxidative stress detection reagent. PC12 cells exposure to (50 µM CoCl2, 50 µM DFO, 
100 µM DMOG and 50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as 
mean of normalized value ± standard deviation (SD). n=1 triplicate, * indicates significant difference 
in comparison to control at each time point (p<0.05). 
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Figure 3.42. Effect of hypoxia mimetic agents on the nitroreductase activity of PC12 
cultured in CN culture condition 
Histogram of percentage of positive cells of PC12 after stain with ROS-ID
®
 Hypoxia/Oxidative 
stress detection reagent. PC12 cells exposure to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 
50 nM IOX2) for 24 hrs, 48 hrs, 72 hrs and 96 hrs. Data are presented as mean of normalized 
value ± standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to 
control at each time point (p<0.01). 
 
HMAs significantly reduced ROS formation under both AO and CN and this may have 
related to activation of antioxidant enzymes by HIF-1 e.g. increased SOD-2 gene 
expression. In contrast, IH after 96 hrs significantly elevated ROS formation and this may 
relate to the mitochondrial changes that associated with IH and this agree with Chandel et 
al. (1998) who dscribed cell fail to increase ROS generation during hypoxia after treatment 
with HMAs at IH. NTR are a family of evolutionarily related enzymeshave ability to reduce 
nitrogen-containing compounds, including those containing the nitro functional group. NTR 
members utilise FMN as a cofactor. HMAs significantly reduced NTR activity under both 
AO and CN and this may have related to activation of antioxidant enzymes by HIF-
1(Owusu-Ansah et al., 2008). 
 
181 
 
3.4. Discussion 
There are many reports that confirm the role of physiological normoxia and precondition 
with hypoxia mimetic agents in cell viability and differentiation of PC12 (Li et al., 2015). 
However, most of these works considered 21% oxygen culture condition as normoxia and 
considered any oxygen concentration lower than 21% as hypoxia and compare the effect 
of hypoxia mimetic agent to that value. To understanding the effect of hypoxia mimetic 
agents on cell viability, apoptosis, cell cycle. It would be useful in comparison to the effect 
of hypoxia mimetic agents to controlled engineered hypoxic conditions which reflect the 
physiological oxygen concentration inside the body. PC12 cell viability, apoptosis, and cell 
cycle were measured and compared these changes to the changes in HIFs expression. In 
this study, we tested the response of PC12 cell lines to different hypoxia mimetic agents 
under air oxygen culture condition, intermittent hypoxia and continous normoxic culture 
conditions: (1) to establish cellular models of PC12 cell behaviour under different oxygen 
culture conditions, (2) to determine if hypoxia mimetic agents mimic physiological 
normoxia in PC12 cell. After dose scan, we selected the doses (50 µM, 50 µM, 100 µM 
and 50 nM of CoCl2, DFO, DMOG and IOX2 respectively) that cause minimal change on 
cell count and MTT activity.  
In this work, we found some variations between cell count and MTT activity of the cells 
that treated hypoxia mimetic agents under both CN and IH culture condition and this may 
have related to the inhibition of mitochondrial activity by HIF-1α stabilisation during 
changes in oxygen level which will affect the production of NAD(P)H, that play important 
role in MTT reagent reduction. 
To define if chosen concentrations still act as hypoxia mimetic agents (induce HIFs), 
PC12 cells were treated with chosen concentrations and incubated in the three oxygen 
conditions and this is first report using such low concentrations of hypoxia mimetic agents 
(especially DMOG and IOX2) to induce HIF expression, higher concentrations usually 
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were used in many studied (Guo et al., 2006; Genetos et al., 2010; Zeng et al., 2011). Our 
results showed that HIF-1α expression was significantly increase in way like intermittent 
hypoxia (Prabhakar & Semenza, 2007).  
There are contradicting reports about the effect of hypoxia mimetic agent on PC12 
differentiation (Kotake-Nara et al., 2005; Genetos et al., 2010; Chen et al., 2014). The 
results of the effect of both hypoxia and hypoxia mimetic agents on PC12 cell shows that 
hypoxia mimetic agents have no additive effect on PC12 differentiation over NGF at air 
oxygen culture condition, however these agents inhibit the differentiation effect of NGF at 
both IH and CN culture conditions and this may relate to prolong ERK1/2 phosphorylation 
leading cell differentiation inhibition (Chen et al., 2014).  
The study of the role of hypoxia and hypoxia mimetic agents on cell death revealed that 
hypoxia mimetic agents significantly increase early apoptosis (Guo et al., 2006; Iglesias et 
al., 2013; Chen et al., 2017), and this may have related to activation of caspase 3/7 direct 
by c-Jun NH2 terminal kinase (JNK)/ stress activated protein kinase (SAPK) or indirectly 
by inhibition of anti-apoptotic protein Bax/ Bak or stabilisation of p53 by HIF-1α (Greijer & 
van der Wall, 2004; Sermeus & Michiels, 2011). 
The cell cycle analysis revealed that PC12 treated with hypoxia and hypoxia mimetic 
agents were trapped in G0/G1 phase of cell cycle (Avramovich-Tirosh et al., 2007; Chen 
et al., 2014; Marin et al., 2016) and this may have related to activation of protein 
phosphatase 2A (PP2A) and inhibition of extracellular signal-regulated kinase 1/2 
(ERK1/2) phosphorylation contribute to inhibiting PC12 proliferation through G0/G1 phase 
arrest (Chen et al., 2014).  
The ROS formation and nitroreductases activity showed significant increase after 96 hrs 
of treatment with HMAs (Kotake-Nara & Saida, 2007; Owusu-Ansah et al., 2008; Zeng et 
al., 2011). ROS/ RNS formation represent the link between HIF expressions, apoptosis 
and cell cycle. PC12 provided us with a good functional model to assess of HMAs as tool 
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for mimic control oxygen culture. To progress with this finding further work is needed to 
look at a primary cell model that is more clinically suitable such as BM-hMSCs. 
3.5 Conclusion  
This study confirms the ability of individual hypoxia mimetic agents to induce HIF-1α 
expression which related to the significant increase apoptosis, and cycle arrest at G0/G1 
phase that associated with an increase ROS formation in PC12 cell in all three oxygen 
conditions. 
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Chapter 4 : Effects of hypoxia mimetic agents on 
BM-hMSCs 
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4.1. Introduction 
Friedenstein et al., were the first to demonstrate that bone marrow contains two 
populations of cells; hematopoietic stem cells (HSCs) and a rare population of plastic-
adherent stromal cells, which were referred to mesenchymal stromal cells (BM-hMSCs) 
(Williams & Hare, 2011). Human bone marrow-derived mesenchymal stem cells (BM-
hMSCs) are in current use in many clinical trials globally (Wang et al., 2016). These trials 
cover many pathological and injury conditions ranging from osteoarthritic lesions of the 
knee (Chen &Tuan, 2008) to neurological indications including ischemic stroke 
(Nesselmann et al., 2008); kidney regeneration (Hopkins et al., 2009), blood precursor 
transplantation (Billet et al., 2008), and wound healing (Fu et al., 2006). BM-hMSCs are 
canonically described as having a multipotent (osteoblast, chondrocyte, adipocyte) 
differentiation potential, a guideline immunophenotype (positive: CD105, CD73 and CD90, 
and negative: CD45, CD34, CD14, CD19 and HLA-DR), and as being a plastic adherent 
cell isolated from the bone marrow (Nery et al., 2013; Yousefifard et al., 2016). The 
architecture of bone marrow consists of a sinusoidal organisation of blood vessels that 
leads to low physiological oxygen levels (Simon & Keith, 2008). Recently it is well 
established that reduced oxygen culture conditions enhance isolation and expansion of 
hMSCs from bone marrow which is important to ensure good clinical outcome 
(Boregowda et al., 2012; Haque et al., 2013; Heywood & Lee, 2016).  
There is accumulating studies that hypoxia and hypoxia mimetic agents can produce 
significant effects on BM-hMSCs at different physiological levels through induction of HIF 
pathway and this include: modifying energy metabolism (Chang & Hung, 2016; Hu et al., 
2016), iron metabolism (Ejtehadifar et al., 2015), intracellular pH (Saraswati et al., 2015), 
vasomotor activity (Shalaby et al., 2016), migration (Choi et al., 2016), motility, and 
modification of the extracellular matrix. However, HIF can also induce apoptosis (cell 
death mechanisms via increased mitochondrial membrane permeability), change ROS 
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and RNS formation, and increase intracellular acidity that leads to significant increase in 
caspases activities (Rodrigues et al., 2012). 
Little research has been performed thus far on the effect of hypoxia mimetic agents on cell 
viability, cell cycle, ROS states and nitroreductases activity in BM-hMSCs. The primary 
aim of this study was to assess the in vitro effect of hypoxia mimetic agents on BM-
hMSCs viability under AO, IH and CN conditions. 
4.2.  Methods 
4.2.1. Materials 
Analytical grade reagents and deionised water (Sigma, UK) were used. All chemicals 
employed are listed in Chapter 2, Section 2.1. 
 
4.2.2. Cell models  
The BM-hMSCs cells were recovered from commercially obtained bone marrow aspirate 
as outlined in Chapter 2. Cell models were maintained at an atmosphere of 37°C and 5% 
CO2 under AO, IH and CN culture conditions. 
 
4.3.  Results  
4.3.1. Effect of hypoxia mimetic agents on BM-hMSCs count and metabolic 
activity 
The toxicity of hypoxia mimetic agents increases as concentrations rise. The aim of these 
experiments was to optimise the concentrations at which cell viability was comparable to 
control for use in subsequent experiments. Cell count and metabolic activity of BM-hMSCs 
was explored via cell count and MTT assay. In this instance cell count and MTT assay 
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were being used as markers of cell viability. Cell count data is presented as cell number x 
104 and MTT data is presented as normalized to the corresponding experimental control. 
Cells were grown under air oxygen, intermittent hypoxia and continuous normoxic 
conditions and in the presence or absence of hypoxia mimetic agents to determine if any 
effects of hypoxia mimetic agents on cell viability change with oxygen concentration 
changes. 
 
4.3.1.1. Determination of BM-hMSCs viability after treatment with different 
concentrations of CoCl2 at different oxygen conditions. 
CoCl2 concentrations ≥75 µM significantly decreased cell count and metabolic activity, as 
measured by MTT assay, over the three oxygen conditions (p<0.01). However, cells 
exposed to CoCl2 50 µM showed the lowest reduction in cell count across all oxygen 
conditions. At this concentration (50 µM), cell count reductions were measured as 20% for 
AO, 14% for IH and 45% for CN culture (Figure 4.1). Furthermore, MTT activity at this 
concentration was 40% for AO, 41% for IH, and 23% for CN (Figure 4.2). 
 
Figure 4.1. Effect of CoCl2 on cell count of BM-hMSCs cultured in the different 
oxygen conditions 
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Cell counts of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of CoCl2 for 14 days. Y-axis indicates cell 
number x10
4
. X-axis indicates different oxygen culture conditions. Data are presented as mean ± 
standard deviation (SD). n=1 triplicate, * indicates significant change in comparison to control in 
each condition (p<0.05). 
 
Figure 4.2. Effect of CoCl2 on MTT activity of BM-hMSCs cultured in the different 
oxygen conditions 
MTT activity of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of CoCl2 for 14 days. Y-axis indicates Abs. 
value normalized to Abs. of control at each time point. X-axis indicates different treatment 
conditions. Data are normalized to untreated controls at each oxygen culture condition. Data are 
presented as mean ± standard deviation (SD). n=1 triplicate, * indicates significant change in 
comparison to control at each condition (p<0.01). 
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4.3.1.2 . Determination of BM-hMSCs viability after treatment with different 
concentrations of DFO at different oxygen conditions. 
DFO concentrations ≥75 µM substantially decreased cell count and metabolic activity, as 
measured by MTT assay, over the three oxygen conditions (p<0.01). However, cells 
exposed to DFO 50 µM showed the smallest reduction in cell count across all oxygen 
conditions. At this concentration (50 µM), cell count reductions were measured as 15% for 
AO culture, 13% for IH and 48% for CN (Figure 4.3). Furthermore, MTT activity at this 
concentration was 48% for AO culture, 44% for IH, and 35% for CN (Figure 4.4). 
 
Figure 4.3. Effect of DFO on cell count of BM-hMSCs cultured in the different 
oxygen conditions 
Cell counts of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of DFO for 14 days. Y-axis indicates cell 
number x10
4
. X-axis indicates different oxygen culture conditions. Data are presented as mean ± 
standard deviation (SD). n=1 triplicate, *indicates significant change in comparison to control in 
each condition (p<0.05). 
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Figure 4.4. Effect of DFO on MTT activity of BM-hMSCs cultured in the different 
oxygen conditions 
MTT activity of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH) , and continuous normoxia 
(CN) following exposure to different concentrations of DFO for 14 days. Y-axis indicates Abs. value 
normalized to Abs. of control at each time point. X-axis indicates different treatment conditions. 
Data are normalized to untreated controls at each oxygen culture condition. Data are presented as 
mean ± standard deviation (SD). n=1 triplicate, * indicates significant change in comparison to 
control in each condition (p<0.01). 
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4.3.1.3. Determination of BM-hMSCs viability after treatment with different 
concentrations of DMOG at different oxygen conditions. 
DMOG concentrations ≥ 250 µM significantly decreased cell count and metabolic activity, 
as measured by MTT assay, over the three oxygen conditions (p<0.01). However, cells 
exposed to DMOG 100 µM showed the smallest reduction in cell count across all oxygen 
conditions. At this concentration (100 µM), cell count reductions were measured as 10% 
for AO culture, 4% for IH and 30% for CN (Figure 4.5). Furthermore, MTT activity at this 
concentration was 34% for AO culture, 30% for IH, and 30% for CN (Figure 4.6). 
 
Figure 4.5. Effect of DMOG on cell count of BM-hMSCs cultured in the different 
oxygen conditions 
Cell counts of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of DMOG for 14 days. Y-axis indicates cell 
number x10
4
. X-axis indicates different oxygen culture conditions. Data are presented as mean ± 
standard deviation (SD). n=1 triplicate, * indicates significant change in comparison to control in 
each condition (p<0.05). 
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Figure 4.6. Effect of DMOG on MTT activity of BM-hMSCs cultured in the different 
oxygen conditions 
MTT activity of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of DMOG for 14 days. Y-axis indicates Abs. 
value normalized to Abs. of control at each time point. X-axis indicates different treatment 
conditions. Data are normalized to untreated controls at each oxygen culture condition. Data are 
presented as mean ± standard deviation (SD). n=1 triplicate, * indicates significant change in 
comparison to control in each condition (p<0.01). 
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4.3.1.4. Determination of human BM-hMSCs viability after treatment with different 
concentrations of IOX2 at different oxygen conditions.  
IOX2 concentrations ≥ 500 nM significantly decreased cell counts over the three oxygen 
conditions (p<0.01) while metabolic activity, as measured by MTT assay, was significantly 
decreased at all vales ≥ 50 nM. However, cells exposed to 50 µM IOX2 *58showed the 
smallest reduction in cell count across all oxygen conditions. At this concentration (50 
µM), cell count reductions were measured as 3.9% for AO culture, 0.6% for IH and 1.3% 
for CN (Figure 4.7). Furthermore, MTT activity at this concentration was 30% for AO 
culture, 31% for IH, and 29% for CN (Figure 4.8). 
 
Figure 4.7. Effect of IOX2 on cell count of BM-hMSCs cultured in the different 
oxygen conditions 
Cell counts of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of IOX2 for 14 days. Y-axis indicates cell 
number x10
4
. X-axis indicates different oxygen culture conditions. Data are presented as mean ± 
standard deviation (SD). n=1 triplicate, *indicates significant change in comparison to control in 
each condition (p<0.05). 
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Figure 4.8. Effect of IOX2 on MTT activity of BM-hMSCs cultured in the different 
oxygen conditions 
MTT activity of BM-hMSCs at air oxygen (AO), intermittent hypoxia (IH), and continuous normoxia 
(CN) following exposure to different concentrations of IOX2 for 14 days. Y-axis indicates Abs. value 
normalized to Abs. of control at each time point. X-axis indicates different treatment conditions. 
Data are normalized to untreated controls at each oxygen culture condition. Data are presented as 
mean ± standard deviation (SD). n=1 triplicate, * indicates significant change in comparison to each 
condition (p<0.01).  
 
In this work, we found even with low HMAs doses that were used in this work, MSCs cell 
showed reduction in cell count and MTT activity and this may relate to changes cell cycle 
and apoptiosis pattern that induced by hypoxia (Ge et al., 2016; Zeng et al., 2011). MTT 
activity reduced by 30-40% with lowest concentration and this may relate to the effect of 
HMAs on mitochondrial function (Genetos et al., 2010). 
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4.3.2. Effect of hypoxia and hypoxia mimetic agents on BM-hMSCs HIFs 
expression 
HIFs expression plays vital role in BM-hMSCs biology. An evaluation of HIF-1α expression 
in AO cultured cells indicated that a consistent baseline expression of 31% of the cell 
population displayed positive expression. In all experimentation, the AO baseline 
expression level is indicated via the point of x-axis / y-axis intersection (Figure 4.9) HIF-1α 
expression was significantly up regulated in the IH culture condition (+29%) (p<0.01) with 
no significant change at CN. HMAs used in combination with AO culture resulted in 
significant upregulation for CoCl2 (38% increase above baseline), DFO (31% increase 
above baseline), DMOG (19% increase above baseline), and IOX2 (29% increase above 
baseline) (Figure 4.9.A). HMAs combined with IH culture resulted in similar increases 
above AO baseline as seen with IH alone with a slight, though significant, ~+10% (of IH 
level) upregulation noted with all HMAs tested (Figure 4.9.B). In contrast to IH but similar 
to AO, CN culture supplemented with HMAs resulted in significant upregulation for CoCl2 
(30% increase above CN baseline), DFO (29 % increase above CN baseline), DMOG 
(28% increase above CN baseline) and IOX2 (30 % increase above CN baseline) (Figure 
4.9.C). The overall profile of HIF-1α expression in HMA supplemented AO cultured BM-
hMSCs was that they bore a close resemblance to IH cultured cells indicating that HMAs 
replicate an IH phenotype. It is also noteworthy that HMAs were not overtly additive to 
HIF-1α expression in IH cultured cells but that were highly so in CN cultured cells. 
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Figure 4.9. Effect of hypoxia mimetic agents on HIF-1α expression in BM-hMSCs 
cultured in the different oxygen conditions 
The percentage of anti-HIF-1α (ab16066) labelled cells is shown. BM-hMSCs cells were exposed 
to (50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 14 days in AO, IH and CN. 
Data are presented as % of HIF-1α positive ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to the % of HIF-1α positive control cells at each culture 
condition (p<0.01).  
 
Similar to above, before beginning HIF-2α experimental analysis the baseline HIF-2α 
expression of AO cultured BM-hMSCs was determined as 74%, this is indicated as the 
intersection point of the x-axis/y-axis in all graphs (Figure 4.10). HMAs used in 
combination with AO culture resulted in significant upregulation of HIF-2α with CoCl2 (10% 
increase above baseline), DFO (13% increase above baseline), DMOG (17% increase 
above baseline), and IOX2 (15% increase above baseline) (Figure 4.10.A). IH culture 
resulted in a significant upregulation of HIF-2α expression (+6%) above baseline (p<0.05). 
In contrast to AO, HMAs supplementation to BM-hMSCs at IH resulted in a varied 
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response, whereas CoCl2 and DFO+IH resulted in no significant change while DMOG and 
IOX2 + IH resulted in significant downregulation versus IH baseline.  
The varied response to HIF-2α expression was continued with CN cultured BM-hMSCs. 
Baseline CN displayed broad similarity to baseline AO while CoCl2 supplemented CN 
resulted in significant HIF-2α upregulation (+21%), DFO and IOX2 supplementation in CN 
resulted in little change and DMOG resulted in a non-significant increase.  
 
Figure 4.10. Effect of hypoxia mimetic agents on HIF-2α expression of BM-hMSCs 
cultured in the different oxygen conditions 
The percentage of anti-HIF-2α (ab8365) labelled cells is shown. BM-hMSCs cells were exposed to 
(50 µM CoCl2, 50 µM DFO, 100 µM DMOG and 50 nM IOX2) for 14 days in AO, IH and CN. Data 
are presented as % of HIF-2α positive ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to the % of HIF-2α positive control cells at each culture 
condition (p<0.01). 
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4.3.3. Effect of hypoxia mimetic agents on BM-hMSCs CFU-F isolation from 
bone marrow  
We next sought to explore the effect of AO, IH, CN, and HMA’s on colony-forming unit 
fibroblasts (CFU-Fs) isolation with reference to a previous study which indicated that MSC 
colony formation was not directly related to HIF changes (Tamama et al., 2011).  
We first explored the role of different oxygen culture conditions on CFU-F isolation from 
bone marrow aspirate under AO, IH and CN. The results showed that both IH culture and 
CN culture resulted in significant increases in the number of CFU-F isolated (+44 and +68 
in IH and CN, respectively) (p<0.01) (Figure 4.11.A). 
We next evaluated the role, if any of HMAs, in replicating the increases observed with IH 
and CN. All HMAs tested in AO resulted in a significant increase (p<0.01) in frequency of 
CFU-F isolation above control; CoCl2 (+22), DFO (+8), DMOG (+18), and IOX2 (+30) 
(Figure 4.11.B). In contrast IH culture supplemented with HMAs resulted in significant 
decreases (p<0.01) in relation to control; CoCl2 (-23), DFO (-62), DMOG (-45), and IOX2 
(-24) (Figure 4.11.C). Finally, CN culture supplemented with HMAs was in agreement with 
IH but again distinct to AO with decreases vs. control noted as; CoCl2 (-60), DFO (-74), 
DMOG (-37), and IOX2 (-48) (p<0.01) (Figure 4.11.D). Pearson correlation showed that 
only IOX2 was negatively related to AO (r2 =0.6195, p<0.0118). Where under IH culture 
condition, CoCl2 and DFO negatively correlated to IH control (r
2 =0.9643, p<0.0001, r2 
=0.7251, p<0.0036) in contrast IOX2 positively correlated (r2 =0.7982, p<0.0012). Under 
CN culture CoCl2 and DFO positively correlated to CN control (r
2 =0.9986, p<0.0001 and r2 
=0.9918, p<0.0001). In summary, the HMAs effect on CFU-F isolation was distinctive from 
that induced by merely changing oxygen level. 
199 
 
 
Figure 4.11. The influence of HMAs on BM-hMSCs CFU-F recovery from bone 
marrow aspirate 
MSCs CFU-F recovery from bone marrow aspirate in three different oxygen culture conditions with 
and without HMA treatment. (A) represents cells incubated under AO, IH and CN culture condition 
(controls). (B) represent cells after treatment with HMAs under AO culture condition. (C) represent 
cells after treatment with HMAs under IH culture condition. (D) represent cells after treatment with 
HMAs under CN culture condition. X-axis indicates different treatment with HMAs. Y-axis 
represents CFU-F / T25 flask. Data presented as mean and the error bar represent standard 
deviation. n=3, * indicates significant difference when compared to the control for each oxygen 
culture condition (p< 0.01). 
 
BM-MSCs represent an important candidate for regenerative applications because of their 
high proliferative capacity and the potential to differentiate into other cell types. HMAs 
were investigated as a preconditioning agent on clonogenic potential of primary MSCs 
cultured under different oxygen culture condition and the results shows that HMAs 
increase colony number in manner similar but with lower magnitude than that noticed 
under IH or CN and this may relate to regulation of Wnt/β-catenin signaling, which is 
critical for maintenance of stemness in MSCs. HMAs like IH by inducing HIF-1 which may 
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have upregulated transcripts glucose-6-phosphate isomerase/autocrine motility factor 
(GPI) and MMP8, and downregulated transcripts: CDH1 (E-cadherin), CTNNA1 (α-
catenin), APC, SMAD2, and SMAD3, all of which are playing role in regulation of 
mesenchymal transition and canonical Wnt signaling through modulation β-catenin 
trafficking and signaling, either directly or through release or increase of cell adhesions 
(Zeng et al., 2011; Boyette et al., 2014).  
 
4.3.4. Effect of hypoxia mimetic agents on BM-hMSCs tri-lineage 
differentiation potential and immunophenotype 
The multi-lineage differentiation capacity of BM-hMSCs is a key reason for their use in 
regenerative medicine (Bernardo et al., 2007). The study of BM-hMSCs tri-lineage 
differentiation capacity both under different oxygen levels and after treatment with HMAs 
was determined via histological staining and imaging of the differentiated cells (Figure 
4.12). The ability of these cells to tri-lineage differentiation is a defining property of BM-
hMSCs and it is essential to confirm this property in primary cells and observe any 
changes as a result of the different oxygen level and after treatment with HMAs.  
Following culture in osteogenic differentiation media, strongly stained mineralised regions 
were noted for BM-hMSC grown in AO, IH, and CN indicating that the different oxygen 
culture conditions had no significant effect on osteogenic differentiation. Kay et al., noted 
reduced levels in CN and this come with broad agreement with previous observations 
(Kay et al., 2015). A global inhibition of osteogenesis was not observed in any culture 
condition combination though non-quantified but noteworthy reductions were noted for AO 
+ HMAs, IH + DFO, CN + HMAs (Figures 4.12, 13 and 14). Adipogenesis was indicated 
by intracellular lipid droplet visualised with oil red O. Clear adipogenic differentiation was 
noted in AO and CN but appeared reduced in IH. HMAs did not observably reduce 
differentiation in AO, promoted differentiation in IH, and had no clear effect in CN (Figures 
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4.12, 13 and 14). Alcian blue staining for chondrogenesis displayed elevation after culture 
in CN even after treatment with HMAs in comparison to control AO. No significant effect of 
HMAs was seen at IH culture condition (except IOX2 at IH). Under CN culture condition 
HMAs had no significant effect on chondrogenesis (except DFO) (Figures 4.12, 13 and 
14).  
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Figure 4.12. Tri-lineage differentiation of BM-hMSCs in three distinct oxygen culture conditions with and without HMAs treatment 
BM-hMSCs were induced to differentiate toward osteogenic lineage and verified by alizarin red staining after induction (scale bar, 150 µm), adipogenic 
lineage and verified by Oil Red O (scale bar, 150 µm), and chondrogenic lineage verified by Alician blue staining (scale bar, 150 µm). (A) represents cell 
incubated in AO, (B) represents cells cultured under IH, and (C) represents cell incubated in CN. One representative of 3 independent experiments is 
shown. 
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To further explore the impact of oxygen culture condition and HMAs on differentiation we 
next employed an antibody-directed fluorescence approach looking at expression of 
osteocalcin (osteogenesis), FABP4 (adipogenesis), and aggrecan (cartilage). Osteocalcin 
expression appeared to be down-regulated in AO + HMAs, IH, and CN + DFO or IOX2 
(Figure 4.13 A, B and C). FABP4 the marker of adipocyte differentiation showed no 
significant effect of HMAs under three culture conditions. Lastly, aggrecan showed no 
significant changes after HMAs except DFO under IH culture where it caused down 
regulation of aggrecan (Figure 4.13 A, B, and C). 
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Figure 4.13. Differentiation specific protein expression in BM-hMSCs following tri-lineage differentiation in three oxygen culture 
conditions with HMA treatment 
Human mesenchymal stem cells were cultured for 21 days in growth media supplemented with specific supplementation according to the Human 
Mesenchymal Stem Cell Functional Identification Kit (Catalogue # SC006). Figure (A) represents hMSCs cultured at AO culture condition with and without 
HMAs treatment. Figure (B) represents hMSCs cultured at IH culture condition with and without HMAs treatment. Figure (C) represents hMSCs cultured at 
CN culture condition with and without HMAs treatment. Red fluorescence represents either Osteocalcin, FABP4, or Aggrecan, as indicated. Blue stain 
represent nucleus stained with DAPI. Scale bar=100 µm. One representative of 3 independent experiments is shown. 
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After confirming the differentiation capacity of these cells, we next sought to define the 
effect of different oxygen culture conditions in combination with HMAs on the BM-hMSC 
immunophenotype. All cells were incubated with antibodies directed towards CD14, 
CD19, CD34, CD45, HLA-DR, CD73, CD90 and CD105 according to the widely identified 
marker panel for BM-hMSCs (Ramos et al., 2016). Staining was compared relative to the 
recommended non-specific isotype control, either IgG1 or IgG2a depending on the 
antibody. Histograms of percentage of positively stained cell for all markers are shown in 
(Figure 4.14). The percentage of cells considered positively stained was determined by 
gating the stained population with a gate that excluded 99% of all isotype control events. 
Both isotype controls stained equally across all oxygen conditions and after treatment with 
HMAs, also matching unstained cells demonstrating minimal non-specific fluorescence. 
CD19, CD34 and CD45, markers typically negative in BM-hMSCs, were all considered 
negative where ≤5% positively stained cells indicating non-haematopoietic lineages was 
observed.  
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Figure 4.14. Immunophenotyping of cells from BM-hMSCs 
Cells recovered in AO, IH and CN were assessed by flow cytometry against the panel of markers used to identify BM-hMSCs. Overlay histograms of each 
antibody was compared to the relevant isotype control at AO, IH and CN culture conditions. The grey area represents isotype control IgG expression and 
the pink area depicts marker expression. The results are representative of three independent experiments. Positive markers (CD73, CD90, and CD105) 
and negative markers (CD14, CD19, CD34, CD45 and HLA-DR) were applied. 
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Significant, though slight, increases in levels of CD14, CD34, CD45, HLA-DR and CD90 
were noted in IH (p<0.01 vs. AO). Similar levels of increase in expression were noted for 
IH with HLA-DR and CD90 with accompanying decreases in CD14 and CD45 (p<0.01) 
(Figure 4.15.A).  
AO supplementation with CoCl2 resulted in significant increases for CD14, CD34, CD45, 
and HLA-DR when compared to AO control (p<0.01) (Figure 4.15.B). DFO exposure 
resulted in significant increases for CD14, and CD34, and significant reductions for CD73 
and CD105 when compared to AO control (p<0.01) (Figure 4.15.B). DMOG exposure 
resulted in significant increases for CD14, CD34, CD45 and HLA-DR, and significant 
reductions for CD19 and CD90 (Figure 4.15.B) when compared to AO control (p<0.01). 
Similarly, to above IOX2 exposure resulted in significant increases for CD14, CD19, 
CD34, CD45 and HLA-DR, and significant reductions for CD90 when compared to AO 
control (p<0.01) (Figure 4.15.B).  
We next sought to describe the impact of HMA supplementation on IH culture. CoCl2 
exposure resulted in significant increases for CD34, CD45 and HLA-DR, and significant 
reductions for CD19 and CD105 when compared to IH control (p<0.01) (Figure 4.15.C). 
DFO exposure resulted in significant decreases for CD34, CD45, HLA-DR and CD90 
when compared to IH control (p<0.01) (Figure 4.15.C) while DMOG supplementation also 
resulted in CD34, HLA-DR, and CD90 downregulation along with CD14. IOX2 exposure 
resulted in significant increases for CD19 when and significant reductions for CD14, 
CD45, HLA-DR and CD90 compared to IH control (p<0.01) (Figure 4.15.C). 
Finally, we determined if the CN cultured BM-hMSCs immunophenotype was sensitive to 
HMA supplementation. CoCl2 exposure resulted in significant increases for CD14, CD34, 
and CD45 and significant reductions for both CD19 and CD105 when compared to CN 
control (p<0.01) (Figure 4.15.D). DFO exposure resulted in a broadly consistent pattern 
where significant decreases were noted for CD14, CD19, HLA-DR and CD90 and 
significant increases in CD45 when compared to CN control (p<0.01) (Figure 4.15.D). 
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DMOG exposure resulted in increases for CD19 and HLA-DR and a decreased CD14 
when compared to CN control (p<0.01). IOX2 exposure, similar to above, also resulted in 
reductions in expression for CD14, CD19, CD34, HLA-DR and reductions for CD14 
(p<0.01) (Figure 4.15.D).  
To sum up, IH significantly elevated all hematopoietic markers especially CD14, CD34, 
CD45 and HLA-DR, in addition to the mononuclear cell origin suggesting high likelihood of 
being monocytes which then further different to macrophage and dendritic cells 
(Vasandan et al., 2016). Under AO culture condition, HMAs induced expression of 
hematopoietic markers especially CD14, CD34, CD45 and HLA-DR and the changes 
mimic IH pattern but with lower magnitude in comparison to AO. In contrast under IH 
culture condition, CD14, CD45 and HLA-DR expression significantly reduces in 
comparison to IH after HMAs treatment. CN culture condition, HMAs more distinctive 
variable pattern of markers of MSCs in comparison to CN was noticed. 
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Figure 4.15. Immunophenotype of BM-hMSCs after treatment with HMAs 
BM-derived hMSCs were recovered in three oxygen conditions (A), AO + HMAs (B), IH + HMAs (C) and CN + HMAs (D). Histograms showed mean 
surface marker expression in AO, IH and CN culture conditions with and without HMA treatment. X-axis represents surface markers. Y-axis represents % 
of positive events. n=3, * indicates significant difference when compared to the control for each oxygen culture condition (p < 0.01). 
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4.3.5. Effect of hypoxia mimetic agents on BM-hMSCs apoptosis 
Exploring the mechanism of BM-hMSCs apoptosis in hypoxia and after treatment with 
hypoxia mimetic agents is important for improving of the efficiency of cell therapy. 
Research has suggested that hypoxia and growth factor withdrawal caused apoptosis via 
a caspase-dependent manner in transplanted BM-hMSCs (Zhu et al., 2006). However, the 
molecular mechanisms of BM-hMSCs have not been fully elucidated, as there are many 
apoptosis-inducing factors in the microenvironment of BM-hMSCs. Two pathways of 
apoptosis have been delineated in BM-hMSCs (Abdelwahid et al., 2016). The first is the 
mitochondrial pathway which involves the release of proteins, such as cytochrome c from 
the mitochondria to cytosol (Galluzzi et al., 2012). Cytochrome c release is usually 
associated with regulation of mitochondrial membrane proteins, such as the Bcl-2 family 
and results in activation of the caspase family (Martinou & Youle, 2011). The second 
pathway is the extrinsic pathway which includes activation of Fas (or CD95-L) and its 
receptor. However, many studies have shown that Fas-pathway seemed not to be 
involved in apoptosis of BM-hMSCs, as a Fas mAb agonist did not induce apoptosis of 
BM-hMSCs (Akiyama et al., 2012). Meanwhile, we presume that other pathways may play 
a vital role in induction of apoptosis of BM-hMSCs, such as extracellular signal-regulated 
kinase (ERK), Akt, HIF and VEGF at hypoxia condition. HIF is activated when a cell is 
exposed to shortage in oxygen and HIF then stimulates the release of VEGF, ERK and 
Akt pathway (Fan et al., 2015). 
An evaluation of BM-hMSCs spontaneous apoptosis frequency identified that IH displayed 
a slight increase in early apoptosis and necrosis and a larger increase in late apoptosis 
abundance while reduction in necrosis was also noted in CN cultured cells in comparison 
to AO (p<0.01) (Figure 4.16.A).  
Under AO CoCl2, DFO and DMOG produced a shared apoptotic induction profile with 
significant increases in early apoptosis and decreases in late apoptosis and necrosis 
(p<0.01). In contrast, IOX2 reduced both early apoptosis and necrosis and increased late 
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apoptosis after HMAs treatment (p<0.01) (Figure 4.16.B). The overall apoptosis pattern 
induced by HMAs did not resemble the pattern observed in AO culture.  
IH culture supplemented with HMAs resulted in a broadly identical response profile 
(Figure 4.16.C). Necrosis was reduced in all supplements vs. IH control (p<0.01). Early 
and late apoptosis were similarly reduced following HMA supplementation with the 
exceptions of DFO (early apoptosis) and IOX2 (late apoptosis) (p<0.01) (Figure 4.16.C). 
Again, the overall apoptosis pattern induced by HMAs did not resemble the pattern 
observed under the IH culture condition. 
CN culture supplemented with HMAs resulted in broadly consistent patterns where 
reductions in early apoptosis and increases in late apoptosis were noted (p<0.01). 
Necrosis displayed more variability with decreases observed with CoCl2 and DMOG and 
increases with DFO and IOX2 (p<0.01) (Figure 4.16). In summary IH and CN culture with 
HMAs reduced the frequency of cells in early apoptosis and necrosis. HMAs reduced late 
apoptosis at AO and IH with significant elevation at CN in some conditions. HMA 
exposure does not replicate the pattern of apoptosis observed in either CN or IH culture. 
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Figure 4.16. Effect of hypoxia mimetic agents on BM-hMSCs 
Following exposure to either 50 µM CoCl2, 50 µM DFO, 100 µM DMOG, or 50 nM IOX2 for 14 days 
early apoptosis, late apoptosis and necrosis at AO culture, IH culture and CN culture, respectively, 
were measured. Cells treated with HMAs at AO. Cells treated with HMAs at IH. Cells treated with 
HMAs at CN. X-axis represents different treatment. Y-axis represent percentage of cells at each 
stage of cell death. Data are presented as mean of percentage of the cell at each stage ± standard 
deviation (SD). n=1 triplicate, * Indicates significant difference in comparison to control at each 
culture condition (p<0.01). 
 
4.3.6. Effect of hypoxia mimetic agents on BM-hMSCs cell cycle 
Oxygen levels modify the expression of many molecules that are directly or indirectly 
involved in cell proliferation and survival (Mohyeldin et al., 2010). The expression of many 
cell cycle molecules is regulated by HIF-1α including p21, anti-apoptotic factors, such as 
Bcl-2, and pro-apoptotic proteins, such as p53 (Velletri et al., 2016). Consequently, BM-
hMSCs show significant difference in proliferation rates when expanded under hypoxia 
compared to those expanded under air oxygen culture (Ranera et al., 2012).  
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Using FACS analysis of BM-hMSCs we established a consistent baseline pattern of cell 
cycle characteristics. AO BM-hMSCs stocks were used to initiate all experiments and 
were measured to establish at zero-time baseline pattern. We noted that AO and IH 
culture conditions has no effect on G0-G1 phase, while CN significantly lower S phase 
and elevated G2-M phase in comparison to baseline (p<0.01) (Figure 4.18.A). 
We next sought to evaluate if AO supplementation with HMAs would mimic either IH or 
CN behaviour. Overall HMAs significantly increased the percentage of cells in G0/G1 
phase when compared to control AO culture (p<0.05). Cells at S-phase showed either a 
significant decrease (p<0.01) after supplementation with CoCl2, DFO and DMOG (19%, 
13% and 21% respectively) or no change (IOX2) when compared to control AO culture. 
G2-M displayed a significant increase (p<0.05) after supplementation with CoCl2, DFO 
and DMOG (8%, 6% and 5% respectively) while no effect was noticed after IOX2 
treatment (Figures 4.17.A and 18.B). 
In IH culture DFO and IOX2 supplementation elevated the percentage of cells in G0/G1 
phase (16% and 28% respectively) (p<0.01), no significant effect was noticed after 
DMOG, and a significant reduction noted with CoCl2 versus control IH. S phase increases 
were only noted with CoCl2 (13%) while in contrast DFO and IOX2 were reduced (20%) 
(p<0.01) and DMOG unchanged when compared to control IH. All HMAs resulted in a 
significant decrease in G2-M phase values (p<0.01) (Figures 4.17.B and 18.C). 
CN culture also resulted in an overall significant increase in G0/G1 composition following 
HMA supplementation (p<0.01). DFO and DMOG significantly elevated S phase values 
while CoCl2 and IOX2 had no effect. Finally, all HMAs down-regulated G2-M phase when 
compared to CN control (p<0.05) (Figures 4.17.C and 18.D). 
In summary, HMAs showed no resemblance in cell cycle pattern to any pattern we found 
under the three-oxygen culture. Where HMAs under AO trapped MSCs at G0/G1 phase 
and drop in S-phase after treatment with HMAs (except IOX2). Again, under IH culture 
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condition, HMAs (except CoCl2) elevated G0/G1 phase and drop in G2-M. Under CN 
culture condition, HMAs trapped cells again in G0/G1 phase with drop in S-phase.  
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Figure 4.17. Cell cycle analysis 
Representative DNA fluorescence histograms of PI stained cells and the peaks indicated G0/G1, S and G2-M (Figure 2.7). BM-hMSCs cultured in AO (A), 
IH (B) and CN (C) following exposure to either 50 µM CoCl2, 50 µM DFO, 100 µM DMOG or 50 nM IOX2 for 14 days assessed by flow cytometry. 
Untreated BM-hMSCs are included for control purposes.  
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Figure 4.18. Effect of hypoxia mimetic agents on BM-MSCs cell cycle cultured in 
three oxygen culture conditions 
Following exposure to either 50 µM CoCl2, 50 µM DFO, 100 µM DMOG or 50 nM IOX2 for 14 days, the 
percentage of cells in each cycle phase at AO, IH and CN culture was determined. Control BM-hMSCs in 
three alternate oxygen conditions. MSCs treated with HMAs in AO.  MSCs treated with HMAs in IH. MSCs 
treated with HMAs in CN. X-axis indicates different treatment groups. Y-axis represents percentage of cells in 
each cycle phase. Data are presented as mean of the percentage of cells in each phase ± standard deviation 
(SD). n=1 triplicate, * indicates significant difference in comparison to control at each oxygen condition 
(p<0.05). 
 
Under CN significantly reduced percentage of cells in S-phase with elevation in G2-M 
phase and this may relate to the alteration in the expression of several G2 checkpoint 
regulators, in particular Cyclin B with reduction phosphorylation of a Cyclin dependent 
kinase (CDK) target in G2 phase cells after hypoxia, suggesting decreased CDK activity. 
HMAs under AO and IH trapped cells at G1 phase PHD1 depletion caused accumulation 
of cells in G2/M phase in AO and IH (Moser et al., 2013). 
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4.3.7 Effect of hypoxia mimetic agents on ROS formation and 
nitroreductase activity of BM-hMSCs  
Oxidative stress results in deregulated production and/or scavenging of reactive oxygen 
and nitrogen species (ROS and RNS, respectively) (Baird et al., 2014). ROS are mainly 
generated from mitochondrial complexes I and III and NADPH oxidase (Schröder et al., 
2009). The accumulation of these radicals will seriously damage many biomolecules such 
as protein, lipids and DNA. Elevation in ROS/RNS levels can cause cellular dysfunction 
and cell death. Basal ROS levels are important in the maintenance of cellular proliferation, 
differentiation, and survival (D’Autréaux & Toledano, 2007; Sena & Chandel, 2012). There 
are conflicting reports about if BM-hMSCs have low baseline ROS levels or high levels or 
high level of cellular antioxidant (e.g. Glutathione) (Valle-Prieto & Conget 2010; Rodrigues 
et al., 2012; Haque et al., 2013; Mumaw et al., 2015; Maraldi et al., 2015). In BM-hMSCs, 
excess ROS impaired differentiation capacity, and proliferation (Ho et al., 2013; Zhang et 
al., 2015; Denu & Hematti, 2016) while increased antioxidants activities or levels, 
stimulated MSC proliferation (Zhou et al., 2014). However, it is important to note that 
studies on the effect of HMAs on ROS/RNS formation are usually carried out in air 
oxygen. 
FACS analysis of suspensions of BM-hMSCs established that AO cultured cells displayed 
a consistent baseline pattern of ROS formation, BM-hMSCs stocks used to initiate all 
experiments and were measured to establish at baseline (BL) pattern. ROS formation was 
increased in both IH and CN (29% and 80%) (p<0.01) vs. control AO (Figure 4.19.A). 
DFO, DMOG and IOX2 significantly elevated ROS formation after incubation at AO 
(p<0.01) while CoCl2 had no effect (Figure 4.19.B). At IH culture CoCl2 and DFO treatment 
reduced ROS formation when compared to control IH (p<0.01) while IOX2 elevated ROS 
formation and no effect was noticed after DMOG treatment. Incubation of BM-hMSCs in 
CN supplemented with HMAs (except CoCl2) displayed a significant reduction in ROS 
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formation when compared to control CN (Figure 4.19). In summary HMAs do not possess 
similar pattern to that of MSCs incubated under AO, IH and CN. 
 
Figure 4.19. Effect of hypoxia mimetic agents on ROS formation in BM-hMSCs  
Histogram of normalized ROS-positive BM-hMSCs after labelling with ROS-ID
®
 Hypoxia/Oxidative 
stress detection reagent. BM-hMSCs were exposed to either 50 µM CoCl2, 50 µM DFO, 100 µM 
DMOG or and 50 nM IOX2) for 14 days and incubated under either AO, IH or CN. BM-hMSCs in 
three oxygen culture conditions (A). MSCs treated with HMAs at AO (B). MSCs treated with HMAs 
at IH (C). MSCs treated with HMAs at CN (D). Data are presented as mean of normalized value ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at 
each oxygen condition (p<0.05). 
 
Nitroreductases activity (NTR) was elevated after 14 day incubation in both IH (slight) and 
CN in comparison to control at AO (P<0.01). Under AO culture, CoCl2, DFO and IOX2 
supplementation significantly reduced NTR activity while DMOG treatment elevated NTR. 
Though significant the AO differences were slight. In IH culture slight, though significant, 
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reductions in NTR activity were noted for both CoCl2 and DFO when compared to control 
IH while IOX2 displayed elevated NTR activity. Reductions in NTR were noted for all 
HMAs (except CoCl2) in CN, significant for DFO, DMOG and IOX2 (p<0.01) (Figure 4.20). 
In summary, Iron chelating and Iron competitive inhibitor HMAs reduce NTR at all oxygen 
culture conditions. 2-oxoglutarate HMAs have variable effect with different oxygen culture 
conditions.  
 
Figure 4.20. Effect of hypoxia mimetic agents on the nitroreductase activity of BM-
hMSCs  
Histogram of normalized positive BM-hMSCs after labelling with ROS-ID
®
 Hypoxia/Oxidative stress 
detection reagent as for BM-hMSCs at three oxygen culture condition (A). MSCs treated with 
HMAs at AO (B). MSCs treated with HMAs at IH (C). MSCs treated with HMAs at CN (D). Data are 
presented as mean of normalized value ± standard deviation (SD). n=1 triplicate, * indicates 
significant difference in comparison to control at each oxygen condition (p<0.05). 
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Both IH and CN significantly elevate ROS formation may relate to elevation NADPH 
oxidase-mediated reactive oxygen species production ERK pathway under control of HIF-
1 (Chung et al., 2014).  
4.4. Discussion 
BM-hMSCs isolated from bone marrow have unique properties which suggest that BM-
hMSCs are suitable for cell therapy application in a series of pathological conditions. In 
addition to being relatively easy to isolate and expand in vitro, they have strong 
immunomodulatory effect making them a promising tool for treating auto and alloimmune 
conditions including inflammatory disease, rheumatic diseases, lupus erythematosus and 
type I diabetes. BM-hMSCs used in regenerative medicine also have the ability of 
differentiation and restoration of tissue homeostasis. They also possess a high migratory 
capacity to sites of injury with very low immunogenicity (Sohni & Verfaillie, 2013; Becker & 
Riet, 2016). The major problem facing the clinical trials is the inadequate number of cells 
for clinical use without prior in vitro expansion (Shi et al., 2011). Most BM-hMSCs 
expansion procedures are conducted under ambient oxygen concentration where cells are 
exposed to 21 % O2, which is 4-10 fold higher than their natural niche (Mohyeldin et al., 
2010).  
The last 10 years have seen a significant increase in the number of studies into how 
culture conditions affect cell behaviour and function, among these factors is the oxygen 
tensions utilised for culture. The influence of oxygen tension in morphology, phenotype, 
proliferative capacity, and functionality of BM-hMSCs has been increasingly studied with 
controversial results. Such controversies could be related to the different culture 
conditions such as use of HMAs or use of hypoxic chambers (Boyette et al., 2014; Liu et 
al., 2015; Zhang et al., 2015). 
In this chapter, we explored the effect of hypoxia mimetic agents on cell viability, 
apoptosis, and the cell cycle. BM-hMSCs (viability, apoptosis, and cell cycle, ROS 
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formation and NTR activity) were measured and compared these changes to the changes 
in HIFs expression. In this study, we tested the response of BM-hMSCs to different 
hypoxia mimetic agents under three oxygen culture conditions to (1) establish BM-hMSCs 
behaviour under different oxygen culture conditions and (2) determine if hypoxia mimetic 
agents mimic any of the oxygen culture behaviour in BM-hMSCs. After screening we 
selected the doses 50 µM, 50 µM, 100 µM and 50 nM of CoCl2, DFO, DMOG and IOX2, 
respectively that caused minimal change on cell count and MTT activity.  
In this work, we found some variations between cell count and MTT activity of the cells 
that treated hypoxia mimetic agents under both CN and IH culture condition. To define if 
chosen concentrations still act as hypoxia mimetic agents (induce HIFs) BM-hMSCs cells 
were treated with chosen concentrations and incubated in the three oxygen conditions. 
This is the first report of the use of low concentrations of HMAs to induce HIF expression. 
Previous studies have relied on higher concentrations for shorter times (Guo et al., 2006; 
Genetos et al., 2010; Zeng et al., 2011). The results show that HIF-1α expression is 
significantly increased in IH versus both AO and CN where the later may be related to the 
ability of the cell to reset HIF mechanism to improve cell adaptation (Prabhakar & 
Semenza, 2007; Yuan et al., 2014). HIF-2α expression was up regulated under IH culture 
condition, this result was in agreement with Rane et al., (2009) who correlate the increase 
in HIF-2α expression to increase Sirtuin (SIRT1) activity. SIRT1 have the ability to inhibits 
transcription of EGLN1 gene (gene responsible of encoding of prolyl hydroxylase PHD2) 
leading to significant reduction of HIF-1α and HIF-2α degradation (Rane et al. 2009). 
Under AO culture, HIF-2α expression elevated by HMAs, this may be related to increase 
Sirtuin (SIRT1) activity and this result was in agreement with Wang et al., (2016). Under 
IH and CN culture condition, HMAs either slightly reduced or have no effect on HIF-2α 
expression. 
CFU-F recovery from bone marrow aspirate significantly increased in CN and IH 
conditions and AO culture supplemented with HMA did not achieve CN or IH CFU-F 
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levels. In addition to above, HMAs inhibited CFU-F isolation when used in conjunction with 
either IH or CN. There are contradicting reports about the effect of hypoxia mimetic agent 
on BM-hMSCs differentiation (Zeng et al., 2011; Boyette et al., 2014; Esfahani et al., 
2015). These results showed that the hypoxia mimetic agents have no additive 
advantageous effect over other cultured cells. The study of the effect of HMAs on cell 
death revealed that CoCl2, DFO and DMOG significantly increased early apoptosis (Das 
et al., 2010; Zeng et al., 2011) in AO culture and late apoptosis only in CN culture 
condition which is perhaps related to the reported alteration in caspase 3/7 and inhibition 
of anti-apoptotic protein Bax / Bak or stabilisation of p53 by HIF-1α independent pathway 
(Ejtehadifar et al., 2015). In contrast Ge et al., (2016) stated that DMOG significantly 
reduce early apoptosis without clarifying the effects on late apoptosis and necrosis. This is 
the first report that suggests that IOX2 significantly reduces early apoptosis increases late 
apoptosis in BM-hMSCs over all oxygen culture conditions. The cell cycle analysis 
revealed that BM-hMSCs treated with HMAs in AO and CN became over-represented in 
G0/G1. A marked contrast was noted in G2-M between AO, IH and CN were the former 
was increase the later reduced.  
ROS formation showed significant increases after CN culture and after DMOG treatment 
in both AO and IH conditions while in CN culture DFO, DMOG and IOX2 reduced ROS 
formation. Nitroreductases activity significantly increased under CN only with no 
significant effect observed under IH culture condition. DFO at AO and DFO DMOG and 
IOX2 at CN culture reduce NTR activity and this may have related to the effect of these 
agent on NRF2 (Loboda et al., 2009; Chung et al., 2014). From all results above, we can 
easily realise that mitochondrial function was affected by hypoxia and HMAs and in the 
further work we will focus on mitochondrial biogenesis, shape and function. 
4.5. Conclusion  
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This study confirms the ability of individual hypoxia mimetic agents to induce HIF-1α 
expression which related to significant changes in apoptosis and cycle arrest at G0/G1 
phase that associated with changes ROS formation and nitroreductases activity in BM-
hMSCs in all three oxygen conditions that does not recapture any pattern that was noticed 
at IH or CN culture condition. 
235 
 
 
Chapter 5 : Effects of hypoxia mimetic agents on 
mitochondrial dynamics of PC12 and hMSCs 
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5.1.  Introduction  
Mitochondria are central to the life and death of the cell and as the major source of ATP in 
eukaryotic cells containing the machinery for both the Krebs cycle and fatty acid oxidation 
(Stein and Imai, 2012). In addition, mitochondria represent the heart of intermediary 
metabolism impacting on processes other than the direct supply of ATP, for instance 
Krebs cycle intermediates can have regulatory roles in cytosolic processes such as 
hypoxia sensing and altering epigenetic modifications to the nuclear genome (Masson & 
Ratcliffe, 2014). Moreover, mitochondria have biosynthetic roles such as in the assembly 
of Fe-S centres and haem biosynthesis. Mitochondria represent the largest consumers of 
oxygen and are the site of the electron transport chain (ETC) which is the main source of 
ROS produced in tissues (Zorov et al., 2014). Mitochondrial respiration accounts for 
approximately 90% of cellular oxygen uptake, and as much as 3% of the oxygen 
consumed is converted to ROS (Marchi et al., 2011). This ROS production contributes cell 
signalling from the organelle to the rest of the cell and to a wide range of pathologies 
(Dröge, 2002; Balaban et al., 2005). There are a limited number of studies investigating 
the effect of different oxygen culture regimes and HMAs on mitochondrial functions such 
as burden, action potential, mitochondrial genome copy number and changes to 
mitochondrial morphology. The primary aim of this study was to assess the in vitro effect 
of HMAs on mitochondrial dynamics under AO, IH and CN conditions. 
 
5.2. Methods 
5.2.1. Materials 
Analytical grade reagents and deionised water (Sigma, UK) were used. All chemicals 
employed are listed in Chapter 2, Section 2.1. 
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5.2.2. Cell models  
The BM-hMSCs were recovered after culture of MNC from commercially obtained bone 
marrow aspirate as outlined in Chapter 2. Cells were maintained in an incubator at an 
atmosphere of 37°C and 5% CO2 under either AO, IH and CN culture conditions. PC12 
were cultured as described in Chapter 2. 
 
5.3.  Results  
5.3.1. Effect of hypoxia mimetic agents on PC12 on mitochondrial dynamic 
Mitochondrial are the most abundant oxygen modulating organelle inside the cell 
representing the largest consumer of oxygen. Any changes in the oxygen level reflect 
directly on different aspects of mitochondrial presence, shape and activity. HIF plays 
many vital roles by induction of a glycolytic phenotyping in energy production through 
modifying transcription to upregulate genes that encode glucose transporting proteins and 
glycolytic enzymes (Semenza, 2010). These can modify lactate metabolism, divert 
pyruvate away from mitochondria and inhibit hypoxic mitochondrial respiration thereby 
reducing the amount of ROS generated by inefficient respiration (Kim et al., 2006; 
Papandreou et al., 2006). It is also clear that optimising respiration efficiency via elevation 
of cytochrome c oxidase (COX) subunit IV isoform 2 (COX4-2) and the mitochondrial 
protease LONP1, which degrades the less efficient COX4-1 (Fukuda et al., 2007) and 
HIF-1α-mediated inhibition of MYC and PGC-1 results in reduced mitochondrial mass and 
biogenesis (Shoag & Arany, 2010). Previous studies have described the effect of oxygen 
level modulation and HMAs on both PC12 (Crispo et al., 2011; Lan et al., 2011; Guo et al., 
2012; Kolamunne et al., 2013; Zheng et al., 2015) and MSCs (Sena & Chandel 2012; 
Schönenberger & Kovacs, 2015; Wanet et al., 2015; Lin et al., 2017). 
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These studies results rise the need to establish baseline effects in the two cell models, 
evaluate the impact of the three oxygen culture conditions, and then study the effect of 
HMAs on mitochondria.  
 
5.3.1.1. PC12 mitochondrial burden 
5.3.1.1.1. Determination of PC12 mitochondrial burden after incubation in different 
oxygen conditions. 
Mitochondrial burden can be applied as a relative measure of mitochondrial mass. PC12 
were cultured and stained as stated in Chapter 2 (2.2.1.11). Before collecting 
measurements, the MitoTracker® Green optimal concentration was established and the 
flow cytometry machine optimised by compensation to FL channels to avoid channel 
bleeding.  
AO cultured cells displayed a consistent baseline fluorescence. PC12 cells used to initiate 
all experiments were measured to establish control levels and this is represented as the x-
axis intersection with the y-axis and all values normalized to this value. IH significantly 
elevated mitochondrial burden over 96 hrs in contrast to CN where there was no change 
in burden except significant reduction significant after 72 hrs in comparison to control AO. 
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5.3.1.1.2. Determination of PC12 mitochondrial burden after CoCl2 treatment in 
different oxygen conditions. 
AO cultured PC12 were exposed to 50 µM CoCl2 which increased mitochondrial burden 
after 24 hrs (13%) in comparison to control AO (p<0.05). In IH culture there were 
significant reductions in mitochondria burden after over 24 hrs, 48 hrs, 72 hrs and 96 hrs 
(60%, 55%, 70% and 55% respectively) in comparison to control IH.  Mitochondrial burden 
reduced after after 72 hrs of CoCl2 supplementation (38%) in comparison to control CN 
(Figure 5.1). 
 
 Figure 5.1. Mitochondrial burden of PC12 cultured with CoCl2 in three different 
oxygen culture conditions 
Incubation of PC12 with CoCl2 for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Green fluorescence was 
measured as indicated earlier. X-axis represent normalized mean fluorescence intensity. Y-axis 
represent different time points. Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at 
each time point under each oxygen culture condition (p<0.01). 
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5.3.1.1.3. Determination of PC12 mitochondrial burden after DFO treatment in 
different oxygen conditions. 
Under AO PC12 were exposed to 50 µM DFO which significantly elevated mitochondrial 
burden after both 24 (38%) in comparison to control with significant reduction noted after 
72 hrs (22%) (p<0.05). In IH there were significant elevation after 48 hrs (18%) with 
reductions after 72 and 96 hrs (77% and 72%) in comparison to control IH. Incubation in 
CN with DFO also resulted in significant elevation after 24 hrs and 96 hrs (23% and 23% 
respectively) with significant reduction after 48 hrs (21%) (Figure 5.2).  
 
5.2. Mitochondrial burden of PC12 cultured with DFO in three different oxygen 
culture conditions 
PC12 incubated with DFO for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Green fluorescence was 
measured as before. X-axis represent normalized mean fluorescence intensity. Y- axis represent 
different time points. Data are presented as normalized mean fluorescence intensity ± standard 
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deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at each time 
point under each oxygen culture condition (p<0.01). 
5.3.1.1.4. Determination of PC12 mitochondrial burden after DMOG treatment in 
different oxygen conditions. 
Under AO culture condition cells exposed to 100 µM DMOG significantly elevated their 
mitochondrial burden after 24 hrs and 96 hrs (40% and 26%) compared to control AO with 
significant dropping noted (26%) after 72 hrs, while under IH culture reductions were 
noted after 24 hrs, 72 hrs and 96 hrs (66%, 53% and 64%, respectively) in comparison to 
control IH (p<0.01). Significant elevation in mitochondrial burden was also noted after 24 
incubations at CN with DMOG (33% and 16%) (Figure 5.3).  
 
Figure 5.3. Mitochondrial burden of PC12 cultured with DMOG in three different 
oxygen culture conditions  
PC12 incubated with DMOG for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Green fluorescence was 
measured as before. X-axis represent normalized mean fluorescence intensity. Y- axis represent 
different time points. Data are presented as normalized mean fluorescence intensity ± standard 
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deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at each time 
point under each oxygen culture condition (p<0.01). 
5.3.1.1.5. Determination of PC12 mitochondrial burden after IOX2 treatment in 
different oxygen conditions. 
AO cultured PC12 cells exposed to 50 nM IOX2 displayed a significantly elevated 
mitochondrial burden after both 24 hrs and 96 hrs (40% and 68%) in comparison to 
control AO (p<0.01) while after 72 hrs significant reduction (26%) was noticed. IH culture 
resulted significant reductions 24 hrs, 72 hrs and 96 hrs (40%, 50% and 64%) in 
comparison to control IH (p<0.01). Significant elevation was also noted after 72 hrs and 96 
hrs incubation in CN with IOX2 where elevation was noted after 72 hrs and 96 hrs (43% 
and 24%) (Figure 5.4).  
 
Figure 5.4. Mitochondrial burden of PC12 cultured with IOX2 at three different 
oxygen culture conditions  
PC12 incubated with IOX2 for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Green fluorescence was 
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measured as before. X-axis represent normalized mean fluorescence intensity. Y- axis represent 
different time points. Data are presented as normalized mean fluorescence intensity ± standard 
deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at each time 
point under each oxygen culture condition (p<0.01). 
 
To sum up, IH increase mitochondrial burden in comparison to control AO over 96 hrs. 
while CN cause significant reduction after 72 hrs in comparison to control AO. HMAs 
undre AO significantly elevated burden after 24 hrs while under IH, HMAs reduced burden 
after 72 hrs and 96 hrs. Under CN culture condition, HMAs (except CoCl2) significantly 
elevated burden after 24 hrs in comparison to control CN. HMAs fail to replicate cells 
behaviour under all culture conditions. These changes may relate to the activation of 
peroxisome proliferator activated receptor γ coactivator-1α (PGC-1α) which is the main 
regulator of mitochondrial biogenesis. It initiates the transcription of nuclear encoded 
mitochondrial proteins such as nuclear respiratory factors 1 and 2 (NRF1 and NRF2), 
oestrogen related receptor α (ERRα), forkhead box class-o (Foxo-1), and peroxisome 
proliferator activated receptors (PPARs) (Puigserver & Spiegelman, 2003) where 
expression of these proteins leads to the eventual increase in mitochondrial mass (Dillon 
et al., 2012). 
 
5.3.1.2. PC12 mitochondrial action potential 
5.3.1.2.1. Determination of PC12 mitochondrial action potential after incubation in 
different oxygen conditions. 
Mitochondrial action potential (mt-AP) plays a vital role in cellular activity. PC12 were 
cultured and stained as stated in Chapter 2 (2.2.1.11). MitoTracker® Red optimal 
concentration was first defined and the flow cytometry machine optimised to avoid 
bleeding across the FL channels. AO cultured cells displayed a consistent baseline 
fluorescence.  PC12 cells used to initiate all experiments were first measured to establish 
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control levels and are represented as the x-axis intersection with the y-axis and all values 
normalized to this value. Both IH and CN culture significantly elevated mt-AP over 96 hrs 
(p<0.01) in comparison to AO. 
 
5.3.1.2.2. Determination of PC12 mitochondrial action potential after treatment with 
CoCl2 at different oxygen conditions. 
AO cultured PC12 cells exposed to 50 µM CoCl2 displayed no significantly effect on mt-
AP, while IH cultured PC12 displayed significant reductions after 24 hrs, 72 hrs and 96 hrs 
(56%, 90% and 30% respectively) in comparison to IH control (p<0.01). Significant 
reductions in mt-AP were also noted after incubation in CN with CoCl2 after 48 hrs, 72 hrs 
and 96 hrs (49%, 75% and 74% respectively) (Figure 5.5).  
 
Figure 5.5. Mitochondrial action potential of PC12 cultured with CoCl2 at three 
different oxygen culture conditions  
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PC12 incubated with CoCl2 for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Red fluorescence was 
measured as described earlier. X-axis represents normalised fluorescence intensity values. Y-axis 
represent time points (hrs). Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at 
each time point under each oxygen culture condition (p<0.01). 
5.3.1.2.3. Determination of PC12 mitochondrial action potential after treatment with 
DFO at different oxygen conditions. 
AO cultured PC12 cells exposed to 50 µM DFO significantly increased mt-AP after 24 hrs 
only (36%) in comparison to control AO (p<0.01), while under IH culture there were 
significant reductions after 24 hrs, 72 hrs and 96 hrs (50%, 82% and 52%) in comparison 
to control IH (p<0.01) with an increase after 48 hrs (107%) (p<0.001). Reductions were 
noted after incubation at CN where DFO reduced mt-AP after 48 hrs,72 hrs and 96 hrs (50 
%, 71% and 55% respectively) (Figure 5.6).  
 
Figure 5.6. Mitochondrial action potential of PC12 cultured with DFO in three 
different oxygen culture conditions  
246 
 
PC12 incubated with DFO for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Red fluorescence was 
measured as indicated previously. X-axis represents normalised fluorescence intensity values. Y-
axis represent time points (hrs). Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at 
each time point under each oxygen culture condition (p<0.01). 
5.3.1.2.4. Determination of PC12 mitochondrial action potential after treatment with 
DMOG at different oxygen conditions. 
AO cultured PC12 cells exposed to 100 µM DMOG significantly elevated mt-AP after 24 
hrs (45%) with significant reduction (27%) in comparison to control AO, while under IH 
culture there were significant reduction after 24 hrs, 72 hrs and 96 hrs (53%, 65% and 
43%) in comparison to control IH. Significant reductions were noted after incubation at CN 
where DMOG reduced mt-AP after 48 hrs, 72 hrs and 96hrs (39%, 61% and 63% 
respectively) (Figure 5.7).  
 
Figure 5.7. Mitochondrial action potential of PC12 cultured with DMOG in three 
different oxygen culture conditions  
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PC12 incubated with DMOG for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Red fluorescence was 
measured following labelling and incubation via FACS. X-axis represents normalised fluorescence 
intensity values. Y-axis represent time points (hrs). Data are presented as normalized mean 
fluorescence intensity ± standard deviation (SD). n=1 triplicate, * indicates significant difference in 
comparison to control at each time point under each oxygen culture condition (p<0.01). 
5.3.1.2.5. Determination of PC12 mitochondrial action potential after treatment with 
IOX2 at different oxygen conditions. 
AO cultured PC12 cells exposed to 50 nM IOX2 have no significant effect on mt-AP, while 
under IH culture there were significant reductions after 24 hrs, 72 hrs and 96 hrs (56%, 
90% and 30% respectively) in comparison to control IH with no significant effect was 
noted after 48 hrs. mt-AP reductions were noted after 48 hrs, 72 hrs and 96 hrs of IOX2 
supplementation at CN (49%, 74% and 74% respectively) (p<0.01) (Figure 5.8). 
 
Figure 5.8. Mitochondrial action potential of PC12 cultured with IOX2 in three 
different oxygen culture conditions  
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PC12 incubated with IOX2 for 24 hrs, 48 hrs, 72 hrs and 96 hrs in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). MitoTracker
®
 Red fluorescence was 
measured as before. X-axis represents normalised fluorescence intensity values. Y-axis represent 
time points (hrs). Data are presented as normalized mean fluorescence intensity ± standard 
deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control at each time 
point under each oxygen culture condition (p<0.01). 
 
To sum up, mitochondrial action potential elevated over the 96 hrs in IH and CN. Where 
after HMAs at IH and CN significantly reduced action potential after 48 hrs, 72 hrs and 
96hrs. While under AO culture condition, little or no significant effect on action potential. 
HMAs treatment again fail to recapture mitochondrial action potential pattern on all culture 
conditions and these changes may relate to fission/ fussion process Mfn-2 regulates 
mitochondrial mass, membrane potential, and glucose oxidation. Mfn-2 induces 
aggregation of small mitochondrial clusters of fragmented mitochondria (Kawalec et al., 
2015). 
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5.3.1.3. PC12 mitochondrial genome copy number  
There is strong association between mitochondrial function and the quantity of 
mitochondrial DNA (mtDNA) (Xu et al., 2013). Elevated levels of ROS formation lead to 
mtDNA oxidative damage, which is associated with multisystem disorders, mainly 
affecting energy dependent functions e.g. central nervous system. Mitochondria play a 
vital role in the regulation of synaptic formation and function and any mitochondrial 
dysfunction may underlie neurological changes under hypoxia. The mechanisms that 
underlie potential mtDNA copy alterations observed under different oxygen levels have 
not been fully elucidated. Mitochondrial copy number changes can trigger many damaging 
processes including apoptosis, oxidative stress and autophagy, which are tightly regulated 
pathways (Guha & Avadhani, 2013). We hypothesised that HMAs and/or may IH/CN 
change the number of mitochondria. Mitochondrial DNA were extracted from PC12 cells 
as described in Chapter 2 (2.4.1) and used for detection of the changes in mitochondrial 
genome copy number. 
There was significant elevation in mitochondrial copy number were noted following 2^ΔΔCt 
qPCR methodology after incubation in IH (while under CN culture conditions there was 
significant reduction in comparison to the baseline AO (Figure 5.9). 
 
Figure 5.9. Mitochondrial genome copy number changes after incubation under 
different oxygen culture conditions  
PC12 were incubated for 24 hrs in either air oxygen (AO), intermittent hypoxia (IH), or continuous 
normoxia (CN) before DNA was extracted. X-axis represents different oxygen culture condition. Y-
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axis represent fold change in ND1 relative to AO. qPCR assessment of mtDNA using the mt-ND1 
gene locus. β actin gene is used as genomic copy number housekeeping gene. Error bars 
represent ± one standard deviation from the mean.  
 
After supplementation with CoCl2 in AO the mitochondrial genome copy number was 
significantly elevated after both 48 hrs and 72hrs (5 and 4 fold respectively) but dropped 
below significance after 96 hrs. No significant change in the mitochondrial genome copy 
number was noticed after IH culture condition over 96 hrs while only slight, though 
significant, reductions were noted in CN after 48 hrs and 72 hrs (0.27 and 0.56 fold 
respectively) in comparison to the baseline AO (Figure 5.10).  
 
Figure 5.10. Mitochondrial genome copy number changes after CoCl2 incubation 
under different oxygen culture conditions 
Mitochondrial genome copy number changes after treatment with CoCl2 in either AO, IH, or CN. 
qPCR assessment of mtDNA using the mt-ND1 gene locus. β-actin gene is used as housekeeping 
gene. X-axis represents different time points. Y-axis represents relative changes in 2
^ΔΔCt
 of treated 
cell to untreated control. The fold change above or below is normalized to mt-ND1 control 
untreated cells at each oxygen condition. Error bars represent ± one standard deviation from the 
mean. 
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Supplementation of PC12 cells with DFO in AO resulted in a significant elevation of 
mitochondrial genome copy number after 48 hrs and 72 hrs (1.7 and 0.7 fold) followed by 
a significant reduction (0.5 fold) after 96 hrs. Under IH a significant elevation in 
mitochondrial genome copy number was observed 24 hrs, 48 hrs and 72 hrs (0.73, 14.5, 
0.5 fold respectively) followed by reduction (0.63 fold). In contrast, no significant change 
was noticed with CN in comparison to the baseline AO (Figure 5.11). 
 
Figure 5.11. Mitochondrial genome copy number changes after DFO incubation 
under different oxygen culture conditions  
Mitochondrial genome copy number changes after treatment with DFO in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). qPCR assessment of mtDNA using the mt-
ND1 gene locus. β-actin gene is used as housekeeping gene. X-axis represents different time 
points. Y-axis represents relative changes in 2
^ΔΔCt
 of treated cell to untreated control. The fold 
change above or below is normalized to mt-ND1 control untreated cells at each oxygen condition. 
Error bars represent ± one standard deviation from the mean.  
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PC12 supplementation with DMOG in AO resulted in a significant elevation of 
mitochondrial genome copy number after 24 hrs, 48 hrs and 72 hrs (0.39, 2.26 and 0.73 
fold). Under IH culture significant elevation of mitochondrial genome copy number 
occurred after 24 hrs (4 fold) followed another elevation after 72 hrs (15 fold). In contrast, 
significant reduction was noted after both 48 hrs and 72 hrs (0.35 and 0.44 fold) in CN in 
comparison to the baseline AO (Figure 5.12). 
 
Figure 5.12. Mitochondrial genome copy number changes after DMOG incubation 
under different oxygen culture conditions  
Mitochondrial genome copy number changes after treatment with DMOG in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). qPCR assessment of mtDNA using the mt-
ND1 gene locus. β-actin gene is used as housekeeping gene. X-axis represents different time 
points. Y-axis represents relative changes in 2
^ΔΔCt
 of treated cell to untreated control. The fold 
change above or below is normalized to mt-ND1 control untreated cells at each oxygen condition. 
Error bars represent ± one standard deviation from the mean.  
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PC12 supplementation with IOX2 in AO resulted in a significant elevation of mitochondrial 
genome copy number after 24 hrs and 96 hrs (5 and 95 fold). Under IH significant 
reduction in mitochondrial genome copy number were noted after both 24 hrs (0.38 fold). 
Significant elevation was noticed after 48 hrs and 96 hrs (8 and 0.5 fold) in CN in 
comparison to the baseline (Figure 5.13). 
 
Figure 5.13. Mitochondrial genome copy number changes after IOX2 incubation 
under different oxygen culture conditions 
Mitochondrial genome copy number changes after treatment with IOX2 in either air oxygen (AO), 
intermittent hypoxia (IH), or continuous normoxia (CN). qPCR assessment of mtDNA using the mt-
ND1 gene locus. β-actin gene is used as housekeeping gene. X- axis represents different time 
points. Y-axis represents relative changes in 2
^ΔΔCt
 of treated cell to untreated control. The fold 
change above or below is normalized to mt-ND1 control untreated cells at each oxygen condition. 
Error bars represent ± one standard deviation from the mean.  
 
To sum up, CoCl2 increase mitochondrial genome copy number after 48, 72 hrs in AO and 
reduced the copy number after 72 hrs in CN. DFO increase mitochondrial genome copy 
number after 48, 72 hrs in AO and 24, 48, 72 hrs in IH with significant reduction after 96 
hrs in IH. DMOG increase mitochondrial genome copy number after 24, 48, 72 hrs in AO 
and 24, 72 hrs in IH with significant reduction noted after 48 and 96 hrs. finally IOX2 
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increase mitochondrial genome copy number after 24, 96 hrs in AO and 48, 96 hrs with 
significant reduction after 24 hrs in IH.  
In conclusion, IH increase mitochondrial burden and action potential without affecting 
mitochondrial genome copy number. HMAs supplementation under all conditions induce 
distinctive pattern of mitochondrial dynamic different than that noted under IH and CN, 
thus HMAs fail to mimic effect of oxygen modulation on mitochondrial level.  
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5.3.2.  Effect of hypoxia mimetic agents on BM-hMSCs mitochondrial 
dynamic 
5.3.2.1. BM-hMSCs mitochondrial burden 
Mitochondrial burden can be applied as a relative measure of mitochondrial mass. MSCs 
were cultured and stained as stated in Chapter 2 (2.2.2.9) and optimisation performed as 
described previously for PC12. An evaluation of AO cultured MSCs used to initiate all 
experiments was performed to establish baseline fluorescence and this is represented as 
the x-axis intersection with the y-axis and all values normalized to this value. IH culture 
conditions caused significant reduction on burden in comparison to AO control. 
Under AO culture condition, supplementation of media with either CoCl2, DFO or DMOG 
significantly reduced burden (23%, 51% and 24%) in comparison to control AO (Figure 
5.14). 
 
Figure 5.14. Mitochondrial burden of hMSCs cultured with HMAs in air oxygen 
culture condition 
hMSCs were incubated for 14 days in air oxygen supplemented with either CoCl2, DFO, DMOG, or 
IOX2 after which mitochondrial burden was assayed. MitoTracker
® 
Green was measured as 
indicated previously. X-axis represents normalized mean fluorescence intensity. Y-axis represent 
different treatment. Data are presented as normalized mean fluorescence intensity ± standard 
deviation (SD). n=3, * indicates significant difference in comparison to control AO (p<0.01). 
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Under IH supplementation of media with DFO and DMOG significantly reduced burden 
(50% and 10%) in comparison to control IH. In contrast IOX2 significantly increase burden 
(23%) in comparison to control IH (Figure 5.15). 
 
Figure 5.15. Mitochondrial burden of hMSCs cultured with HMAs at intermittent 
hypoxia culture condition 
hMSCs were incubated for 14 days in intermittent hypoxia supplemented with either CoCl2, DFO, 
DMOG, or IOX2 after which mitochondrial burden was assayed.  MitoTracker
®
 Green was 
measured as indicated previously. X-axis represents normalized mean fluorescence intensity. Y-
axis represent different treatment. Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control IH 
(p<0.01). 
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Under CN supplementation of media with HMAs significantly reduced burden after CoCl2, 
DFO, DMOG and IOX2 (17%, 60%, 17% and 21% respectively) in comparison to control 
CN. (Figure 5.16). 
 
Figure 5.16. Mitochondrial burden of hMSCs cultured with HMAs in continuous 
normoxia culture condition 
hMSCs were incubated for 14 days in continuous supplemented with either CoCl2, DFO, DMOG, or 
IOX2 after which mitochondrial burden was assayed. MitoTracker
®
 Green was measured as 
indicated previously. X-axis represents normalized mean fluorescence intensity. Y-axis represent 
different treatment. Data are presented as normalized mean fluorescence intensity ± standard 
deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control CN 
(p<0.01). 
 
To sum up, hMSCs mitochondrial burden reduced under IH. CoCl2, DFO and DMOG 
significantly reduce mitochondrial burden in AO. Under IH culture DFO and DMOG 
reduced mitochondrial burden with elevation noted after IOX2. All HMAs reduce 
mitochondrial burden in CN.  HMAs recapture mitochondrial burden pattern only with IOX2 
under AO and CoCl2 under IH.  
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5.3.2.2. BM-hMSCs mitochondrial action potential. 
Mitochondrial action potential (mt-AP) plays a vital role in cellular activity. hMSCs cultured 
and stained as stated in Chapter 2 (2.2.1.11). AO cultured cells displayed a consistent 
baseline fluorescence. MSCs used to initiate all experiments were first measured to 
establish control levels and are represented as the x-axis intersection with the y-axis and 
all values normalized to this value. IH significantly elevate mt-AP in comparison to AO with 
no significant effect was noted with CN. 
Under AO culture condition, supplementation media with CoCl2 and DMOG significantly 
reduced mt-AP (18% and 26%) in comparison to control AO with significant elevation was 
noted after IOX2 supplementation (70%) (Figure 5.17). 
 
Figure 5.17. Mitochondrial action potential of hMSCs cultured with HMAs in air 
oxygen culture condition 
hMSCs were incubated for 14 days in air oxygen supplemented with either CoCl2, DFO, DMOG, or 
IOX2 after which mitochondrial burden was assayed. MitoTracker
®
 Red was measured as indicated 
previously. X-axis represents normalized mean fluorescence intensity. Y-axis represent different 
treatment. Data are presented as normalized mean fluorescence intensity ± standard deviation 
(SD). n=1 triplicate, * indicates significant difference in comparison to control AO (p<0.01). 
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Under IH culture condition, supplementation media with DFO and DMOG significantly 
reduced mt-AP (63% and 33%) in comparison to control IH. In contrast IOX2 significantly 
elevated mt-AP (50%) in comparison to control IH (Figure 5.18). 
 
Figure 5.18. Mitochondrial action potential of hMSCs cultured with HMAs in 
intermittent hypoxia culture condition 
hMSCs were incubated for 14 days in intermittent hypoxia supplemented with either CoCl2, DFO, 
DMOG, or IOX2 after which mitochondrial burden was assayed. MitoTracker
®
 Red was measured 
as indicated previously. X-axis represents normalized mean fluorescence intensity. Y-axis 
represent different treatment. Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control IH 
(p<0.01). 
  
260 
 
Under CN culture condition supplementation media with CoCl2 and DFO significantly 
reduced burden (28% and 38%) in comparison to control CN with significant elevation was 
noticed after IOX2 supplementation (35%) in comparison to control CN (Figure 5.19). 
 
Figure 5.19. Mitochondrial action potential of hMSCs cultured with HMAs in 
continuous culture condition 
hMSCs were incubated for 14 days in continuous normoxia supplemented with either CoCl2, DFO, 
DMOG, or IOX2 after which mitochondrial burden was assayed. MitoTracker
®
 Red was measured 
as indicated previously. X-axis represents normalized mean fluorescence intensity. Y-axis 
represent different treatment. Data are presented as normalized mean fluorescence intensity ± 
standard deviation (SD). n=1 triplicate, * indicates significant difference in comparison to control 
CN (p<0.01). 
 
To sum up, hMSCs mitochondrial action potential increase in IH. CoCl2 and DFO reduced 
mitochondrial action potential under AO with significant increase noted after IOX2 
supplementation. Under IH culture DFO and DMOG reduced mitochondrial the action 
potential with elevation noted after IOX2. CoCl2 and DFO reduce mitochondrial action 
potential in CN with significant elevation after IOX2 supplementation. HMAs recapture 
mitochondrial burden pattern only with IOX2 under AO and CoCl2 under IH.   
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5.3.2.3. BM-hMSCs mitochondrial genome copy number  
Mitochondria are sites of energy production in human cells which usually contain 100s to 
1000s of mitochondria/cell and each mitochondrion contain 2–10 mitochondrial DNA 
(mtDNA) copies that form the mitochondrial network (Gilkerson et al., 2013). The amount 
of energy produced is related to the number of mtDNA copies and the abundance of 
mitochondria under different physiological conditions (Trinei et al., 2006). The human 
mtDNA is a circular DNA with 16,569 bp (Berdanier, 2005). It encodes only for 13 
polypeptides that are essential for the assembly of respiratory enzyme complexes I, III, IV, 
and V. The remaining ~90 polypeptides constituting the respiratory enzyme complexes 
are encoded in nuclear DNA (nDNA) (Lin & Wang, 2013). The complex II subunits are 
totally encoded in nDNA. mtDNA replication and transcription regulated by number of 
proteins such as mitochondrial transcription factor A (TFAM) which play dual roles in 
mtDNA replication and transcription by interaction to the noncoding D-loop region. TFAM 
plays an important role in the regulation of mitochondrial biogenesis under different 
oxygen level (Holt & Reyes, 2012). Limited studies have discussed the role of HMAs on 
mitochondrial genome copy number in BM-hMSCs.  
Following the procedures outlined previously DNA was extracted from hMSC and qPCR 
performed for ND1 and ACTB to establish an indicator of mt genome copy number.  Both 
IH and CN displayed a significantly elevation in mitochondrial genome copy number in 
BM-hMSCs in comparison to AO with no significant effect was noted with CN (Figure 
5.20). 
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Figure 5.20. Mitochondrial genome copy number changes after incubation under 
different oxygen culture conditions 
Following incubation of BM-hMSCs for 14 days in either air oxygen (AO), intermittent hypoxia (IH), 
or continuous normoxia (CN) DNA was extracted and qPCR performed. X-axis represents different 
oxygen culture condition. Y-axis represent fold change in ND1 relative to AO. qPCR assessment of 
mtDNA using the mt-ND1 gene locus. β-actin gene is used as housekeeping gene. The mean 
normalized to control AO. Error bars represent ± one standard deviation from the mean. * indicates 
significant difference in comparison to baseline (p<0.01). 
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Under AO cultured BM-hMSC supplemented with either CoCl2, DFO, or IOX2 significantly 
elevated ND1 (11, 2, and 1.5 fold) in comparison to baseline was observed, no significant 
effect was noted with DMOG (Figure 5.21). 
 
Figure 5.21. Mitochondrial genome copy number changes after incubation with 
HMAs under air oxygen culture condition 
Mitochondrial genome copy number changes after treatment with either CoCl2, DFO, DMOG, or 
IOX2 in AO culture. X-axis represents individuals HMAs. Y-axis represent fold change in ND1 
relative to AO. qPCR assessment of mtDNA using the mt-ND1 gene locus. β-actin gene is used as 
housekeeping gene. The fold change above or below is normalized to mt-ND1 control untreated 
cells at each oxygen condition. Error bars represent ± one standard deviation from the mean, * 
indicates significant difference in comparison to baseline (p<0.01). 
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Under IH culture condition, DFO and DMOG significantly elevated ND1 (2.83 and 7.15 
fold, respectively) with a significant reduction noted after either CoCl2 (0.26 fold) or IOX2 
(0.87 fold) treatment compare to baseline (Figure 5.22). 
 
Figure 5.22. Mitochondrial genome copy number changes after incubation with 
HMAs under intermittent hypoxia culture condition 
Mitochondrial genome copy number changes after treatment with either CoCl2, DFO, DMOG, or 
IOX2 in IH culture. X-axis represents individuals HMAs. Y-axis represent fold change in ND1 
relative to IH. qPCR assessment of mtDNA using the mt-ND1 gene locus. β-actin gene is used as 
housekeeping gene. The fold change above or below is normalized to mt-ND1 control untreated 
cells at each oxygen condition. Error bars represent ± one standard deviation from the mean, * 
indicates significant difference in comparison to baseline (p<0.01). 
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Under CN culture condition CoCl2, DFO and DMOG significantly elevated ND1 (4.25, 
1.97, and 13.8 fold respectively). In contrast, a significant reduction was noted after IOX2 
treatment when compared to baseline (0.47) (Figure 5.23).  
 
Figure 5.23. Mitochondrial genome copy number changes after incubation with 
HMAs under continuous normoxia culture condition 
Mitochondrial genome copy number changes after treatment with either CoCl2, DFO, DMOG, or 
IOX2 in CN culture. X-axis represents individuals HMAs. Y-axis represent fold change in ND1 
relative to CN. qPCR assessment of mtDNA using the mt-ND1 gene locus. β-actin gene is used as 
housekeeping gene. The fold change above or below is normalized to mt-ND1 control untreated 
cells at each oxygen condition. Error bars represent ± one standard deviation from the mean, * 
indicates significant difference in comparison to baseline (p<0.01). 
 
To sum up with exception of DMOG in AO, HMAs induced significant change in 
mitochondrial genome number which not mimics any of patterns seen under the three 
oxygen culture conditions. 
 In conclusion. IH decrease both mitochondrial burden and mitochondrial genome copy 
number with increase in action potential. HMAs supplementation of under all conditions 
induce distinctive pattern of mitochondrial dynamic different than that noted under IH, thus 
HMAs fail to mimic effect of oxygen modulation preconditioning on mitochondrial level.   
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Now it is clear that HMAs does not mimic any pattern that was noticed under all studied 
oxygen culture conditions. We still need to determine the effect of different oxygen level 
on MSCs ultrastructure in order connect these effect with previous finding.  
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5.3.3. Effect of different oxygen level on BM-hMSCs ultrastructure 
Mitochondria play a number of important cellular role including ATP production, 
homeostasis of intracellular Ca2+, reactive oxygen species formation, and the release of 
cytochrome c (Perier & Vila, 2012). Moreover, they play a major role in triggering 
programmed cell death (apoptosis) (Carmona-Gutierrez et al., 2010). Mitochondrial 
dysfunction has been described as playing a part in many physiological conditions such 
as aging and pathological conditions as neurodegenerative disorders for example 
Parkinson’s disease (Uttara et al., 2009). Mitochondrial dysfunction is associated with 
accumulation of misfolded or unfolded proteins which relate to endoplasmic reticulum 
(ER) stress (Cao & Kaufman, 2014). Mitochondria may undergo various morphological 
alterations reflective of different physiological and pathological conditions (Sasaki, 2010). 
The TEM remains the most effective tool to study morphological changes of mitochondrial 
and other ultrastructural changes. The changes in these organelles are reflected as 
changes in mitochondrial mass, action potential and oxidative stress.  
Under AO culture, BM-hMSCs cells have an ultrastructure that is held in common across 
animal cells. Cells have polymorphic nuclei with clear border, deep invaginations, 
euchromatin, and conspicuous nucleoli. The cytoplasm possesses well-developed 
cisternae of rough endoplasmic reticulum and cytoskeleton filaments with areas of 
depleted cytoplasm. The cells have branched plasma membranes which resemble 
filopodia that served in attaching to the surface. Mitochondria are rod–like structure and 
distributed around and near to the nucleus. Cytoplasm there are well-developed cisternae 
of rough endoplasmic reticulum and cytoskeleton filaments expanded within areas of 
depleted cytoplasm (black arrow). We also observed that mitochondria appeared 
branched close proximity/near attachment to each other and located very close to the ER. 
This may be reflective of the fusion process described by Van der Bliek et al., (2013) 
(Figure 5.26). (Figure 5.24, 25 and 26).  
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Figure 5.24. BM-hMSCs ultrastructure after incubation in air oxygen 
TEM image of BM-hMSCs after 14 days incubation in AO. Cells have well defined nucleus (N). The 
cytoplasm has a well-developed endoplasmic reticulum (ER) and cytoskeleton filaments within 
areas of depleted cytoplasm. Mitochondria (M) show as dark-road-shape structures. MSCs have 
cytoplasm processes (CP). Scale= 4 µm. 
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Figure 5.25. Mitochondria in air oxygen culture condition 
TEM image of BM-hMSCs after 14-days incubation in AO. Cells display an expanded endoplasmic 
reticulum (ER) and cytoskeleton filaments (CF) with areas of depleted cytoplasm. Mitochondria (M) 
have well defined crista. Scale= 1 µm. 
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Figure 5.26. BM-hMSCs ultrastructure during incubation in air oxygen  
TEM image of BM-hMSCs after 14-days incubation in AO culture cells shows cell have well defined 
nucleus (N). Cytoplasm is well-developed with depleted areas (black arrow), and endoplasmic 
reticulum (ER). Mitochondria (M) are dark-road-shape structures that look branched and apparently 
bind to each other in some points (red arrow). Scale= 2 µm. 
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Under IH culture, mitochondria are shorter than that in AO and distributed near to the 
nucleus. More gaps in cytoplasm were noticed near to both the mitochondria and ER in 
comparison to that noted in AO and areas of parallel microfilaments appeared expanded 
in comparison to that noted in AO. We also observed that mitochondria were divided into 
defined portions at specific sites (red arrow) and this may reflect an ongoing fusion/ fission 
process (Van der Bliek et al., 2013) (Figure 5.27). 
 
Figure 5.27. BM-hMSCs ultrastructure after incubation under intermittent hypoxia  
TEM image of BM-hMSCs after 14 days incubation in IH culture. Cells have well defined nucleus 
(N). A Cytoplasm with a high number of depleted areas (black arrow) and an expanded 
endoplasmic reticulum (ER). Mitochondria (M) show as short dark-road-shape structures with 
structural thinning on occasion (red arrow). Scale= 2 µm. 
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Under CN culture a quite distinct morphology was observed where mitochondria clustered 
in globular structures. A highly dense cytoplasm made endoplasmic reticulum (ER) and 
cytoskeleton filaments (CF) not evident with very small areas of depleted cytoplasm 
(Figure 5.28). 
 
Figure 5.28. BM-hMSCs ultrastructure after incubation under continuous normoxia  
TEM image of BM-hMSCs after 14-days incubation in CN. Cells have a well define nucleus (N) and 
a cytoplasm with very small depleted areas. Endoplasmic reticulum (ER) was not evident due to 
dense cytoplasm. Mitochondria (M) are evident with a faint-grey colour structure (red arrow). 
Scale= 2 µm. 
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TEM image analysis revealed that mitochondrial volume fraction (which obtained by 
dividing mitochondrial area in section on total area of the section using analysSIS® 
software) which represent by the (percentage of mitochondria volume) / cell. No significant 
change after IH culture, while significant elevation was noticed after CN culture (p<0.001) 
in comparison to AO cultured cells (Figure 5.29). 
 
Figure 5.29. Mitochondrial volume fraction of BM-hMSCs after incubation under 
three different oxygen culture conditions 
BM-hMSCs after 14-days incubation in three alternate oxygen culture conditions. TEM images 
were taken and analysed using TEM software. The histogram represents mitochondrial volume 
fraction represented by the percentage of mitochondrial volume/cell. X-axis represents different 
oxygen treatment. Y-axis represents mitochondrial volume fraction. Error bars represent ± one 
standard deviation from the mean. n=3, * indicated significant difference in comparison to BM-
hMSCs cultured in AO. 
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In contrast, mitochondrial density that obtained by dividing number of mitochondria in 
section / area of the section showed significant elevation only after IH culture (p<0.001) in 
comparison to AO culture (Figure 5.30). 
 
Figure 5.30. Mitochondrial density of BM-hMSCs after incubation under three 
different oxygen culture conditions 
BM-hMSCs after 14-days incubation in either of three alternate oxygen culture conditions. TEM 
images were taken and analysed using analysSIS
® 
software. The histogram represents 
mitochondrial density represented by the number of mitochondrial volume/total cytoplasm area. X-
axis represents different oxygen treatment. Y-axis represents mitochondrial density/ section. Error 
bars represent ± one standard deviation from the mean. n=3, * indicated significant difference in 
comparison to BM-hMSCs cultured in AO. 
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Moreover, the TEM study revealed that IH culture condition induced a resemblance to a 
scenario observed in apoptosis with an electron-dense nucleus with nuclear 
fragmentation, and intact cell membrane even late in the cell disintegration phase, 
disorganised cytoplasmic organelles with apoptotic bodies, and large clear vacuoles that 
may bleb out of the cell as described by Elmore (2007) (Figure 5.31). In addition, IH 
cultured cells possess feature like features of mitophagy (Gomes et al., 2011) where 
mitochondria are engulfed by double-membrane-delimited vesicles and condensed to a 
circular structure with vesicles merged to form larger structures (Figure 5.32). 
 
 
Figure 5.31. BM-hMSCs after incubation under IH culture condition 
BM-hMSCs after 14 day incubation at IH culture. TEM image was taken and analysed using TEM 
software. The image revealed that MSCs have an intact cell membrane with a depleted cytoplasm 
and disorganised cytoplasmic organelles with apoptotic bodies and large clear vacuoles. Scale= 10 
µm. 
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Figure 5.32. BM-hMSCs possess feature like mitophagy after incubation under IH 
culture condition  
BM-hMSCs after 14-days incubation at IH culture. TEM images were taken and analysed using 
TEM software. The image revealed that mitochondria were engulfed by double-membrane-
delimited vesicles and the condensed to circular structure and the vesicles merged to form lager 
structure. Scale= 2 µm. 
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5.4. Discussion  
Mitochondria are the most dynamic organelles inside the cell that response to different 
cell’s demand such as energy production, oxygen presence and ROS status. Mitochondria 
continuously undergo structural remodelling and this dynamic activity plays major role in 
regulation of several vital cellular activities such as cell cycle, autophagy, and age-related 
diseases. In PC12 cells IH significantly reduce mitochondrial burden with significant 
increase in mitochondrial genome copy number that result increase in mitochondrial 
action potential this agree with results obtained by Onyango et al., (2010) but disagree 
with Li et al., (2015) who described significant reduction in mitochondrial mass and action 
potential. Many studies discussed the possible mechanisms of this effect. Oxygen level 
changes suppress mitochondrial biogenesis, so reduce mitochondrial mass. Suppression 
of mitochondrial biogenesis involve replication of the mtDNA and harmonise expression of 
many nuclear/ mitochondrial encoded genes such PGC-1α. PGC-1α is the master 
regulator of all mitochondrial biogenesis aspects, as it regulate respiratory chain and fatty 
acid oxidation genes, increased mitochondrial number, mtDNA replication, and 
augmentation of mitochondrial respiratory capacity by direct interaction with and co-
activation of PPARs, the nuclear respiratory factors NRFs, and estrogen-related receptors 
ERRs (Scarpulla et al., 2012). PGC-1α activity is control by oxygen, and cellular energy 
balance at both the transcriptional and posttranslational level (Dominy et al., 2010). In 
addition, PGC-1β and PRC have the similar role on mitochondrial biogenesis (Scarpulla et 
al., 2012). Low oxygen also reduces mitochondrial ROS formation by optimising 
respiration efficiency through inducing cytochrome c oxidase (COX) subunit IV isoform 2 
(COX4-2) and the mitochondrial protease LONP1, which degrades the less efficient 
COX4-1 (Fukuda et al., 2007) 
Our results revealed that despite the HMAs does not follow the hypoxia pattern, but they 
have no effect on mitochondrial mass and copy number with significant reduction in 
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mitochondrial action potential and this agree with (Neitemeier et al., 2016; Niatsetskaya et 
al., 2010). 
Bone marrow-derived mesenchymal stem cells present good therapeutic tool in treatment 
in many disease conditions. Oxygen level changes lead to reduction in mitochondrial 
mass and genome copy number with compensatory elevation in mitochondrial action 
potential and may be related to reduction in Mfn-2 activity. Mfn-2 is the regulator of 
mitochondrial mass, membrane potential, and glucose oxidation. Mfn-2 induces 
aggregation of small mitochondrial clusters of fragmented mitochondria (Kawalec et al., 
2015) which is functionally impaired and release cytochrome c to the cytosol, thus leading 
to apoptotic cell death and this agree with Wang et al., (2016) and disagree with Stab et 
al., (2016). HMAs (except IOX2) reduced mitochondrial mass and action potential under 
all oxygen culture condition with increase in mitochondrial genome copy number and this 
may be related also to the reduction Mfn-2 activity that reduced mitochondrial mass, 
membrane potential, and glucose oxidation (Wang et al., 2016) lead to production of non-
functional mitochondria and this result disagree with Zhang et al., (2014). 
We found that mitochondrial potential directly correlated to HIF-1α changes and this may 
have related to inhibition of the mitochondrial F0 F1-ATPase leads to an increase in the 
mitochondrial membrane potential and slowing down of electron transport (Gong & Agani 
,2005; Hagen, 2012). The number of mitochondria per cell change according to the 
energy demands, oxygen availability and oxidative stress inside the cell, so the copy 
number of mitochondrial DNA (mtDNA) can vary depending upon the energy needs of a 
cell (Shay et al., 1990) and oxidative stress conditions (Lee & Wei, 2005). HMAs change 
mitochondrial genome copy number in way not matches any oxygen culture condition and 
this different mechanism of action.  
Now we can have stated that HMAs does not mimic effect different oxygen culture 
condition, thus further work will focus on the effect of changes in oxygen culture condition 
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on MSCs ultrastructure and as we previously proposed that HIF-α signaling affects 
mitochondrial biogenesis, shape, size and function. 
In this study, we described the effect of different oxygen culture condition on ultrastructure 
of BM-hMSCs the results revealed that with HIF-1α change is directly related to 
mitochondria density/ cell, this result was in line with Mason et al., (2004) study. In 
addition, the AO and IH culture significantly lower mitochondrial volume fraction that 
reflecting in the images. 
 
5.5. Conclusion  
This study suggested that each hypoxia mimetic agents induced significantly different 
pattern of mitochondrial burden, action potential and genome copy number from that seen 
at three oxygen culture condition. In addition, preconditioning MSCs cell with 2% IH 
produce more serious damage that was noticed with CN. 
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Chapter 6 : Summative discussion, conclusions 
and future works 
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6.1.  Summative discussion 
During the review of literature and the practical laboratory work in this thesis we are facing 
many controversies in the terminology or definition of oxygen culture condition. Many 
studies described 21% oxygen as normoxia (Höhler et al., 1999; Tai et al., 2009; Naranjo-
Suarez et al., 2012; Boyette et al., 2014; Teixeira et al. 2015), whereas, oxygen culture 
condition lower than 21% oxygen defined as hypoxia (Mohyeldin et al., 2010; Ejtehadifar 
et al., 2015; Widowati et al., 2015; El-Moataz et al., 2016;). Cells grow in vivo at oxygen 
level much lower than 21%, thus, hypoxia definition is inapplicable. In this work, air 
oxygen culture term used to describe the 21% oxygen culture condition. Throughout this 
work, air oxygen culture induced some changes on specific cellular activities different from 
that we find at continuous 2% oxygen culture, which mimics the native in vivo growth 
environment. In vivo, cells are exposed to different oxygen concentrations and this 
depends on many factors, such as location, vasculaturisation and cell function. In order to 
mimic an in vivo environment, in vitro conditions should have the similar oxygen levels. 
BM-hMSCs grow in 1.4 - 4.2% oxygen level (Spencer et al., 2014) in vivo, hence in vitro 
oxygen levels should be comparable. We have used a continuous control oxygen 
workstation in the form of an hypoxic incubator to generate useful information about cell 
survival and behaviour under continuous 2% oxygen culture, referred to throughout this 
thesis as continuous normoxia (CN). IH also represents cell growth at 2% oxygen, 
however oxygen levels under this condition change as result of the incubator door 
opening (not more 5 min./ open). This condition aimed to mimic hypoxia/reoxygenation 
found after ischaemia in vivo. 
From early 1970s, lan Richter et al., (1972), Packer and Fuehr (1978) described the effect 
of low oxygen on the plating efficiency (which is reflect the number of colonies originating 
from single cells) and lifespan of human cells. Since that time, researchers continued to 
focus more on the biology of physiological oxygen concentration and how it affects cells, 
despite that, low oxygen culture conditions have not received much attention.  
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The term hypoxia mimetic agents does not really reflect the role of these chemical agents 
in cell behaviour as these agents may induce HIF-1α expression. However, they induce 
variable expression of HIF-2α and change many other cellular activities including; 
attenuating cell proliferation, apoptosis, interruption of the cell cycle, changes in ROS 
production and changes in mitochondrial biogenesis. Based on this, it would be more 
logical to call them HIF-1α inducer rather than hypoxia mimetic, as the results from this 
thesis suggest that HMAs donot recapture all aspects of hypoxia response that we have 
noticed under both IH and CN.  
Preconditioning is another term used to describe exposing cells to brief hypoxia or anoxia, 
which makes cells more resistant to subsequent oxygen stress. this helps to enhance the 
effectiveness of transplantation therapies by improving cell survival, increasing the 
production of paracrine factors and a reducing the inflammatory gene expression (Kloner 
et al., 2006; Haider & Ashraf, 2008; Wei et al., 2016;). Pharmacological hypoxia of cells 
with hypoxia mimetic agents does not fit the principle of preconditioning, as this work 
found that these agents did not recapture patterns that we noticed at IH or CN culture 
conditions. Our results demonstrate that HMAs reduce proliferation, induced cell 
apoptosis and changed both cell cycle and ROS formation. This is in agreement with a 
number of literature sources (Guo et al., 2006; Yang et al., 2008; Lopez-Sánchez et al., 
2014; Mansfield et al., 2005; Correia & Moreira, 2010). 
After dose screening for HMAs and HIF analyses by flow cytometer, the outcome of the 
PC12 model, showed that HIF-1α expression was induced in much lower doses than 
stated in majority of works that involve HMAs for treatment of cultured cells (Boorn, 2010; 
Najafi & Sharifi, 2013; Peng et al., 2014; Wu et al., 2014; Ciavarella et al., 2015; Liu et al., 
2015). Interstingly, even at these lower doses adverse effect on cellular viability and 
metabolic activity is comparable with that reported in the literature. We suggest that HMAs 
at used concentraton does not activite the full spectrum of hypoxia response and this may 
explain adverse effect of these on cellular viability and metabolic activity. This study also 
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showed that HMAs induce HIF-1α expression under both AO and CN culture conditions. 
In addition, HMAs induced HIF-2α after 96 hrs under all oxygen culture condition, and this 
related to the ability of these agents to inhibit PHD activity (section 4.3.2). This is also in 
good agreement with previous work studying these pathways (Gao et al., 2004; Tai et al., 
2009; Yuan et al., 2014; Choi et al., 2016; Wigerup et al., 2016). 
Additionally, HMAs appeared to affect apoptosis under all culture conditions. This may be 
related to the elevation in HIF-1α expression, which initiates hypoxia-mediated-apoptosis 
by enhancing the expression of Bcl-2 binding proteins (BNIP-3 and NIX) Tai et al., (2009), 
Zeno et al. (2012), Hashimoto-Torii et al., (2014) and Neitemeier et al., (2017). Under all 
culture conditions, HMAs trapped cells in G0/G1 phase, effectivly reducing the number of 
cells in G2-M phase. This may be related HIF-1α stabilised p53 activating p21, a pro-
apoptotic protein (Holzwarth et al., 2010; Zeng et al., 2011).  
HMAs increased electron leak from the ETC, leading to an elevation in ROS formation 
(Khan et al., 2012). This suggests that under IH culture, HMAs induce ROS formation and 
nitroreductase activity. This could be due to up regulation of activator protein-1 (AP-1) or 
nuclear factor kappa B (NF-κB) that harmonise the expression and function of cell cycle 
regulators cyclin D1, p53 and p21 (Toffoli & Michiels, 2008). 
The major problem facing the clinical implementation of MSCs is the low yield of these 
cells from bone marrow aspirates. Based on our findings, in vitro expansion under 
continuous normoxia, or alternatively using HMAs could improve the expansion capacity 
and quality of therapeutic cells doses (section 4.3.3).   
After the initial work studying PC12, we repeated dose screening experiments in BM-
hMSCs, ensuring that the doses used did not adversely cell viability but still induced HIF-
1α expression. These results showed that HIF-1α was induced in much lower doses than 
that stated in the literature (Boorn, 2010; Najafi & Sharifi, 2013; Wu et al., 2013; Peng et 
al., 2014; Liu et al., 2015; Ciavarella et al., 2016; Yoo et al., 2016). Our results reflect the 
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effect of higher doses used in these studies, which showed dose-dependent adverse 
effect pattren on cellular viability and biological activities. Our results showed that MSCs 
cultured under IH, CN and HMAs at AO culture enhance the recovery (section 4.3.3) and 
this is in agreement with a recent similar study (Ge et al., 2016) Prolonging MSCs survival 
after transplantation has been shown to be important for potential treatments of the 
ischemic heart (Hu et al. 2008; Wang et al., 2008) and ischemic brain (Theus et al., 2008). 
Our results are also in agreement with Yang et al., (2011) who described the recovery 
enhancement of BM-MSCs aspirates upon exposure to IH and CN conditions, compared 
with AO culture. This may be related to HIF-1α increases the proliferation of MSCs 
through the enhancement of TWIST expression, which downregulates the E2A-p21 
pathway. Moreover HIF-1α maintain MSCs survival by activating glucose 6-phosphate 
transporter (G6PT) to increase their metabolic flexibility (Yang et al., 2011). 
Iron dependent HMAs (CoCl2 and DFO) reduced MSCs proliferation when compared with 
2-OG (2-oxoglutarate) analogues, which had no effect on MSCs proliferation (section 
4.3.1). This may be related to the iron-dependent mechanism of action of these drugs, 
which reduces many iron-dependent enzymes involved in the critical citric acid cycle 
enzyme aconitase via a translational mechanism involving iron regulatory protein activity, 
thus influencing the citric acid cycle and oxidative phosphorylation (Oexle et al., 1999).  
This study also identified a difference between cell count and MTT activity of the cells 
grown at IH and CN. Such effects may be related to the inhibition of mitochondrial activity 
by HIF-1α stabilisation during changes in oxygen levels. This has been shown to affect the 
production of NAD(P)H which plays an important role in MTT reagent reduction in 
NAD(P)H-dehydrogenase (Natarajan and Becker, 2012). Under IH conditions, expression 
of HIF-1α increased, which is commonly reported in the literature (Semenza, 2007; Kaelin 
et al., 2008; Ježek et al., 2010). HIF-1 upregulates numerous downstream target genes, 
including those whose products phosphorylate and downregulate the activity of the 
pyruvate dehydrogenase complex (PDC) (Kim et al., 2006; Papandreou et al., 2006; 
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Semenza, 2007; Lu et al., 2008). The inhibition of PDC is a key regulator of mitochondrial 
oxidative metabolism depression under IH (Kim et al., 2006; Papandreou et al., 2006; 
Ježek et al., 2010). Interestingly, more variation was noticed after treatment with HMAs 
and this may be related to the different mechanism of action of these agents as those who 
replace or chelate iron could also affect many downstream events such as mitochondrial 
pyruvate dehydrogenase (Borcar et al., 2013). Based on these findings, the use of HMAs 
could not be a viable alternative to engineered control oxygen technique. However, if 
there no other option, drug selection will require stringent quality control assesment to 
thoroughly evaluate cell behaviour. HMA treated cells showed more distinct changes in 
metabolic activity compared with cells cultured under both CN and IH conditions. This may 
have related to the inhibition of mitochondrial activity by HIF-1α stabilisation which showed 
higher elevation at IH during changes in oxygen levels. This will affect the production of 
NAD(P)H, which as stated previously, plays important role in MTT reagent reduction 
(Yuan et al., 2011). 
Following the metabolic profiling of our different treatments, we sought to clarify how the 
differentiation potential of BM-MSCs was affected.  This was assessed using histological 
and immunostaining methods. The results of this study showed that HMAs + AO and CN 
inhibited osteogenesis in BM-hMSCs after 21 days (section 4.3.4) This could be due to 
HIF elevation inhibit the osteogenic differentiation of MSCs by decreasing the expression 
of RUNX2. (Yang et al., 2011). Our result was in agreement with Park et al., (2009) study. 
Our results then showed that both CN and HMAs under all culture conditions (except IH) 
increased adipogenesis. This could be due to upregulation of the signalling from Wnt and 
Rho, shown to be important in the initiation of adipogenic differentiation (Ge et al., 2016). 
Terminal differentiation of preadipocytes is induced by activation of peroxisome 
proliferator-activated receptor‑γ (PPARγ) which is in coordination with CCAAT/enhancer-
binding protein transcription factor, which maintains adipocyte gene expression 
(Cristancho & Lazar, 2011). Finally, we showed an elevation in chondrogenesis after 
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culture in CN even after treatment with HMAs in comparison to control AO. No significant 
effect of HMAs was seen at AO and IH culture condition (except IOX2 at IH). Under CN 
culture condition HMAs had no significant effect on chondrogenesis (except DFO) and this 
disagree with Lee et al., (2015) who have shown hypoxia-enhanced chondrogenesis of 
BM-MSCs occurs via activation of the mitogen-activated protein kinase p38 pathway. 
Many studies have focused on the possible mechanisms involved in HMAs-induced early 
apoptosis in MSCs under AO culture condition (Sermeus & Michiels, 2011; Zeng et al., 
2011; Tang et al., 2014; Ge et al., 2016; Li et al., 2017). HMAs affect an array of 
proapoptotic proteins by activating the dissociation p53/murine double minute 2 (MDM2) 
complex, enabling p53 binding to pro-apoptotic proteins, including PUMA, NOXA, CD95, 
Apaf-1, Bax, Bid and caspases (Green & Kroemer 2009). In addition, p53 has the ability to 
induce autophagy by activation of damage-regulated autophagy modulator (DRAM). In 
agreement with our results, these studies have confirmed that HMAs affect apoptosis, 
possible through a p53-dependent mechanism. In IH and CN cultures, HMAs significant 
reduction in early apoptosis and cellular necrosis. This may be related to survivin 
expression (Semenza, 2010) and downregulation of Bax, Bid and caspases. Moreover, 
p53 induces autophagy by DRAM and upregulation of beclin-1, BNIP-3 and NIX (Mazure 
& Pouysségur, 2010). TEM imaging confirmed apoptosis in hMSCs, which could be 
related phosphatidylinositol `3-kinase PI3K/Akt/mTOR cascade (Zhang et al., 2016; Zhou 
et al., 2011). 
Cell cycle analysis showed that under CN culture condition S phase was reduced and G2-
M phase was elevated with no significant effect on G0/G1 phase and this may have 
related to inactivation of enzymes responsible for nucleotide synthesis, ultimately 
inhibiting DNA replication (Semenza et al., 1994). In contrast HMAs trapped cells in 
G0/G1 phase and this may have related to induces cell cycle arrest that may exert a 
markerbiliy different pattern of regulation at various cell cycle checkpoint genes such as 
ataxia telangiectasia mutated (ATM), ataxia telangiectasia and Rad3 related (ATR), p53, 
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p21, p27 and p21 (Chen et al., 2013) another possible mechanism is modulation of p53 
activity. p53 plays an important role in regulating cell cycle progression at G1 and G2 
checkpoints. Specifically, in response to DNA damage, activation of molecular pathways 
regulated by p53, leads to cell cycle arrest at G0/G1 (Obacz et al., 2013). Furthermore, 
more recently it has been reported that expression of a p53 is involved in cell cycle arrest 
at G2 in response to different cell stress conditions, including endoplasmic reticulum 
stress, unfolded protein response and hypoxia (Obacz et al., 2013). 
Our results suggestes showed that ROS formation significantly increased after CN culture 
and after DMOG treatment in both AO and IH conditions. while in CN culture DFO, DMOG 
and IOX2 reduced ROS formation (Loboda et al., 2009; Chung et al., 2014). 
Controversies was noticed in the studies related to ROS formation in hypoxia, in which 
some studies showed a significant increase in ROS formation (Loboda et al., 2009; Chung 
et al., 2014Bell et al., 2007), while other works showed a decrease in ROS formation 
(Vaux et al., 2001; Agani et al., 2000; Callapina et al., 2005). The elevation in HIF-1α 
expression contributes to ROS formation specifically the mitochondrial ROS (Agani et al., 
2000). However, other studies have demonstrated a CN decrease in HIF-1α with 
increasing ROS and this was in agreement with our results and this may be related to 
induction of superoxide generator which elevate ROS formation, HIF-1 is downregulated, 
as PHD activity is upregulated (Wartenberg et al., 2003; Callapina et al., 2005) and this 
can be representing feed-forward loop, where ROS reduce HIF-1 by upregulation of PHD2 
or by donating oxygen in hypoxic condition. HMAs under AO culture condition significantly 
increase ROS formation and this may be related to the inhibit PHD activity and induce 
mitochondrial changes that lead to produce more H2O2 due to electron leaking from 
respiratory chain (Granger & Kvietys, 2015). 
Under IH condition, iron-dependent HMAs (CoCl2 and DFO) reduced ROS formation and 
this may be related to an iron-dependent mechanism; in contrast to 2-oxoglutarat 
analogue (DMOG and IOX2) which elevated ROS formation. This was disagreeing with 
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Boorn (2010) study. Under CN culture condition, HMAs reduced ROS formation and this 
may be related to the reduction in mitochondrial mass, as these agents increase 
mitochondrial autophagy when it combined with adaptive response to chronic hypoxia. 
This was in agreement with Prabhakar & Semenza (2012) and Schönenberger & Kovacs 
(2015) studies. 
Nitroreductases are a family of flavin-dependent enzymes which facilitate the conversion 
of nitro-groups to amines or hydroxylamines, depending on NAD(P)H as an electron donor 
and as hypoxia upregulate number of genes that results a redox potential shift by switch 
from oxidative phosphorylation to glycolysis with increase in NAD(P)H production 
(Wheaton & Chandel, 2011; Brocato et al., 2014) that cause significantly elevated 
reductive stress, causing upregulation in nitroreductase activity (Krohn et al., 2008; Li et 
al., 2013) and this was in agreement with the results of our study. 
Mitochondrial dynamic analysis showed that IH reduced mitochondrial burden and 
mitochondrial genome copy number in comparison to AO cultured cells and this may be 
related elevation in autophagic activity (Mathew et al., 2013, Chen et al., 2014) and this 
result agreed with Rocheteau et al., (2015). HMAs (except IOX2) under AO culture 
condition, reduced mitochondrial burden but not mitochondrial genome copy number and 
this may be related to production of inactive mitochondria (Bigarella et al., 2014). 
 our result also showed that under AO condition HMAs decreasing mitochondrial 
membrane potential and this associated with increases the ROS production is which is 
commonly reported in the literature (Sena & Chandel, 2012; Cai et al., 2016; Yang et al., 
2015). From all above, IH and HMAs induced morphology changes of mitochondria with 
lower metabolic activity, as determined by lower mitochondrial burden and action potential 
and this agree with results obtained by Simsek et al., (2010). The novel HMA (IOX2) at 
used concentration follow same path of the other HMAs in changing the measured 
parameter. 
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6.2. Conclusions 
The results presented in this thesis demonstrate that continuous normoxia has a positive 
impact on the growth profiles of multipotent stem cells and that attenuation of ROS 
production increases cell proliferation even further. Different avenues were explored to 
test the hypothesis that HMAs mimic oxygen control engineering. HMAs induced both 
HIF-1α and HIF-2α under AO culture even with low doses that were used in this work. 
These agents elevate MSCs proliferation but lower than does with CN. These agents 
change apoptosis, cell cycle patterns and mitochondrial dynamic and morphology. HMAs 
fail to recapture the biology activities that found in IH. Rely on the above evidence, 
application of these agents on cells associated with no additive but many adverse effects 
in comparison to oxygen control culture. In addition, culture of multipotent stem cells with 
2% oxygen IH cause significant damage in comparison to CN and this create an obstacle 
in clinical application of multipotent stem cells in degenerative medicine.   
 
6.3. Future perspectives 
The results of this thesis raised many considerations for the future work as detailed below. 
In order to ensure a successful preconditioning for cultured MSCs. Future study can focus 
on the difference between oxygen cultured cells and these cultured by HMAs in animal 
model to obtained better knowledge of how these cells behave inside live system and 
what are the main difference between the two methods of preconditioning. More work can 
be done on effect of HMAs on inducing MSCs neurogenic differentiation in vitro and in 
vivo model which will help in treatment of many neurological disorder.  Further work also 
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can examine the effects of HMAs on the mitochondria morphology using TEM (which was 
stopped due to limitations in time and finance) with addition of more autophagic markers. 
Moreover, future work can focus on the effects of each preconditioning technique on 
MSCs secretome which is considered new option as immunomodulator in treatment of 
autoimmune diseases. The current experience with hypoxia using oxygen control 
engineering will help in developing unbiased model for obesity and metabolic syndrome 
using cell culture. Moreover, this work gives a base for future work that explain the role of 
HIF pathway activation by iron chelating agents in patient with thalassemia major a 
condition that common in Mediterranean area. 
The preconditioning of MSCs in 2% oxygen CN represents the best method for 
preconditioning in comparison to IH preconditioning which is the method use for 
preconditioning in many centres around the world. 
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